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Abstract
Oligomers composed of unnatural building blocks which preferentially adopt 
defined conformations are known as “foldamers”. This project is concerned with the 
design and synthesis of such foldamers, in the form of p-peptides composed of 
nucleoside (3-amino acids, and the investigation of their structural properties.
Starting from the corresponding natural deoxynucleosides thymidine and 2’- 
deoxyadenosine, the synthesis of the nucleoside p-amino acid monomers was 
designed to include easily accessible 3’-azido-3’-deoxy intermediates and also 
amine and nucleobase protecting groups compatible with solid-phase peptide 
synthesis (SPPS). p-Peptides were produced from the corresponding nucleoside p- 
amino acids utilising SPPS protocols optimised to suit these highly unusual amino 
acids. Homo-oligomers varying in length from 2 to 8 residues were obtained by this 
method as was a single mixed sequence. Examination of peptides derived from 
thymidine by TOCSY, NOSEY and VT NMR together with UV melting studies 
showed the presence of secondary structure in the form of an intramolecular 
hydrogen bonding network. This was assigned as an 8-helix. The furanose sugars 
formed a zigzag motif at the core of the helix with the nitrogenous bases located 
alternately on opposite sides of the scaffold. Unsuccessful deprotection of peptides 
derived from 2’-deoxyadenosine prevented detailed structural analysis of these 
oligomers.
As an extension to peptide synthesis studies with nucleoside p-amino acids, 
initial investigations into the replacement of solid-phase protocols with novel “heavy” 
fluorous-phase chemistry were undertaken. A large, highly fluorinated dendrimer 
was used as a “fluorous support” and reactions, such as removal of protecting 
groups and amino acid coupling were successfully achieved. Products were 
effectively purified without the use of chromatography and characterised by NMR 
without cleavage from the fluorous support. These preliminary results soundly 
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A large proportion of natural processes rely on some form of macromolecule 
with a highly ordered structure that is specially adapted to perform a specific role; 
the two most obvious examples of this are proteins and nucleic acids exemplified by 
deoxyribonucleic acid (DNA). Proteins are assemblies of peptide chains which, in 
turn, are polymers of amino acids formed by condensation of the amine group of 
one amino acid with the carboxylic acid group of its neighbour creating a “peptide 
bond”. DNA, on the other hand, is an assembly of sugars and nitrogenous bases 
called nucleosides held together by phosphate bridges between neighbouring units 
to give polymeric chains, known as polynucleotides. Both peptides and 
oligonucleotides contain a high concentration of potential H-bond donors and 
acceptors and consequently a number of intricate structures result from both intra 
and intermolecular interactions of these hydrogen bonding sites. It is this tendency 
to adopt distinct conformations and attempts to mimic such properties that has 
made the study of both of these types of macromolecules a major area of research 
over the last half a century.
1.1 Primary Structure of DNA
Miescher was the first to physically isolate DNA from white blood cells in 
1869 by adding alkali to cells obtained from bandages sourced from his local 
hospital.1 He was also the first to postulate that this substance that he christened 
“nuclein” was a chemical code for biological information, yet curiously he disagreed 
with Hertwig’s statement that nuclein was “responsible for the transmission of 
hereditary characteristics”.2 In Miescher’s view DNA was too simple a molecule to 
carry genetic information and this had to be the responsibility of more complex 
protein molecules. By 1900 it was known that DNA consisted of a sugar, phosphate 
and four nucleobases; adenine, cytosine, guanine and thymine, (A, C, G, and T).
Levene first showed the order of linkage as phosphate to sugar to base in 
19293, but then went on to suggest that DNA contained equal amounts of each of 
the four nucleobases and hence something with such little diversity was less likely 
to contain any chemical code than the richly diverse amino acid sequences in 
proteins. The advent of X-ray crystallographic techniques in the 1940’s culminated 
in the famous picture of B-form DNA produced by Franklin4 (see fig. 1) which led to 
Watson and Crick’s seminal paper on the double helical structure in 1953.5
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Figure 1: X-ray diffraction pattern of DNA isolated from calf thymus (taken from 
reference 4).
Before considering the conformational properties of a DNA strand it is important to 
examine the structural features of individual nucleotide units which ultimately define 
the helix shape adopted. Nucleotides consist of a furanose sugar; a nitrogenous, 
heterocyclic base and a phosphate ester (see fig. 2).
Figure 2: Chain of 4 nucleotides. In RNA R = OH and T is replaced by U where X = 
H (figure adapted from reference 6).
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The heterocyclic base is attached to the furanose at the anomeric T- position and 
this sugar/base combination is collectively known as a nucleoside. Heterocyclic 
bases are bonded on the same face of the sugar ring as the 5’-hydroxymethyl 
function by the glycosylic bond. This is designated the (3-configuration. Bases are 
either purines (adenine and guanine) or pyrimidines (thymine and cytosine). 
Pyrimidines are connected to the sugar by the N1 atom, purines by the N9 atom. In 
ribonucleic acid (RNA), thymine is replaced by uracil; the difference being the lack 
of the C5 methyl group. Adjacent nucleosides are joined together by the formation 
of a phosphodiester linkage between the a- configured 3’-oxygen of one nucleoside 
and the 5’-oxygen of its neighbour.
In single nucleosides the major, helix defining structural features are the 
position of the base with respect to the sugar, the sugar pucker and the relative 
positions of C4’ and C5’ with respect to the rest of the sugar ring. Bases are 
oriented almost perpendicular to the sugar ring in two main conformations, “anti’ 
and “syn” (see fig. 3), but in the majority of cases nucleosides prefer the anti 
conformation to the syn. The anti conformation is exclusively adopted by 
pyrimidines to keep H6 above the ring and avoid the steric clash of 02 with H3’. 
Adenosine also prefers to be anti as this keeps the bulk of the bicyclic base ring 
away from steric interference with the sugar in favour of the much smaller H8. 
Guanine, however, has been shown to prefer syn conformations in certain 
circumstances where there is favourable hydrogen bonding between the exocyclic 
amine and 5’-0-phosphate in oligonucleotides.6 In these cases, syn becomes 
energetically favourable and this results in some unusual structures in G rich 
oligonucleotides.
O O
Figure 3: Favoured anti (left) and disfavoured syn (right) conformations in thymidine.
Sugar pucker is a description of the displacement of C2’ or C3’ out of the 
C1’-04-C4’ plane of the ring and is the major channel by which the non-bonding
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interactions of the ring are minimised so as to reduce the overall energy of the sugar. 
Displacement of either the C2’ or C3’ carbons towards the same face as the 
heterocyclic base is referred to as “endo”, whereas movement towards the lower 
face is designated “exo" (see fig. 4). The nomenclature “north” and “south” is used 
for C3-endo and C2’-endo respectively as these are the positions of these preferred 
conformations in the pseudorotation cycle. “N” and “S” are also conveniently the 
approximate shapes of the C1’-C2’-C3’-C4’ bonds (see fig 4) and the configurations 
are shown to be in rapid equilibrium in solution due to the low energy barrier of 20 
kJmol'1 between them.
Figure 4: C3'-Endo (“North”, left) and C2’-endo (“South”, right) sugar puckers.
The average or preferred conformation is determined by the orientation of the base 
and also electronic effects within the ring itself. DNA generally prefers the S-type 
pucker7 but whilst up to 95 % of purines are found in this conformation, pyrimidines, 
especially cytidine, can adopt N-type puckers with a frequency of up to 40 %.8
1.2 DNA and RNA Helices
The structure proposed by Watson and Crick for B-form DNA is a right- 
handed double helix composed of two strands of DNA running anti-parallel to each 
other and held together by hydrogen bonding between nucleobases on opposite 
strands. Hydrogen bonds between only specific pairs of bases, adenine and 
thymine and cytosine and guanine, accounted for the observation of Chargaff that 
DNA contained approximately equal amounts of the four nucleobases9 (see fig. 5). 
Adenine and thymine anneal together with two hydrogen bonds and cytosine and 
guanine have an extra hydrogen bond and are, therefore, more strongly bound than 
A-T pairs.10 tt- tt stacking of the heterocyclic bases within the helix structure is also 
a major stabilising influence.10
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Figure 5: Watson-Crick hydrogen bonding between A-T (left) and C-G (right).
Oligonucleotide helices exist in several forms and have structural features 
common to all forms of helix (see fig. 6). There are two “grooves” running down the 
helical axis at 180 ° to each other, one large, the major groove, and one smaller, the 
minor groove. The difference arises due to the bonds from sugar to base not being 






Figure 6: Representation of a DNA double helix (taken from reference 11).
There are three main classes of double helix, A, B and Z (see fig. 7) and numerous 
polymorphic substructures which are broadly related have also been observed. The 
right-handed helix of A-form DNA has anti-parallel strands running from 03 ’ -  P -  
0 5 ’ with the bases displaced 4.5 A from the helical axis. This results in a hollow
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core which is 3 A in diameter. The mean length, or pitch, of an A-type helix 
measures 24.6 A and has 11 base pairs per turn with a rotation of 32.7 ° per base 
pair around the axis. The major groove measures 2.7 A in width but this slim 
opening is far deeper than the B-form at 13.5 A12 and its sugar pucker is 
predominantly C3’-endo. The slim but deep major groove naturally produces a 
complimentary wide but shallow minor groove, at 11.0 A wide but only 2.8 A deep. 
A-type helices are also slightly wider than B helices at 26 A across.
In contrast with the A-form, B-form DNA has a wide major groove, 11.7 A, 
and a narrow minor groove, 5.7 A, both of comparable depth, 8.8 A and 7.5 A  
respectively, and is also a right-handed helix. A full turn of the helix contains 10 
base pairs and results in a turn of 36 ° around the helix axis for every base pair.13 
The furanose sugar has a predominantly C2’-endo pucker and full turn of a B-form 
helix has a pitch of 33.2 A; longer than A-form but shorter than the elongated Z-form, 
and the diameter of the structure measures 20 A across.
Figure 7: Comparison of A-form (left), B-form (centre) and Z-form (right) helices 
(taken from reference 14).
Z-Form DNA helices have a much more unusual shape than A- or B-form 
helices and are regarded as a transient features occasionally induced by biological
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activity rather than a permanent structure.15 Although more rare than the other 
forms of DNA, it was actually the first of the main forms to have its structure solved 
by x-ray crystallography; by Rich and co-workers in 1979.16 They found a rather 
more inelegant structure than the A- or B-form. This time, the helix was left-handed, 
long and thin, but retained the anti-parallel arrangement of strands. Two nucleotides 
formed the repeat unit giving the Z-form a zigzag conformation with a pitch of 45.6 A 
and 12 base pairs forming a single helix turn. Further studies of single crystals of 
small d(CGCG) sequences have also found this helix conformation.17 The 
conformational switch occurs as a result of a change in glycosylic torsion angle from 
anti to syn of one purine of a base pair. For a Z-form helix, every other base must 
maintain this syn-conformation and hence Z-helices are found in regions with 
alternating purine-pyrimidine sequences, particularly d(C-G)18 as the pyrimidines 
preferentially adopt the anti-conformation due to steric factors, leaving the purine to 
switch to syn. Sugar pucker is, therefore, correspondingly C3’-endo at purine and 
C2’-endo at pyrimidine.
Of the three main forms of DNA discussed, the B-form is the most common 
seen under normal cellular conditions,19 followed by A then Z is found in more 
specialised cases. The A-type helix is less common than its B-DNA counterpart and 
is found in RNA duplexes,20 helices containing DNA/RNA hybrids21 and also in 
DNA/enzyme complexes.22 It is not known what the true function of Z-DNA is in the 
cellular environment, but it is thought that it may be involved in regulation of gene 
transcription23 and several Z-DNA binding proteins have also been identified 
including nuclear-RNA-editing enzyme ADAR1 and the EL3 protein, responsible for 
the pathogenicity of vaccinia virus.15
1.3 Higher Order DNA Structures
Not long after the popularisation of the double helix structure, a number of 
other structures involving multiple strands of DNA were beginning to emerge. An 
important feature of structures comprised of multiple strands of DNA is another form 
of inter-strand hydrogen bonding known as Hoogsteen base pairing.24 In Watson- 
Crick base pairs thymine and adenine associate by hydrogen bonding between the 
thymine N3-H and adenine N3 as well as the thymine C4 carbonyl and adenine N6 
amino group. However, in Hoogsteen pairs the thymine N3-H switches hydrogen 
bonding partner to adenine N7 (see fig. 8). This is a major structural feature of many 
of the more complex DNA structures as it allows unusual modes of binding, for 
instance, that of an additional single strand to duplex DNA in the major groove.
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Figure 8: Comparison of Hoogsteen (left) and Watson-Crick (right) A-T base pairs.
This arrangement is adopted by the closest related structure to the classical 
DNA duplex, the triplex. Here, an additional strand of DNA anneals to a duplex in 
either parallel, in the case of homopyrimidine strands, or anti-parallel, for 
homopurine strands, fashion.25 Other, more specialised DNA substructures include 
the Holliday Junction, G-quadruplex and the /-motif. The Holliday junction (see fig 
9.) was proposed in order to account for the anomaly in genetic recombination that 
allowed genes on the same chromosome to segregate from each other to produce 
gametes with differing ratios of the parent gene.26 The crossing strands can be 
arranged in either an open planar or anti-parallel conformation27 and this depends 
on the presence or absence of Mg2+ ions.
Figure 9: Electron microscope image of a Holliday junction (taken from reference 
2 9 f8.
G-quadruplexes, or G-tetraplexes, are formed in G rich sequences of DNA and are 
assemblies of G-tetrads; square-like formations of four guanine bases stabilised by 
Hoogsteen hydrogen bonding and also by the presence of monovalent metal ions,
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especially potassium,29 co-ordinating between the plane of stacked tetrads (see fig. 
10).
Figure 10: Structure of a G-tetrad and some folding topologies of G-quadruplexes 
(adapted from reference 31).
The G rich sequences can come from four different strands, two strands or 
even be different sections of the same single strand (see fig. 10) but all have 
different topologies depending on their constitution.30 G-quadruplexes are found in 
various places in the human and other genomes and Balasubramanian et al. have 
recently suggested that up to 376,000 sequences within the human genome have 
the potential to form such structures.31 Of particular interest are G-quadruplexes 
which are found at the end of eukaryotic chromosomes, termed telomeres.32 Here 
the extreme 3’- end of the telomeric sequence is single stranded, between 100 -
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200 nucleotides in length and G-quadruplex formation in human telomeres has been 
shown to inhibit the activity of the telomerase enzyme33 which has been implicated 
in up to 85 % of cancers.34
The most unusual higher order DNA structure is the /-motif. Formed in 
cytidine rich strands complementary to the G-rich strands found in telomeric 
sequences, two parallel duplexes intercalate and the assembly is held together by 
hemi-protonated C-C+ base pairs35 (see fig 11).
Figure 11: Representation of an i-motif (taken from reference 36).
The stability of the i-motif is thus pH dependent; it is most stable at or near the pKa 
of cytosine but is less stable at neutral pH.36 The two interacting duplexes run 
antiparallel to each other and, as with the G-quadruplex, the four strands of the 
duplex can be sourced from four single strands,35 two hairpins37 or a single strand 
with multiple C-rich sequences.38 The biological function of the i-motif is not fully 
understood, however, several proteins that specifically bind telomeric C-rich 
sequences have recently been identified.39
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1.4 Secondary Structure in a-Peptides
The twenty common, genetically coded amino acids observed in nature are 
known as a-amino acids, that is, the carboxylic acid functionality is attached to the 
same carbon as the amino moiety (see fig. 12). As carboxylic acids and amine 
groups have a high propensity for hydrogen bonding, when combined with other a- 
amino acids to give peptides, these peptide chains will fold up to give distinct, 
complex secondary structures, such as a-helices and (3-sheets.
Figure 12: An a-amino acid.
Secondary structure in peptides was first proposed by Astbury in 1931 when 
he observed significant differences in the x-ray fibre diffraction patterns of stretched 
and non-stretched natural fibres such as wool.40 He suggested that there were two 
forms of protein molecules, a- and 3-, a- Was the form present in the unstretched 
fibre and was a coiled helix conformation; 3- was produced when stretching the fibre, 
causing the helix to uncoil. Although inaccurate, his models were extraordinarily 
close to being correct and formed the basis of the later work by Pauling and co­
workers in which the key to secondary structure, the planar peptide bond, was 
postulated.41 Astbury’s nomenclature was retained and in a later paper to appear in 
1933 he also tentatively identified structures in keratins which are today called 3- 
sheets.42
It was predicted by Pauling that the six atoms involved in the peptide 
structure must be in a single plane to support the resonance forms of the whole unit 
(see fig. 13). This, in turn, constrained the conformation of the entire peptide chain 
which defined limited sites for intramolecular hydrogen bonding to occur. In 
collaboration with Corey he proposed that in an a-helix the amino acids were 
arranged with a rise of 5.4 A with 3.7 residues per turn and hydrogen bond lengths 
of 2.72 A .43 He also proposed that the other major structure that was possible, given 
the constraints of the planar amide structure, was a helix with 5.1 residues per turn 




Figure 13: Pauling’s planar amide structure (adapted from reference 42).
Pauling’s a-helix model was, however, not entirely correct. The helix was 
depicted as left-handed with all the amino acids in the D-form, the opposite 
enantiomer of the natural L-form. We now know the reverse of this to be true. Today 
the accepted dimensions for an a-helix are a pitch of 5.4 A with 3.6 residues per 
turn and n, n + 4 hydrogen bonding, that is, the hydrogen bonding occurs between 
carbonyl groups and amide protons separated by four residues in the direction of 
the C-terminus (see fig. 14). It is thought that around 31 % of all amino acids with 
secondary structure are in the a-helix form.44 Variations of a-helices that have been 
observed include the 310 helix which accounts for approximately 4 % of amino acid 
structures. This is a tighter helix where there are 3.2 residues per turn and hydrogen 
bonding is reduced to n, n + 3 forming a 10-membered hydrogen-bonded ring.45 The 
tt helix, where hydrogen bonding increases to n, n + 5, is considered rare and 
unstable.44
Figure 14: Hydrogen bonding patterns in a-peptides.
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There is much debate over the basis of the stability of a-helices in aqueous 
solution and it has been suggested that there are up to 10 major empirical effects 
that affect this property, including pH dependent formation of salt bridges between 
side chains, charge stabilisation of the dipole and interaction with metal ions.46 The 
role of the solvent is also vitally important when considering the folding propensities 
of peptide sequences. Before the advent of peptide design it was rare to find short 
and stable a-helices with aqueous solubility outside of the protein environment,47 as 
it is easy for polar solvents such as water to destructively interfere with 
intramolecular hydrogen bonding. However, even with advances in molecular 
modelling techniques and production and study of many de novo designed peptides 
and peptidomimetics,48 the complex relationship between all of the factors involved 
in a-helix folding is still not fully understood.
The biological role of the lesser observed classes of helices are the subject 
of some speculation; one theory is that the 310 helix is an intermediate in the folding 
pathway of a conventional a-helix,49 but it is the a-helix itself that is the most well 
understood. Properties of the a-helix can be split into two distinct groups, those 
derived from the conformational characteristics and those which relate to the 
electronic features such as dipole. The dipole of an a-helix is derived from the 
almost linear orientation of the C=0 and N-H bonds along the axis of the helix by 
hydrogen bonding, resulting in alignment of 97 % of the individual amino acid 
dipoles towards the /V-terminus.50 It is thought that this charge differential plays a 
key role in processes such as ion transport and crystal packing51 and that as many 
as 1 in 4 enzymes have a helix dipole influencing the active site.52 Phosphate 
binding proteins utilise positively charged side chains at the N-terminus to bind 
biologically important compounds such as adenosine triphosphate, nicotinamide 
adenine dinucleotide, DNA and RNA,53 however, some other DNA and RNA binding 
proteins rely instead on specialised structures for this purpose, rather than 
electrostatics. Several conformations have been identified in numerous proteins that 
appear to be specially adapted to recognise DNA,54 most notably the helix-turn-helix 
motif that possesses a helix diameter exactly matched to the width of the major 
groove in B-form DNA.55
In the same journal issue as their a-helix paper, Pauling and co-workers also 
published the first work on pleated 3-sheets. These, they observed, were extended 
networks of hydrogen bonded peptide chains, but this time the hydrogen bonds 
were intermolecular, rather than intramolecular, causing a sheet-like array of chains 
running either parallel or anti-parallel to each other.56 3-Sheets are made up of 3-
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strands, which are roughly the equivalent of a helix with two residues per turn. The 
pleated nature of (3-sheets is derived from the sp3 bond angle of the side-chain 
bearing carbon causing neighbouring carbon atoms to be alternately above and 
below the plane of the sheet. It is thought that these type of structures contain 
between 20 -  28 % of all residues contained within globular proteins.57
The (3-sheets known today have those two classes, parallel and anti­
parallel58 (see fig 15). Anti-parallel sheets are thought to be more stable than 
parallel as parallel are usually found in the hydrophobic core of proteins and are 
less common.59 Anti-parallel 3-sheets can be made up of as few as two strands and 
generally each strand contains six amino acid residues with a repeat dipeptide 
distance of approximately 7 A. They are slightly less pleated than their parallel 
counterparts as the chains are marginally more extended. The inter-strand 
hydrogen bonding pattern found in anti-parallel sheets consists of alternating 10- 
and 14-membered H-bond rings and the peptide dipoles running in an anti-parallel 
fashion cancel each other. Parallel sheets contain five or more strands and are 
slightly more uniform, with a consistent 12-membered H-bond ring structure, 6.5 A  
repeat unit and an overall dipole running towards the N-terminus of the chains.60 
Inter-chain distance in 3-sheets is approximately 5 A and H-bonds are 0.1 A shorter 
than those of an a-helix. The H-bonds are also more linear by 3 -  4 °; the average N 
-  H -  O bond angle is 160 ° in antiparallel sheets, 161 ° in parallel sheets and 157 0 
in an a-helix.61 3-sheets have a lower potential energy than a-helices, however, a- 
helices can be considered to have an entropic advantage due to the intramolecular 
nature of the H-bonds.62
Figure 15: Parallel (left) and anti-parallel (right) /3-sheet hydrogen bonding.
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Alongside their structural function, one of the most important properties of 3- 
sheets is their amphiphilic nature. Side chains are alternately arranged on opposite 
faces of a 3-sheet due to the trans nature of the peptide bond. Thus, sheets 
containing alternating hydrophobic and hydrophilic residues present these side 
chains on opposite sides of the sheet, giving faces with either hydrophobic or 
hydrophilic preferences (see fig. 16).63
© ©
Figure 16: Representation of an amphiphilic (3-sheet at physiological pH.
The result is that 3-sheets are often found at the surfaces of proteins to act as an 
interface between aqueous and lipid-rich environments; a notable example of which 
is porins.64 Porins are also known as “beta barrel” proteins as they are constructed 
from a large 3-sheet that forms a cylindrical tube somewhat reminiscent of a barrel. 
These structures are often found as membrane proteins that can control the flow of 
small molecules across a cell, chloroplast or mitochondrial membrane.65
With natural systems providing such a richness of intricate and functional 
secondary scaffolds it is not surprising that much effort has been invested into 
attempting to mimic the properties of both peptides and oligonucleotides. An 
enormous array of peptide and nucleotide mimetics can be found in the literature 
and those that are found to adopt secondary structure have been termed 
“foldamers”.66'67
1.5 Secondary Structure in 3-Peptides
3-Peptides are amongst the most intensively studied of the foldamer family 
because of their close relation to natural a-peptides. 3-Peptides are sequences of 3- 
amino acids; these have an additional carbon atom between the amine and carboxyl
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groups compared to their a-counterparts (see fig. 17). The only common, naturally 
occurring (3-amino acid is (3-alanine which is found in mammals as a degradation 
product of uracil68 and also as a component of the dipeptide carnosine.69
Figure 17: a-Alanine (left) and (3-alanine (right).
The most attractive aspect of (3-peptides, when considering possible therapeutic 
applications of peptidomimetics, is stability towards cellular enzymes, in particular, 
peptidases.70 Most peptidases only recognise a-peptides and thus (3-peptides have 
good resistance both in vitro and in vivo.71 It has recently been shown that 
substituting even a single a-amino acid with a p-residue in a model peptide antigen 
confers this type of stability without the loss of activity.72
Secondary structure was first identified in |3-peptides as early as 1965 by 
Kovacs and co-workers who suggested poly-(33-/_-aspartic acid adopted a 14-helix.73 
The term 14-helix refers to the number of atoms in the hydrogen-bonded ring of a 
helix (see fig. 18). Some doubt over the interpretation of the experimental data led 
to confusion over the exact conformation and this also affected the findings of Yuki 
and co-workers, who eventually assigned the structure of nylon-3 derivative poly-p- 
(a-isobutyl-L-aspartate) as a p-sheet like formation instead of a helix74 although their 
original theory of a helix was later shown to be true.75 The strong preference of p- 
peptides for formation of helical structures was demonstrated by examination of 
nearest neighbour interactions in derivatives of p-alanine and y-butyric acid by FT- 
IR. One of the reasons for folding occurring in a-peptides is the predominance of 
hydrogen bonding between donors and acceptors that are not adjacent, over 
interactions of residues with their nearest neighbours.76
O
O
O O O O O
Figure 18: Hydrogen bonding patterns in (3-peptides.
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Gellman asserted that the lack of nearest neighbour connections between 
sequential H-bond donors and acceptors in (3-alanine derivatives indicated that 
long-range conformational order would be preferred over local, short range 
hydrogen bonding as H-bonds are stronger when the N-H-O bond angle is closer to 
180 °.77 In essence, this meant (3-peptides should favour the formation of hydrogen- 
bonded rings containing 10 or more atoms over those with just 6 or 8 atoms (see fig. 
19). y-Butyric acid derivatives, on the other hand, did show evidence of hydrogen 
bonding between nearest neighbour donors and acceptors and, therefore, these 
interactions were thought likely to predominate over any form of higher order folding.
Figure 19: Disfavoured 6 and 8 atom nearest neighbour H-bonds.
Pleated sheets, turns, helices and other structural motifs have all since been 
observed in (3-peptides.78 The most significant difference between a- and |3-derived 
oligomers is the variety of different substructures assumed by (3-peptides within 
these classes and their relative stabilities compared to the corresponding a- 
analogues. Taking the example of helices, the a-helix is the dominant form of helix 
in a-peptides; however, depending on their constitution, (3-peptides have been 
observed to form helices based on hydrogen-bonded rings containing between 8 to 
14 atoms66 and remarkably these helices have been shown to be significantly more 
stable than their a-analogues.79,80 A possible contributing factor to this increase in 
stability is a hydrophobic effect, where organic side chains of the amino acids shield 
the hydrogen-bonded core from solvent interactions thus preventing the break-up of 
H-bonds by polar solvents.80 To some extent this effect should also be present in a- 
peptides81 and this alone, therefore, is not adequate to explain the increased 
stability.
As a result of the extra methylene group there are two possible substitution 
patterns of (3-amino acids; p2 and (33. p2 refers to those amino acids with the side 
chain on the carbon adjacent to the carbonyl whereas p3 have the side chain 
attached to the same carbon as the amine (see fig 20).
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Figure 20: ft2- (left) and (33- (right) substituted /3-amino acids.
Folded p-peptide conformations require a gauche conformation at the C2 -  
C3 bond around torsion angle (0) (see fig. 21). A significant contribution to helix 
stability is made by the preference of p-amino acids for such conformations, thought 
to be derived from an intra-residue electrostatic interaction between partial charges 
of the amide nitrogen and carbonyl.82 The result is a favourable steric arrangement 
in which the R’ group is oriented away from the extended chain.
Figure 21: Intra-residue electrostatic interaction in (3-peptides.
The more highly substituted the amino acid, the larger its preference for adopting 
the gauche conformation, except in the case of syn-p2-p3-disubstituted residues 
which favour a trans conformation.78
p-Peptides containing proteinogenic side chains such as lysine, valine, 
leucine and alanine show preferences for the type of secondary structure adopted 
by the oligomer. This is defined by the backbone substitution pattern and 
stereochemical composition.83 A peptide consisting of six or more homochiral p2or 
P3 residues will adopt a 14-helical conformation, one containing (S)-p2/p3 or 
geminally disubstituted p2,2 amino acids will prefer 10-membered hydrogen-bonded 
rings and sections with {R)-p2 and (S)-p3 units form pleated sheets.84
At approximately the same time, both Gellman and Seebach produced very 
different short oligomeric p-peptides which displayed remarkably similar helical 
conformations. Seebach and co-workers produced acyclic hexapeptide (H-p-HVal- 
P-HAIa-p-HLeu)2-OH and tripeptide Boc-p-HVal-p-HAIa-p-HLeu-OMe from the 
parent a-amino acids by an elegant Arndt-Eistert/fragment coupling approach.85 The
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tripeptide was shown by X-ray crystallography to adopt a (3-sheet like conformation 
in the solid state; the hexapeptide, on the other hand, showed markedly different 
behaviour. The circular dichroism spectrum of the hexapeptide showed similarities 
with a-peptides that were known to have (3-sheet conformations. However, the fact 
that this spectrum was independent of concentration or solvent suggested an intra 
rather than intermolecular hydrogen bonding network. COSY and nOe NMR 
experiments finally revealed the hexapeptide to adopt a 14-helical arrangement of 
residues in c/5-pyridine.
Figure 22: Comparison of an a-peptide a-helix (left) and a [3-peptide 14-helix (right) 
(taken from reference 79).
This was considered a somewhat surprising result given that the accepted minimum 
number of a-residues required to form a secondary structure is approximately 15.86 
It was also thought that the extra flexibility imparted by the additional methylene 
group in a (3-amino acid would mean that even more than 15 p-residues would be 
required to achieve the same effect; a theory supported by the finding that poly-p-L- 
alanine was known to be unordered in solution.87 In contrast to the a-helix, the 14- 
helix hydrogen bonding pattern is n, n + 2 with the dipole running in the opposite 
direction towards the C-terminus. As a result there are 3 residues per helix turn83 
and, unlike the a-helix where the amino acids side chains are approximately evenly 
distributed around the helical core, the side chains of every third residue in a 14- 
helix reside almost on top of each other (see fig. 22).
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Gellman et al. also shared the view that longer oligomers would be required 
in order to generate folding tendencies in the more flexible [3-peptides. This is 
reflected in their use of carbocycles in an attempt to constrain the number of 
degrees of freedom and induce structure in shorter chains. By modelling helices 
based on (3-alanine, Gellman and co-workers suggested that incorporating the a- 
and p- carbons of p-alanine into a cyclohexane ring would produce a potentially 
stable helix by restricting the C2 -  C3 bond to a gauche configuration. This 
hypothesis proved to be correct when, upon oligomerisation of trans-2- 
aminocyclohexanecarboxylic acid (frans-ACHC, see fig. 23), a stable 14-helix was 
observed in methanol solution by both NMR and isotope exchange experiments, in 
peptides as short as 6 residues.88
Figure 23: trans-(ACHC) (far left), trans-(ACPC) (centre left), APC (centre right) and 
AP (far right) f3-amino acids.
By reducing the size of the carbocycle from cyclohexane to cyclopentane a 
similar propensity for helix formation was found in trans- 2- 
aminocyclopentanecarboxylic acid (frans-ACPC, see fig. 23). In this instance a 12- 
helix with n, n + 3 hydrogen bonding, 2.5 residues per turn and the same polarity as 
an a-helix was observed in equally short oligomers in c/5-pyridine solution89 and this 
illustrated the extraordinary degree to which p-peptide secondary structure could be 
controlled by minor changes to the backbone. ACPC oligomers also highlighted a 
major drawback suffered by many p-peptide compounds; poor aqueous solubility.90 
In an attempt to circumvent the problems posed by insufficient solubility, inclusion of 
P-amino acids such as p-lysine and p-glutamate suggested that, unlike their a- 
counterparts, both oligomers containing cyclic and acyclic residues could retain 
helical conformations in the presence of water.90,91 Another method for increasing 
the aqueous solubility was to substitute the carbocycle of trans-(ACPC) with a 
heterocyclic pyrrolidine analogue. Both f/-ans-aminopyrrolidine-4-carboxylic acid 
(APC) and (2f?,3f?)-aminoproline (AP) (see fig.23) have been incorporated into p- 
peptides and confer water solubility whilst retaining the propensity for helix 
formation.92
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Since the initial identification of helical tendencies in 3-peptides, countless 
examples of different scaffolds consisting of a wide variety of 3-annino acids have 
been produced. Extending the cyclic theme of Gellman, both Fleet et al. and 
Seebach and co-workers observed helical conformations in compounds containing 
4- and 3-membered rings respectively (see fig. 24). Oligomers of cis-oxetane 
derived amino acids (see fig. 24) displayed a left-handed, 10-helix when analysed 
by NMR in deuterated chloroform or benzene.93 10-membered hydrogen-bonded 
rings were estimated to be the limit for stable structure formation in p-peptides as 
nearest neighbour hydrogen bonding interactions were considered unfavourable.77 
This made the emergence of 8-helices an unexpected discovery.
OR
Figure 24: Oxetane (left) and cyclopropane (right) derived (3-amino acids.
Peptide chains containing a cyclopropane motif (see fig. 24) were shown to 
adopt a “ribbon-like” arrangement of 8-membered hydrogen-bonded rings.94 
Although it was a deviation from the strategy of constraining the C2 -  C3 bond to 
gauche, the amino acid being essentially (32,2 disubstituted, the limitation in this 
instance was the preference of the 0= 0  -  cyclopropane bond for the s-cis 
conformation. It is interesting to note that the peptides adopted a 10-helical shape 
when the cyclopropane ring was replaced with a cyclohexane. 8-Helices have since 
been characterised in numerous oligomers, each appearing to demonstrate that the 
key to smaller hydrogen-bonded ring sizes is a steric or electronic demand 
favouring nearest neighbour over longer range interactions.95,96 Homo-oligomers 
almost always produce regular, easily classified structures with a single identifying 
repeating hydrogen bonding unit. However, mixed sequence oligomers with unlike 
residues often produce unexpected and unconventional results.
“Mixed helices” are frequently obtained when amino acids with unlike 
substitution patterns are included in the same oligomer; Characteristic of this class 
of compounds is the deviation from regular 14- and 12-helices towards structures 
with alternating and, in some cases, co-existing hydrogen-bonded rings. The most 
well known example of this is the 12/10/12 helix97 and this was discovered during
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the study of a series of p-peptides derived from (3-alanine. These peptides 
possessed leucine and valine-like side chains in an alternating (32 and ^substitution 
pattern. Rather than being intrinsically favoured, molecular mechanics calculations 
showed formation of this atypical helix resulted from steric interactions of aliphatic 
side chains de-stabilising conventional helices in favour of the 12/10/12 pattern.98
Whilst the mixed 12/10/12-helix was constructed with exclusively (3-amino 
acids, other more recent examples of mixed helices have featured combinations of 
a/(3 amino acids as well as a variety of non-peptidic residues.99 Similarly remarkable 
structures have been characterised within these peptides. Oligomers made up of 
frans-ACPC and a-amino/sobutyric acid were shown to adopt either an 11- or mixed 
14/15-helix by crystallography and the exact conformation adopted was highly 
sequence dependent.99,100 Mixed 11/9-helices were characterised by Srinivasulu 
and co-workers in peptides consisting of alternating a-D-phenylalanine and p-H- 
valine by NMR. Baldauf et al have shown by a series of ab initio calculations that 
the intrinsic flexibility of y-amino acids may afford easy access to 12/10-, 18/20-, 
11/13-, and 20/22-helices.101
Figure 25: cis-fi-furanoid sugar amino acid (left) and representations of mixed 11-, 
14-, and 15-helices (right, taken from reference 103).
These calculations were borne out when Sharma and co-workers identified 
the first example of a 12/10-helix without p-amino acids in a peptide containing L- 
alanine residues sequenced with y-amino acids derived from D-mannose.102 An 
11/13-helix was also identified in oligomers of D-xylose derived p- and y-residues 
and these compounds reflect the increasing use of sugars in peptide chemistry. 
Possibly the most unusual example of a mixed helix is also found in peptides 
containing carbohydrate derived amino acid residues. Jagadeesh et al produced 
peptides with alternating c/'s-p-furanoid sugar amino acid and L-alanine residues 
and found coexisting 11-, 14- and 15-helices by NMR (see fig. 25).103
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When considered as a whole, all of these results demonstrate that 3- 
peptides have the potential to be tuned to adopt specific shapes, possibly for 
specific applications, by altering their constitution. Currently, 3-peptides have a wide 
variety of applications including peptidomimetics104 and nanomaterials.105 
Significantly, 3-peptides, such as those shown in figure 26, have also demonstrated 
anti-microbial activity against both Gram positive and negative organisms.106
33HPhe - 32HVal - 33HPhe - 32HVal - 33HLys - 32HVal - 33HLys - 32HVal - 33HPhe 
Figure 26: (3-peptides with anti-microbial activity.
It is thought that the mode of action involves disruption of membrane viability by 
binding to the membrane and forming amphiphilic helices which facilitate diffusion 
across the cell boundary. Activity against Staphylococcus aureus, Enterococcus 
faecium, Escherichia coli and other bacteria has been observed, importantly at 
much lower concentrations than is required for haemolysis of mammalian cells.
1.6 Higher Order Structure in 3-Peptides
A major goal of the study of synthetic peptides is to enable the construction 
of artificial proteins. Recently, several groups have taken significant steps towards 
demonstrating that “3-proteins” are a realistically attainable target and have 
produced ordered assemblies of 3-peptide helices resembling naturally occurring a- 
helix bundles, as well as semi-synthetic enzymes containing 3-peptide components. 
Arnold and co-workers replaced Asn113 and Pro114 in ribonuclease A with an di- 
nipecotic acid unit resulting in a gain in conformational stability whilst enzymatic 
activity was fully retained.107 Gellman and co-workers have identified helix bundle 
structures in oligomers containing alternating a- and 3-amino acid residues108 whilst 
Schepartz et at. observed an octameric bundle of parallel 12-residue 3-peptide 
helices containing exclusively 33-residues. This bundle displayed similar properties 
to an a-helix bundle, such as a hydrophobic core.109 This structure, however, was 
only observed at high concentrations of the 3-peptide as the helices were relatively
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poor at self-recognition. A more stable analogous structure was produced when the 
12-residue peptide was bound together by 4 (3-homoalanine residues into a 28- 
residue anti-parallel helical dimer which then associated into a tetrameric bundle­
like arrangement.110
These examples clearly demonstrate the potential for mimics of natural 
biopolymers to possess extremely desirable properties. By further functionalisation 
and modification of peptide analogues, enormous volumes of novel compounds are 
now under development and more useful properties and specialised applications 
are being both sought and discovered.
1.7 (3-Peptides with Nucleobase Modifications
Another method of introducing ordered structure to peptide analogues is to 
utilise the predictable associative properties of nucleobases in order to bind 
structural units together. Peptides modified to contain nucleobases as side chains 
are the oldest class of peptide/oligonucleotide hybrid compounds; the synthesis of 
nucleobase derived alanine dates back to 1969.111 Although much of the work 
regarding peptide backbones with nucleobase moieties is now focussed on the 
oligonucleotide binding peptide nucleic acid (PNA, see section 1.8), there are 
several examples of true polypeptides functionalised with nucleobases.
Figure 27: Triplex forming tetrapeptide.
Many of these oligomers have proved unsuccessful at binding to 
complementary oligonucleotides, but not surprisingly the most successful 
oligonucleotide mimics are those which closely match the physical dimensions of an 
oligonucleotide. Yamazaki and co-workers reported triplex formation by a series of
O R O R
R = H, CH2OH, CH(OH)CH3 or CH2C6H5OH
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tetrapeptides consisting of glycine, serine, threonine and tyrosine residues 
alternately sequenced with an L-a-amino acid unit functionalised with adenine (see 
fig. 27). The spacing between the pair of heterocyclic bases was approximately 
equal to that found in oligonucleotides and, even though this was a particularly short 
peptide, the binding affinity for both poly d(T) and poly d(U) sequences was 
significantly higher than that of a natural d(A) dinucleotide.112 This was thought to be 
due to lack of electrostatic repulsion between the neutral polypeptide and anionic 
oligonucleotide.
As it became more apparent that conformational restriction of the backbone 
was an important factor in improving the stability of secondary structure in (3- 
peptides, interest in a-peptide hybrids naturally shifted to more rigid amino acids. 
The 5-membered ring motif, which had so successfully provided a platform for the 
formation of secondary structure in (3-peptides, was introduced in the form of 
proline113 and oligomers containing hybrid proline/nucleobase monomers were 
eventually to evolve into pyrrolidine-type PNA (see section 1.8). However, (3- 
peptides containing nucleobases which were not designed to recognise 
oligonucleotides are increasingly being used as tools for assembly of complex 
structures.
The predictability of both association of nucleobases and the helicity of 13- 
peptides is a powerful combination for the de novo design of molecular scaffolds. 
14-helices in (33-peptides are arranged with 3 residues per helix turn and 
Diederichsen et at. demonstrated that placing a nucleobase side chain in an n, n + 3 
pattern resulted in one side of the helix being exclusively occupied by the bases114 
(see fig. 28). The strands were water solubilised by the inclusion of lysine residues. 
Antiparallel duplex formation via Watson-Crick base pairing was then observed for 
strands containing 4 homologous bases between A-T, T-T, C-C+, T-C and T-G pairs 
as determined by UV melting experiments.115 The lack of specific interactions 
between homo-G and homo-C strands was a surprising result given that a self- 
recognising GCGC sequences had C-G pairs with the highest melting temperature 
(Tm = 80 °C) of any of the base pairs tested so far.116 Two conclusions can, 
therefore, be drawn from these results. Firstly, nucleobase association is a useful 
tool in the construction of higher architectures from helical [3-peptides and secondly, 
the molecular design is yet to reach an optimal level as aggregation is still prevalent 
in some sequences where Watson-Crick pairing is also possible.
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Base = A, T, C, G
Figure 28: Nucleobase functionalised (3-peptide (top) and a representation of 
duplex formation (bottom, taken from reference 116).
1.8 Peptide Nucleic Acids
The study of peptides functionalised with nucleobases has led to the 
discovery of a remarkable class of oligonucleotide analogues known as peptide 
nucleic acids (PNA). Peptides bearing a nucleobase side chain can be regarded as 
the chemical ancestors of PNA; indeed some PNA strands are still produced with (3- 
peptide residues,117 however there are some key differences between PNA and a 
“true” peptide. PNA consists of nucleobases bound to a neutral pseudo-peptide 
backbone via an acyl linker and was designed as a sequence specific DNA duplex 
recognition agent by Nielsen and co-workers in 1991.118 It was hoped that PNA 
would be able to mimic single strands of DNA that can bind to duplexes via 
Hoogsteen hydrogen bonding in the major groove to form a triplex. However, PNA 
was later found to be an extremely effective structural mimetic of DNA and RNA and 
posses unusual properties of its own.119 As a consequence of very different 
chemical and physical properties to natural oligonucleotides PNA has, over the last 
15 years, attracted much attention in the area of antisense and antigene therapy.120 
Unlike DNA, PNA is acid stable and will not suffer cleavage of the glycosylic bond
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even under the most harshly acidic conditions.121 PNA is also stable to mildly basic 
environments but will undergo N-acyl transfer reactions in the presence of a strong 
base122 (see figure 29). PNA can, therefore, be synthesised by both Boc and Fmoc 
solid-phase methods.
Base
Figure 29: N-acyl transfer reaction in PNA.
In terms of biological stability, PNA is attractive as a potential drug candidate 
because of its resistance to both peptidase and nuclease enzymes under conditions 
that result in total degradation of unmodified control oligomers. Both homologous 
and mixed sequence PNAs have been shown to be stable to human and other 
mammalian peptidases as well as those found in fungi and bacteria such as E- 
coli.123 Similar sequences also show no decomposition when incubated with S1 
nuclease or DNase124 and for these reasons PNA is considered ideal for in vivo 
therapeutic applications.
One of the problems associated with PNA for such applications is 
solubility.125 As the pseudo-peptide backbone bears no charge, unlike an 
oligonucleotide, and possesses no hydrophilic side chains as natural peptides do, 
aqueous solubility is often very poor and decreases with increasing chain length. 
PNA duplexes remain viable in concentrations of up to 70 % of an organic co­
solvent such as DMF,126 illustrating the stark contrast in solubility properties 
compared to DNA or RNA. A common strategy to improve the solubility, and hence 
bioavailability, of PNA is incorporation of natural hydrophilic amino acids, especially 
lysine, as additional side chains or as modifications to the pseudo-peptide 
backbone.127 As the primary amine of the lysine side chain has a pKa of 10.5, it is 
usually protonated in aqueous solution at pH 7 and thus helps to improve the 
solubility of the otherwise uncharged peptide chain.
The archetypal PNA consists of an /V-(2-aminoethyl)glycine backbone which 
is bound to the nucleobase at the amino moiety via an acetyl linker118 (see fig. 30). 
Monomers containing the four DNA nucleobases were synthesised by varying 
routes,128 then the PNA was assembled using standard BOC protocols.121 This
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provided a good basis for duplex recognition as it mirrored the bonding pattern seen 
in oligonucleotides; 6 bonds between neighbouring nucleotides and 3 bonds 
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Figure 30: N-(2-aminoethyl)glycine monomer unit of PNA.
PNA has been shown to anneal with single stranded DNA and RNA to form 
helical structures which are similar to unmodified duplexes (see fig. 31), self 
recognise to form PNA/PNA duplexes and will also bind duplex DNA as it was 
originally designed to do. The complexes formed as a result of the latter two 
interactions have some unusual and distinctive characteristics. PNA/DNA duplexes 
are the least stable of the hybrid duplexes formed by PNA followed by PNA/RNA 
and PNA/PNA duplexes are the most stable.129 The strands are arranged anti­
parallel; that is the amino terminus of the PNA strand is opposite the 3’- end of the 
oligonucleotide. In contrast to natural oligonucleotides, parallel arrangements of 
PNA/DNA and PNA/RNA duplexes have also been observed but these are less 
stable than the anti-parallel arrangements130 with very much slower kinetics of 
formation.131
The DNA strand of a PNA/DNA duplex resembles the conformation found in 
B-form DNA and the sugar pucker of the deoxyribose ring is retained as C2’-endo 
but the helix also contains elements of the RNA like A-form.132 The helix is right- 
handed with a slightly larger pitch, 13 base pairs per turn compared to 10 in B-form 
DNA, and the major and minor grooves are wider and narrower than B-form DNA 
respectively. The amides of the PNA backbone are all in a trans conformation and 
are mostly orientated towards the solvent. The amides of the nucleobase linkers are 
aligned towards the carboxy terminus of the pseudo-peptide but interestingly there 
is no hydrogen bonding present between any amide and carbonyl groups.133 
PNA/RNA duplexes are also a composite of A-form and B-form helices. In this case 
the backbone amide bonds switch to cis stereochemistry and, in common with 
PNA/DNA duplexes, the ribose sugar retains the C3’-endo pucker seen in normal 
RNA duplexes. No hydrogen bonding is observed within the PNA strand. A
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significant contribution to the stability of annealed PNA hybrid duplex structures is 
made by the neutral nature of the peptide based backbone. In DNA and RNA 
duplexes there is a repulsive electrostatic effect between the two anionic strands; 
however, the lack of charge on the PNA oligomer eliminates this, thereby helping to 
decrease the overall energy of the helix.134
Figure 31: Representations of a PNA/RNA duplex (left) and a PNA/DNA duplex 
(right) (taken from reference 132).
The PNA/PNA duplex forms a unique helix which is known as “P-form”135 
(see fig. 32). Like the analogous duplexes seen with DNA and RNA, the PNA duplex 
shares characteristics with both the A- and B-form helix and also possesses some 
individual features.




As is evident from the deviation of PNA/DNA/RNA hybrid duplexes from 
standard models of A-form and B-form helices, ethylaminoglycine based PNA’s are 
not ideal DNA or RNA binders. As a consequence of this there are now a multitude 
of modified PNA’s made from a wide variety of monomers (see fig. 33). By violating 
the 6 + 3 rule, for example by extending the linker to the heterocyclic base or 
extending the backbone chain136, many of these PNA’s possess inferior Tm’s to the 
original ethylaminoglycine PNA by as much as 22 °C.137 However, there are a few 





Figure 33: Modified PNA monomers.
In energetic terms, helix formation is a large gain in enthalpy and a large 
drop in entropy. The loss of entropy is due to the formation of order within the 
extended structure. Conformational constraint of the ethylene linker to a gauche 
configuration around the C-C bond,132 much like that seen in 3-peptides (see 
section 1.5), ensures that this loss of entropy is not large enough to be prohibitive 
for helix formation. This led to the hypothesis that further limitation of the flexibility of 
the pseudo-peptide would further increase the already impressive stability of 
PNA/DNA/RNA hybrid duplexes. In a similar manner to modifications made to 3- 
peptides, some of the most successful of these alterations to the backbone have 
come with the introduction of cyclic motifs. Pyrrolidine,138 aminoproline,139 
cyclohexane140 and cyclopentane141 sub-units have all been incorporated into PNA 
backbones (see fig. 34) with varying degrees of success. The pyrrolidine and 
cyclohexane motifs also demonstrate that stereochemistry has an influence on the 
binding properties of the oligomer.
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Cyclohexyl PNA binds to both DNA and RNA with only a minor loss of 
duplex stability; however, this is only holds true for the (S,S)-isomer. The (S,S)- 
configuration was shown by molecular modelling studies to constrain the backbone 
to a conformation similar to ethylaminoglycine PNA whereas the ( fl^ - iso m e r 
significantly perturbed this structure and resulted in loss of stability.140 Pyrrolidine 
derived PNA, which clearly violates the 6 + 3 rule, showed distinct preferences for 
binding DNA over RNA, anti-parallel over parallel binding modes and, unusually, 
hybridisation between self-complimentary strands was not apparent.138 This 
indicates that the introduction of more complexity into PNA oligomers imparts 
certain binding selectivity rules which are highly dependent on factors such as local 
stereochemistry.
Figure 34: Cyclic PNA monomers.
The effect of stereochemistry was more vividly demonstrated by a simple 
chiral modification to A/-(2-aminoethyl)glycine PNA’s. Introduction of an ¿.-serine 
type side chain at the y-carbon (see fig. 35), whilst also functioning as a solubility 
enhancer, brought about helical structure, reminiscent of foldamers seen in 14- 
helical p-peptides, in single stranded oligomers which retained strong binding affinity 
for both DNA and RNA.142 This result demonstrates that it should, in theory, be 
possible to design PNA possessing the conformational constraint thought necessary 
to afford PNA/DNA/RNA hybrid duplexes with near-natural helicity and hence, 
produce PNA oligomers with tuneable binding properties.
Base
Base
Figure 35: y-modified PNA monomer.
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Possibly the most interesting property of PNA is its binding modes during 
triplex formation. The type of triplex formed by PNA and DNA is highly sequence 
dependent. For example, PNA oligomers with high proportion of pyrimidines will 
bind to DNA to afford a (PNA)2/DNA triplex, whereas C-rich PNA hybridised with GC 
rich DNA prefer (DNA)2/PNA triplexes. The (PNA)2/DNA triplex is extraordinarily 
stable with a Tm for a 10-mer homothymine sequence binding to d(A-T)10 of 73 °C, 
compared to 23 °C for an unmodified T10.118 (PNA)2/RNA triplexes are also known to 
have equally high stabilities and this leads to another remarkable phenomenon; 
duplex invasion.143 Under certain circumstances, when targeted to a duplex with an 
A-T rich region, the tendency to form the (PNA)2/DNA triplex is so strong that the 
DNA duplex will be invaded, displacing one strand out and forming a triplex inside 
the host duplex (see fig. 36). This is a highly unusual binding mode and is thought to 
be stabilised in part by hydrogen bonds between the pseudo-peptide amides and 
the phosphate bridge of the DNA strand.144
It is also interesting to note that higher order structures such as G- 
quadruplexes and the /'-motif can also be formed by PNA. Both hybrid 
PNA/DNA/RNA G-quadruplexes145 and /'-motifs146 have been observed and 
analogous structures can also be formed by PNA alone147, emphasising the fact that 
PNA is an extraordinarily good oligonucleotide mimic.
Figure 36: Schematic of duplex invasion by (PNA)2/DNA triplex, (adapted from 
reference 132).
PNA can be thought of as a hybrid between peptides and oligonucleotides in 
which nucleobases are introduced to a pseudo-peptide backbone. Whilst PNA is 
structurally similar to a standard peptide it is logically desirable to attempt to 
incorporate modifications into natural oligonucleotide backbones. One approach is
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to replace the phosphate bridge in a standard oligonucleotide with a peptide bond 
generating a class of oligonucleotide/peptide hybrids which are more structurally 
related to oligonucleotides than peptides.
1.9 Internucleoside Amide Linkages
As with most analogues of nucleic acids or peptides, there are a multitude of 
structurally related oligomers bearing an internucleoside amide linkage. The five 
easily accessible amide isosteres of the natural 3’-5’-phosphodiester unit have been 
produced (see fig. 37) and show interesting properties when incorporated into 
oligonucleotides and hybridised with complementary DNA or RNA strands. Both 
isomers of 3’-amides have a destabilising effect on DNA/RNA duplexes in the region 
of -2 -  -4 °C on average per residue where the DNA strand carries the amide 
modification.148 This effect is more pronounced when the R group is sterically 
larger149 and is also observed to a lesser effect in 5’- analogues.150
Figure 37: Five isosteric internucleoside amide linkages.
It was suggested by DeMesmaeker and co-workers that the destabilisation 
was brought about by a shift in the preference of the deoxyribose sugar ring to a
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rather unusual C4’-exo or OA'-endo conformation induced by the structural rigidity of 
the amide bond. This hypothesis was supported by the observation that amide 
linkages not directly connected to either of the sugars did not significantly alter the 
backbone torsion angles or sugar pucker from that of the “ideal” A-form helix. This 
resulted in either a very minor destabilisation of the duplex or, in some cases, a 
minor stabilising effect of less than 1 °C.151 These results were highly sequence 
dependent and, as with the 3’-amides, increasing the R group size resulted in a 
larger decrease in duplex stability.152 Much of the work on hybridisation of amide 
modified oligonucleotides is focussed on hybridisation with RNA for two reasons; 
firstly, RNA is often the target for therapeutic applications of such modified 
oligomers and secondly, modified nucleosides tend to prefer RNA-type sugar 
puckers and thus form more stable duplexes with RNA. The second factor has been 
exemplified by the destabilisation of a DNA/DNA duplex by amide linkages by 
approximately -1.5 °C per residue152 and was also exemplified in 2’ -  5’ amide 
linkages where, although a 12-residue 2’ -  5’-phosphate DNA/3’ -  5’-phosphate 
RNA helix was significantly destabilised by around -8 °C, the corresponding 2’ -  5’ 
amide DNA/3’ -  5’-phosphate DNA duplex stability decreased by more than - 
12 °C.153
One unusual property of modified oligonucleotides bearing an 
internucleoside amide linkage is their ability to stabilise hybrid DNA duplexes 
containing a single base pair mismatch. This improved stability is achieved when 
the amide group is not directly linked to either of the nucleoside sugar rings and 
confers almost a 3 °C enhancement in duplex stability compared to an unmodified 
DNA strand.152 Contrary to previous results, increasing the steric bulk of the R group 
from H to methyl further stabilised the mismatched strands. This may be an 
indication that the rigidity of the amide linkage is a stabilising factor by more 
effectively mimicking an A-form helix, whilst a mismatched DNA nucleotide may 
prefer to revert to a B-form like conformation, reducing the overall stability of the 
duplex. Recently, amide modifications have been inserted into RNA strands 
resulting in the identification of the 3’-CH2NHCOCH2-5’ linkage as a superior 
stabiliser of RNA/RNA duplexes compared to the isomeric 3’-CH2CONHCH2-5’ by 
between 1 and 2.4 °C per modification.154 The reason for this behaviour remains 
uncertain, but may be due to differential interactions within the hydrogen bonded 
solvent network.
Amide-type linkages which are not isosteric with a phosphodiester have also 
been examined as oligonucleotide analogues. An extra atom was introduced in an
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attempt to offset the shorter length of the amide bonds when compared to those of 
the phosphodiester and thereby improve duplex stability.155 Gait and co-workers 
showed in early work with acetamidate linkages (see fig. 38) that oligomers 
exclusively joined with this group did not possess the ability to recognise 
complementary polyribonucleotides156 probably due to an unfavourable 
conformation of the backbone. In a similar study, Pallan et al. showed that the 
introduction of a methyl substituent to the acetamidate group facilitated RNA 
recognition157; thus, changing the substituent could assert at least some control over 
backbone conformation. These duplexes, however, remained considerably less 
stable than an unmodified control.
Figure 38: Non-isosteric amide-type internucleoside linkages.
The inclusion of a 2’-methoxy group at the 5’-nucleoside of the methyl 
modified acetamidate brought about stabilisation of the duplex compared to the 
control. 2’-OMe groups are well known to induce an RNA-like sugar pucker in 
deoxynucleotides158 and this indicated that the bulkier methyl bearing linker may 
tend to favour an RNA-like C3’-endo conformation in the sugar. This suggests that 
the most important factor for RNA recognition and duplex stability with amide 
modified DNA strands is the ability of the linkage to constrain the sugar to a C3’- 
endo conformation. The same study demonstrated that switching from an 
acetamidate to a 5-atom amide linkage by changing 3’-O to 3’-C whilst retaining the 
2’-OMe moiety also produced a duplex stabilising effect; again highlighting that the 
critical nature of the sugar pucker. It was also shown that imparting a preference on 
sugar pucker through stereochemical means may be possible, given that the R 
stereoisomer of a methyl substituted amide linkage (see fig. 38) was more 
stabilising than the S isomer.157 Since these findings, various 5-atom amide linkages
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have been observed to bind to RNA in a similar manner to that of isosteric 
modifications. Some were found to improve the stability of duplexes whilst 
increasing bioavailablity; for example those bearing a thioether modification (see fig. 
38).159
1.10 Project Aims
The primary goal of this project was to produce (3-peptides derived from 
nucleoside (3-amino acids and examine the structure of these highly functionalised 
oligomers (see fig. 39). Encouraged by the striking similarity of the proposed 
oligomers with foldamers produced by Gellman and co-workers from frans-ACPC, 
the objectives set were to synthesise a nucleoside (3-amino acid derived from 
deoxynucleoside thymidine which was compatible with peptide synthesis by 
standard solid-phase peptide synthesis methodologies. This monomer would then 
be utilised to synthesise nucleoside (3-peptide homo-oligomers of varying length and 
these, in turn, would be examined for the presence of ordered secondary structure 
by NMR and, if applicable, other spectroscopic techniques.
Figure 39
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A logical extension of this work was to apply these methods to other 
deoxynucleosides, particularly 2’-deoxyadenosine, and investigate hybridisation of 
the thymidine derived P-peptides with complementary p-peptide and natural DNA 
sequences. It was also desirable to use these unique amino acids to explore the 
possibility of peptide synthesis by means other than solid-phase chemistry, 
especially more non-traditional based approaches.
It should be noted that after the commencement and publication of the 
findings of this work regarding P-peptides derived from thymidine, independent 
studies on oligomers of the same constitution were published by Chandrasekhar et 
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2 Results and Discussion
2.1 Thymidine-derived p-Amino Acid Synthesis
Many previous synthetic studies of 3’-amino-3’-deoxythymidine have the 
corresponding azide as a common intermediate. It was clear that an efficient 
synthesis of 3’-azido-3’-deoxythymidine (AZT) would be integral to the overall route 
design (see fig. 40). The proposed route to our target protected amino acid (1) from 
AZT (2) involved reduction of the 3’-azide group to afford a 3’-amine. This amine 
could then be protected appropriately in preparation for solid-phase peptide 
synthesis leaving the last step as oxidation of the 5’-C to yield the desired amino 
acid.161 The choice of Fmoc as the amine protecting group for SPPS was driven by 
the sensitivity of the glycosylic bond in 2’-deoxynucleosides to acid catalysed 
hydrolysis and the desire to avoid such a side reaction occurring during SPPS. 
Base-labile Fmoc protection would avoid the need for acidic deprotections which are 
required by some other protecting groups, such as ferf-butoxycarbonyl (BOC).
Figure 40
Having been so intensively studied as the frontline defence against HIV,162 a 
variety of syntheses of AZT were available in the literature.163 The range includes an 
11 step total synthesis method beginning from 3’3-diethoxypropionate,164 
carbohydrate-based approaches165 and modifications of thymidine via 2,3’- 
anhydronucleosides166 or 3’-xy/o-0-methanesulfonyl derivatives.167,168 The latter two 
methods have proved to be the most popular routes and first appeared in the early 
reports of AZT in the 1960’s & 1970’s. The underlying strategy for both of these 
reactions is essentially the same. Two SN2 reactions are performed at the 3’-carbon 
centre by converting the 3’-OH to a 3’-Omethanesulfonyl (3’-OMs) derivative by 
reaction with methanesulfonyl chloride.
2,3’-anhydro compounds were prepared by Glinski and co-workers166 by 
displacement of 3’-OMs, using neighbouring group participation from the
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heterocyclic base169 and the anhydro species subsequently opened with lithium 
azide. The alternative method also generated the 2,3’-anhydro species in the same 
manner, but instead of direct displacement, both Horowitz167 and later Lin,168 chose 
to open the anhydro and isolate a protected 3’-xy/o-thymidine before performing a 
second SN2 with another equivalent of methanesulfonyl chloride and lithium azide 
(see scheme 1).
O O
Tr = Trityl or trityl derivative
Scheme 1: Synthetic routes to AZT by Glinski (red) and Horowitz/Lin (blue)
At the same time, Fox and co-workers produced 3’-amino-3’-deoxythymidine via 
2,3’-anhydro intermediates by reaction with phthalimide.169 Also, Glinski, Horowitz 
and Lin all achieved 3’-amino-3’-deoxy compounds by reduction of the 3’-azido 
nucleosides.
The 2,3’-anhydro compounds have now mostly replaced the dual mesylate 
Sn2 approach in pyrimidine nucleosides and have since proved to be popular as 
tools for substitution of 3’-OH with a variety of nucleophiles whilst retaining the 
natural stereochemistry170. The only previous literature syntheses of the target
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nucleoside of this project171 and the related, free amino acid172 both appear in patent 





Varma and co-workers developed two routes to azido acid (4) using 
RuCI3/K2S208. The first and simplest was oxidation of commercially available AZT. 
The same azido acid compound could also be produced by oxidising the 2,3’- 
anhydro species (3) with the RuCI3 system then opening the heterocycle with LiN3171 
(see scheme 2). Cole and co-workers also began with a commercial sample of AZT 
and oxidised en route to the free amino acid. However, in their work on the 2’- 
deoxycytidine derived free amino acid, the 2,3’-anyhdro was formed by reaction, not 
with methanesulfonyl chloride, but with (PhO)2SO. This was then opened from the 
a-face by nucleophilic attack with azide.172
For this study, the method of choice for AZT production was Czernecki and 
co-workers’ elegant tandem Mitsunobu approach173 (see scheme 3). Sequential 
protection of the 5’-OH with para-methoxybenzoic acid then 2,3’-anhydro formation 
could be achieved by two successive Mitsunobu reactions174 performed in the same 
reaction vessel.
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1.5 Equivalents of PPh3 were charged to a vessel containing thymidine and para- 
methoxybenzoic acid in anhydrous DMF solution and excess di- 
/'sopropylazodicarboxylate (DIAD) added drop wise over approximately 30 minutes. 
This process was then repeated with the omission of para-methoxybenzoic acid. (5) 
Was obtained pure by addition of a large volume of diethyl ether, to force the 
product to precipitate out of solution, and subsequent filtration. The yield of this 
reaction was optimised to quantitative by reducing the temperature during DIAD 
additions to 0 °C.
O O
Scheme 3
The increased yield at low temperature could possibly be ascribed to an 
increase in the half-life of the reactive nitrogen species generated from DIAD or the 
stability of the 3’-0-phosphonium intermediate with respect to elimination to form the 
2’-3’-dideoxy compound during the second Mitsunobu procedure. The unusual 1H 
NMR shift for the H3’ proton of 5.41 ppm was the most indicative sign of successful 
2,3’-anhydro formation. Due to extended conjugation through the pyrimidine base 
the large electron withdrawing effect could also be observed in 13C NMR where C3’ 
saw a downfield shift of 7 ppm compared to thymidine.
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Opening of the anhydro species was conducted with excess azide in 
anhydrous DMF at 125 °C. Lithium azide is generally thought to be superior to 
sodium azide in this type of displacement due to enhanced solubility in polar 
solvents such as DMF.175 In this case the yield with a lithium cation was indeed 
marginally greater, at around 65 %. The addition of benzoic acid as a proton source 
to assist in reprotonation of the pyrimidine N3176 brought no improvement in reaction 
yield. However, losses of material during a consistently problematic work-up of 
reactions containing benzoic acid may account for this observation. It has been 
suggested that improved yields for such anhydro opening reactions may be 
obtained by alkylating at N3 with a removable group such as benzyl triflate177 as an 
alternative to acidic reprotonation. Such methods have yet to prove significantly 
beneficial.
The reported 90 % yield of protected AZT via the anhydro route was not 
approached over the course of many attempts to produce the 3’-azido compound. 
Recovery of small quantities of anisic acid during chromatography of the final 
product suggested that the 5’-OH protecting group was not completely suited to the 
harsh reaction conditions, despite claims in the original paper that no ester bond 
cleavage was observed.
O O
Figure 41: rearrangement of 2,3’-anhydrothymidine.
Rearrangement to A/-3 thymine isomers via glycosylic bond cleavage is also 
possible under the conditions used178 (see fig. 41). No evidence for the formation of 
such by-products was obtained; although this does not eliminate the possibility of 
degradation rather than isomerisation resulting from breaking of the glycosylic 
linkage. The appearance of an azide asymmetric stretch at 2099 cm'1 in the IR 
spectrum confirmed the insertion of N3. A simple deprotection of the 5’-O-para- 
methoxybenzoyl group with NaOMe in aqueous MeOH followed by neutralisation 
with Amberlite® H+ ion exchange resin afforded AZT in 46 % yield from thymidine.
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In Cole’s methodology172 the route to the desired p-amino acid from AZT 
proceeded by oxidation of the 5’-C position with K2S20 8 and catalytic RuCI3,179 then 
reduction of the azido function by hydrogenation over palladium. Finally, Fmoc 
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As an alternative to oxidation of the 5’-carbon followed by reduction of the azide, to 
enable access to the Fmoc amino acid via the free amino acid,180 it was decided to 
investigate the possibility of reducing of the azide moiety and protecting the 
resulting amine prior to 5’-oxidation (see scheme 4).
Although alternative reductions for the transformation of azide to amine, 
such as the Staudinger reaction181 and H2S182 were available, catalytic 
hydrogenation appeared to be the simplest and most efficient method.183 It is known 
that both pyrimidine carbonyl groups and double bonds are stable to hydrogenation 
using palladium catalysis184 and this was the natural choice for a highly 
functionalised nucleoside containing both such groups. Hydrogenation of the azide 
catalysed by palladium on activated charcoal suspended in MeOH solution, gave 3’- 
amino-3’-deoxythymidine in quantitative yield within 2 hours. Disappearance of the 
azide absorption in the IR spectrum coupled with another significant shift of 0.8 ppm 
upfield for H3’ confirmed the formation of the amine (7). (7) Was then easily 
protected with 1.3 equivalents of FmocCI in 33 % aqueous 1,4-dioxane to give the
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masked amino alcohol (8). In the proton NMR, de-shielding by the newly formed 
carbamate group resulted in a downfield shift of 0.7 ppm for the H3’ proton. This 
resonance was now flanked on either side by signals belonging to the protons 
bonded to the saturated carbons of the Fmoc group. Appearance of the fluorenyl 
aromatic peaks distributed between 7 and 8 ppm also confirmed successful 
protection.
There are a multitude of procedures in the literature for oxidation of the 5’-C 
position of a nucleoside and traditional transition metal-based procedures remain a 
common method. The most popular reagent of this type is pyridinium dichromate185 
(PDC). The very similar pyridinium chlorochromate (PCC) does not appear 
frequently and KMn04 uses relatively harsh conditions which are not favourable for 
many nucleoside based transformations.186 Heavy transition metal-catalysed 
formation of carbonyl groups is also well tolerated by nucleosides, reliable routes 
include persulfate with RuCI3179 and the more direct 0 2 insertion over activated 
platinum in aqueous NaHC03.187
Organic, metal-free oxidation systems are increasing in popularity due to the 
problems associated with transition metals in terms of purification and over 
oxidation. Amongst the less mainstream options for nucleosides is biotransformation 
using the enzyme nucleoside oxidase. First isolated by Isono and co-workers from 
Stenotrophomonas maltophilia188 the enzyme has subsequently been shown to 
tolerate a wide variety of synthetic and natural nucleobases with a rapid substrate 
turnover,189 but has limited application due to poor stability at room temperature.
As with the nucleoside oxidase reaction, the primary product of most metal- 
free oxidation reactions performed with nucleosides are aldehydes; an additional 
oxidant is required to generate the carboxylic acid. A good example of such a 
reaction was developed by Moffatt and co-workers using a sulfur ylide derived from 
the reaction of DMSO with dicyclohexylcarbodiimide (DCC) in the presence of 
pyridinium trifluoroacetate.190 In the original paper the aldehyde produced was 
oxidised further to the carboxylic acid for characterisation purposes with periodate. 
This can also be achieved with other co-oxidants such as mCPBA191 or NaCI02.192
The search for even milder conditions for metal-free oxidations has led to the 
popularity of hypervalent iodine compounds for this purpose because of the ease of 
access to aldehydes with very little over oxidation, unless co-oxidants are 
specifically added. The Dess-Martin procedure employs a cyclic periodinane (see fig 
42) offering short reaction times, easy separation of products and it is selective for
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alcohols in the presence of other easily oxidised groups such as furan rings or 
sulfides.193 The mechanism of the oxidation is one of ligand exchange at the I centre 
followed by proton exchange between the substrate and one acetate ligand. The 
newly oxidised product is then eliminated with corresponding reduction of l(v) to l(iii).
The Dess-Martin reagent is not selective between primary and secondary 
alcohols and also cannot be applied catalytically. These are the properties which 
make the combination of another hypervalent iodine complex, bis- 
acetoxyiodobenzene (BAIB) with the free radical 2,2,6,6-tetramethylpiperidinyloxy 
(TEMPO), such a powerful and attractive system for oxidation.194 The most 
attractive aspect of the TEMPO/BAIB system in terms of our target compound was 
the direct access to carboxylic acids, when the reaction is performed in aqueous 
acetonitrile, and the known propensity of nucleosides to precipitate out of the 
reaction solution without requiring further purification.195
Figure 42: Dess Marlin periodinane (left) and bis-acetoxyiodobenzene (right).
Nitroxyl radicals such as TEMPO have been identified as useful reagents for 
oxidations using a number of different conditions and co-reagents over a remarkably 
large range of substrates.196 As expected of a metal-free technique, the product of 
TEMPO oxidations is an aldehyde with additional reagents required to oxidise 
further to an acid. TEMPO can be applied in oxidation reactions in two ways. It has 
been identified that the active species for oxidation is not the free radical itself, but 
the oxoammonium species197 and thus it is possible to consider utilising either a 
stoichiometric or a catalytic quantity of TEMPO. In a stoichiometric reaction the 
oxoammonium salt can be either prepared and isolated separately from the 
substrate198 or generated in situ by use of an additional oxidant such as mCPBA.199 
Catalytically applied, only a small amount of the free radical is required and this can 
be converted in situ to the oxoammonium species by a co-oxidant in a catalytic 
cycle. It is these systems that are the most mechanistically interesting that have 
been the most intensively studied.
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The absolute mechanism of the overall conversion remains uncertain, 
however, there are two definite pathways for the generation of the oxoammonium 
species; syn and dis-proportionation.200 Below pH 2, disproportionation is favoured. 
This is induced by the acidic conditions and the radical is regenerated by the co­
oxidant from the hydroxylamine (see fig. 43).
Figure 43: Disproportionation
Above pH 3, it is suggested that syn-proportionation of the oxoammonium salt and 
hydroxylamine occurs to give two nitroxyl radicals which are then oxidised by the 
co-oxidant to the active oxoammonium salt (see fig. 44). A variety of co-oxidants 
can be used in both syn- and disproportionation cycles including NaOCI/Br2,201 
CuCI/02,202 Oxone203 and oxidation can also be achieved electrochemically.204 In the 
case of BAIB it is thought that, even though no extra acid is used, the 
disproportionation route is almost certainly followed due to the generation of acetic 
acid upon ligand exchange with the substrate at the I (iii) centre. In this reaction 
BAIB has a dual role as both the co-oxidant and source of protons. The nitroxyl 
radical is then converted to the oxoammonium salt and the aldehyde is formed by 
one of three possible intermediates (see fig. 45).
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Figure 44: Syn-proportionation
When the Fmoc amino nucleoside was treated with TEMPO/BAIB in 50 % 
aqueous acetonitrile the corresponding carboxylic acid ( 1, p.48) did indeed 
precipitate from the reaction solution and was obtained in 40 -  50 % yield, without 
the need for purification. Disappearance of the H5’ protons from the 1H NMR 
coupled with the shift of C5’ to 172 ppm made for easy characterisation of the 
protected amino acid. The free amino acid (9, scheme 4) was also produced in 
23 % yield by applying the TEMPO oxidation conditions to amino thymidine (7).
Figure 45: Possible reaction mechanisms of TEMPO oxidation.
Attempts to determine the fate of the remaining 50 % of the starting material 
proved unsuccessful. The only recognisable products in the reaction liquors being
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the expected by-products acetic acid and iodobenzene. A possible explanation for 
the loss of the starting material came to light when Miyamoto and co-workers 
identified hypervalent iodine compounds, including BAIB, as an ozone equivalent for 
oxidative cleavage of carbon -  carbon double bond in the presence of water.205 The 
double bond of thymine is known to be susceptible to ozonolysis206 and it is 
plausible that exposure to BAIB in water led to decomposition of the starting 
material. However, no physical evidence has been obtained to support this theory.
2.2 Solid-Phase Peptide Synthesis of Thymidine-derived p-Peptide
As alluded to earlier, the Fmoc group was chosen for amine protection in 
order to conserve the nucleoside glycosylic bond. Acidic conditions could not, 
however, be completely avoided but resin and reagents for SPPS were selected 
with minimum acidic conditions in mind. The resin chosen for solid phase synthesis 
was Sieber amide resin with the hyper-acid labile xanthen-9-amine linker group207 
(see fig. 46). This enabled cleavage of the oligomer from the solid support to be 
achieved under very mildly acidic conditions, 1 % trifluoroacetic acid (TFA) in DCM 
solution, minimising the chance of cleavage of the glycosylic bond. The Sieber 
amide resin, as the name suggests, produces terminal amides upon cleavage as 
opposed to carboxylic acids. For preliminary synthetic studies this was not 
perceived to be of any significant consequence and SPPS was thus pursued with 
this resin.
NHFmoc
Figure 46: Sieber Amide Resin.
A common problem with p-peptides and PNA oligomers alike is their poor 
solubility in aqueous solvents due to the neutral nature of the peptide backbone90,125. 
Initially it was believed that oligomers derived from the thymidine p-amino acid could 
also be insufficiently soluble in aqueous solution to allow either purification by 
reverse-phase HPLC or subsequent structural studies to be performed. A common 
strategy to increase solubility of PNA type peptide chains is to include additional 
lysine residues within the chain.118,127 Tagging either the C o r N terminus of PNA 
oligomers with Fmoc-protected hydrophilic natural a-amino acids is known not to
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known not to hinder hybridisation with complementary DNA strands.125 For our 
purposes it was most appropriate to include any additional residues at either 
terminus so as to minimise any impact on secondary structure formation. It was 
therefore decided to append each end of the peptide chain with a natural /.-lysine 
residue to maximise the solubilising effect. The initial SPPS experiments with the 
thymidine derived amino acid were conducted with this in mind (see fig. 47). During 
the peptide synthesis itself, this amine side chain would require protection to 
prevent unwanted side reactions. An orthogonal, acid-labile monomethyltrityl (Mtt)208 
group was chosen for this purpose. This enabled both the peptide and the side 
chain protecting group to be cleaved from the acid sensitive resin concurrently at 
the end of the synthesis to give a fully deprotected oligomer chain.209
Figure 47: Nucleoside (3-peptide appended with L-lysine residues.
Peptide synthesis was conducted as follows: The resin was swelled 
overnight in DCM then drained and washed with DMF. The Fmoc protecting group 
on the resin was then removed by agitating the resin with 20 % piperidine in DMF 
solution before again draining and washing the resin bed. The amino acid to be 
coupled was then dissolved in DMF and pre-activated for 60 seconds with the 
amide bond forming reagent 0-benzotriazole-/\/,A/,/V,/V-tetramethyluronium 
hexafluorophosphate (HBTU) and di/'sopropylethylamine before being added to the 
resin bed and agitated. Upon completion of the coupling reaction the amino acid 
solution was removed. After washing, the resin bed covered with a “capping” 
solution containing 10 % acetic anhydride and 10 % 2,4,6-collidine in DMF to 
acetylate any amines that had not reacted before the next coupling cycle was 
commenced. At the end of the synthesis the resin bed was washed with DMF, DCM 
and methanol then dried under vacuum overnight. Re-swelling with DCM for 30 
minutes was followed by treatment with 1 % TFA in DCM, to cleave the peptide from 
the resin, and 5 % triethylsilane (TES) in DCM, to scavenge the monomethyltrityl 
group. These liquors were drained into a flask containing 10 % pyridine in DCM in
H2N
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order to neutralise the TFA and, after removal of all the solvents under reduced 
pressure, the peptide was precipitated by the addition of diethyl ether.
Figure 48: Mechanism of Fmoc removal and adduct formation with piperidine.
Initial attempts to construct oligomers of the form Lys-5’-mTn-3’-Lys using the 
Sieber amide resin failed to produce a significant amount of peptide, as determined 
by HPLC of the crude cleavage mixture. It was clear that the coupling conditions 
would require optimisation. During the optimisation process, coupling yields could 
be monitored by a UV spectroscopic assay of deprotection solutions for the 
presence of dibenzofulvene (DBF).210 DBF is liberated upon exposure of the Fmoc 
group to base, however, piperidine can add to DBF in a Michael fashion leading to a 
distortion of the concentration of DBF and, consequently, underestimation of 
coupling efficiencies211 (see fig. 48). At this point 20 % piperidine solution was 
replaced as the deprotection agent by a 2 % solution of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU).212 DBU will not add to DBF in the same 
manner as piperidine and is considered more accurate for these purposes.213
As both terminal residues of the peptide were to be lysine, the first coupling 
reaction to be optimised was that of Fmoc/Mtt protected lysine with the resin itself. 
Both FIBTU and benzotriazol-1-yl-oxytripyrrolidinophosphonium
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hexafluorophosphate (PyBOP) were tested as amide bond forming reagents (see fig. 
49). Several solvents,214 DMF, dimethylacetamide (DMAc), /V-methylpyrrolidone 
(NMP) and 20 % DMSO in DMF, were also examined for this reaction.
Figure 49: HBTU (left) and PyBOP (right).
Table 1 shows the most efficient conditions for the coupling of lysine to the resin 
were using either DMF or DMAc with HBTU as coupling reagent. HBTU has been 
shown to give excellent coupling performances with model PNA sequences,122 
however, PyBOP was only slightly inferior as a coupling reagent, as was 20 % 
DMSO/DMF as a solvent. NMP was a poor solvent in this test. The two best 
performing combinations were progressed to couplings with the modified nucleoside. 
The results show that coupling efficiency between the modified nucleoside and 
lysine was only slightly better with DMF and further improved by the use of PyBOP 
in place of HBTU. The reason for the failure of the first SPPS attempt using DMF 
then became clear when the coupling between the modified nucleosides was 
examined.
Very poor coupling yields were obtained when DMF was employed in 
combination with HBTU. Performing the coupling reaction twice before the capping 
step, known as double coupling, also failed to improve yields. PyBOP continued to 
produce superior yields over HBTU in DMF; however, couplings in DMAc between 
the nucleosides were quantitative with HBTU. Thus DMAc was introduced in place 
of DMF. HBTU was retained as the coupling agent as the overall yields for the 
whole synthesis were projected to be better with HBTU than with PyBOP. The 
reason for the vast difference between these comparable solvents is unclear. 
Efficient peptide synthesis is often achieved using these types of polar, aprotic 
solvents in order to suppress aggregation between chains215 and retain good resin 
solvation.216 The physical and electronic properties of DMF and DMAc are 
approximately equal and consequently there are no obvious variations in solvating 
power or electronic effects that could be identified as a possibly cause of this 
disparity.
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Amino Acid3 Solvent Coupling Agent Coupling Yield / %
Lysine DMF HBTU 94
mT1 DMF HBTU 88
mT2 DMF HBTU 23
Lysine DMF PyBOP 91
mT1 DMF PyBOP 99
mT2 DMF PyBOP 92
Lysine DMAc HBTU 94
mT1 DMAc HBTU 86
mT2 DMAc HBTU 99
Lysine 20 % DMSO/DMF HBTU 92
Lysine NMP HBTU 54
Table 1 3 T h e  en try  “ Lys ine” re fe rs to  th e  cou p ling  o f Fm oc-L ys in e -(M tt)-O H  w ith  th e  resin . “m T 1 ” re fers to  the  
firs t th ym id in e  de rived  am ino  ac id  cou p ling  to  lys ine  and “ m T2” to  the  se co nd  th ym id in e  de rived  am in o  ac id  cou p ling  
to  m T  1.
Concurrently with development of suitable reaction conditions, a suitable 
method of testing the resin at various stages of the peptide synthesis cycle was 
identified. Solid-phase resin testing during peptide synthesis is commonly performed 
to test for the presence of free amine groups on the resin. Free amine groups are 
indicative of a successful deprotection reaction or a failed coupling reaction and can 
be a useful tool in determining the progress of a given synthesis. Traditionally a 
Kaiser test217 is used to show the presence of amines in solid-phase synthesis. It is 
performed by heating a mixture of 5 % w/v ninhydrin in ethanol solution, 80 % v/v 
phenol in ethanol solution and 2 % v/v (2 mM KCN solution in water) in pyridine 
solution at 120 °C for 4 minutes in an ignition tube containing a few of the resin 
beads. If free amine groups are present, i.e. if a deprotection succeeded or a 
coupling failed, then the beads become stained blue as a ninhydrin adduct forms at 
the free amine site and subsequent hydrolysis leads to the formation of the 
compound known as “Ruhemann’s purple” (see fig. 50). If the beads remain 
colourless then this indicates that there are no free amine sites present after a failed 
deprotection or successful coupling reaction. The Kaiser test is, however, not 
suitable with serine, asparagine, aspartic acid and secondary amino acids such as 
proline.218 This was also found to be the case with the modified thymidine
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nucleoside. After the first thymidine residue was coupled the Kaiser test invariably 




Figure 50: Ruhemann’s Purple from ninhydrin in the Kaiser test.
Trinitrobenzene sulfonic acid (TNBS)219 and chloranil (see fig. 51) are both 
well known alternative reagents for resin testing of this type, chloranil being 
especially noted for use with proline 220 Both of these tests were initially superior to 
the Kaiser method in that visual contrast between test solution (bright yellow) and 
beads testing positive for free amines (blue for chloranil, red for TNBS) was high. 
However, chloranil could not detect free amine sites on the thymidine residues 
leaving TNBS, despite the handling hazards, as the most suitable resin testing 
reagent.
With a now optimised coupling process and reliable methods for both 
monitoring coupling efficiency and amine visualisation, further SPPS to produce 
lysine appended peptides was attempted. DBF assay during the synthesis showed 
that, although coupling yields were lower than may have been expected, the 6-
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residue peptide was prepared in 15 % overall yield. UV analysis of the post 
cleavage mixture following the synthesis indicated the presence of thymine with a 
significant absorption at 256 nm. HPLC analysis showed a single large peak with a 
retention time of 14.4 minutes. However, when subjected to electrospray mass 
spectrometry, no parent ions for peptides of any length could be identified in either 
the crude cleavage mixture or samples purified by HPLC. The reason for the failure 
of these peptides to fly during mass spectrometry is not known. One hypothesis is 
that the presence of residual compounds or salts from the cleavage procedure or 
HPLC purification overwhelmed the relatively weaker, multi-charged ions of peptide 
spectra. In an attempt to circumvent this characterisation problem two alterations 
were made to the SPPS system.
Figure 51: Trinitrobenzenesulfonic acid (left) and chloranil (right).
Firstly, the cleavage procedure was revised by removing the TFA by rapid 
evaporation under reduced pressure instead of neutralising with pyridine, in order to 
eliminate the presence of salts. The second change was to discontinue the use of 
lysine as the terminal residues with the aim of reducing superfluous compounds in 
the final cleavage mixture i.e. Mtt derived TES. This also decreased the probability 
of producing failure sequences, diminishing the need for purification by HPLC.
-R
n
(10) n = 2, R = H
(11) n = 4, R = H
(12) n = 4, R = Fmoc
(13) n = 8, R = H
(14) n = 8, R = Fmoc
Figure 52: Nucleoside (3-peptides derived from thymidine produced by SPPS.
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Figure 53: HPLC trace of a crude sample of peptide (14).
These modifications to the procedure proved successful to the point of obtaining a 
series of peptide oligomers of the form shown in figure 52 which were isolated from 
cleavage mixtures by trituration with diethyl ether. Peptides produced using this 
modified method were sufficiently pure upon isolation to be analysed by NMR 
without the need for further purification by HPLC (see fig. 53).
Oligomer n R Molecular Formula HR mass required
HR mass 
found
10 2 H C2oH26N708+ 492.18 492.18
11 4 H C4oH48Ni3016Na+ 988.32 988.13
12 4 Fmoc C55H57Ni30i8Na+ 1210.38 1210.38
13 8 H C80H91 N25032Na+ 1936.62 1936.61
14 8 Fmoc C95Hi0lN25O34Na+ 2158.68 2158.69
Table 2
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Peptides 1 0 - 1 4  were successfully characterised by high resolution mass 
spectrometry (see table 2 and fig. 54).
[M + Na]+
[M - (Thymine) + Na]+ 
[M - (Thymine) + H]+
[M - 2(Thymine) + Na]+
[M - 2(Thymine) + H]+ 
[M - 3(Thymine) + Na]
[M - 3(Thymine) + H]
I














L l .k 4 . . .n l
1032.2532
1077 3138 1166.3560
1000 1050 1100 1150
Figure 54: Electrospray mass spectrum of peptide (11)
With a now reliable method for SPPS and peptide characterisation, the 
opportunity was taken to examine the viability of alternative resins for conducting 
SPPS. This was undertaken with the aim of producing C-terminal carboxylic acids 
instead of amides for possible application in the study of formation of cyclic 
structures by this class of peptide. Again, taking into account the desire to avoid 
resins requiring strong acid to cleave the finished peptide, Rink acid221 and 4- 
hydroxymethyl-3-methoxyphenoxybutyric acid benzhydrylamine (HMPB-BHA)222 
resins (see fig. 54) were tested. Neither of these resins gave superior results when 
compared to the Sieber amide resin (see table 3).
Resin Solvent Coupling Agent Coupling Yield/%
Rink Acid DMAc HBTU 10
Rink Acid DMAc PyBOP 9
HMPB-BHA DMAc HBTU 51
HMPB-BHA DMAc PyBOP 60
Table 3
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This may be due to changing the connection between the linker and the amino acid 
from an amide bond to an ester bond. In later, related work on fluorous supports 
(see chapter 3) it was indeed found that the nucleoside was reluctant to esterify and 
the choice of the amide resin was, therefore, justified.
OH OMe
Figure 54: Rink acid resin (top) and HMPB-BHA resin (bottom).
2.3 Structural Characterisation of Thymidine-derived P-Peptide
In collaboration with Leeds University, DFQ-COSY, NOSEY, TOCSY, VT- 
NMR and UV melting experiments were used to examine the solution conformations 
of the peptide chains.223 It was possible to obtain a complete resonance assignment 
for oligomer (12) and, by analogy, assign conformational features of oligomer (13). 
The NH protons of tetramer (12) were all unambiguously assigned and it was 
observed that the three inter-nucleoside amide protons showed a marked difference 
in chemical shift, 8.85, 8.92 and 8.94 ppm, to that of the terminal, Fmoc protected 
amine, 8.13 ppm (see fig. 55). This was the first indication of an intramolecular 
hydrogen bonding network incorporating these inter-residue amide protons.95 A 
variety of nOe connections were also identified (see fig. 55) and these constraints 
were then included in the construction of a model of the short peptide strand.
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3 x H-6 Fmoc
NH (4)/H-6 (3) J
NH (2)
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Figure 55: Aromatic region of 1D NMR spectrum and selected nOe connections 
observed in peptide (12).
The model suggested that a helix-like pattern was indeed present (see figs. 
56 and 57). The core of the helix was occupied by a zigzag arrangement of the 
sugar rings, forcing the sterically demanding thymine bases to protrude into two 
well-defined planes either side of the chain in a right-handed helical arrangement.
Further evidence of the presence of a hydrogen-bonded network within the peptide 
was obtained by the observation of larger, high-field shifts of the inter-residue amide 
protons, approximately 6 ppbK'1, compared to that of the terminal amine, 3 ppbK'1, 
in variable temperature experiments. This result was to be expected given that the 
model suggested a near-linear configuration.224 Combining all these findings
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together, examination of the environment of the amide protons showed hydrogen 
bonding between the amide protons and the carbonyl oxygen belonging to the n+2 
residue of the chain. An atom count along the chain revealed an 8-helix.
Figure 56: Side and top view of model of 8-helix formed by peptide (12) (model 
constructed using MacroModel,225 courtesy of C. Kilner).
8-Helices, whilst more unusual than 12- or 14-helices, have previously been 
observed in conformationally constrained cyclic 3-peptides.94,95 It is believed that the 
constraints in this case are derived from the steric demands of the heterocyclic base.
Similar observations were made when examining octamer (13) indicating 
comparable structural behaviour proliferates within longer peptides. However, with a
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much more complicated spectrum, only the resonances belonging to the terminal 
residues have so far been assigned.
Figure 57: Alternative model showing helical core of peptide (12) (model 
constructed using Spartan, courtesy of N. Berry).
The suggestion that ordered structure was present in the peptide chain was 
supported by UV melting studies. Single-stranded DNA and RNA have UV 
absorption maxima at approximately 260 nm with a large extinction coefficient. 
When two single strands of natural DNA or RNA anneal to form a duplex, a drop in 
UV absorption of the solution containing the strands of up to 30 % occurs due to the 
hypochromic effect.10 This phenomenon is caused by base stacking; the interactions 
of TT-electrons between nearest neighbour heterocyclic bases. Dissociation of the 
duplex caused by heat can, therefore, be observed by measuring the UV 
absorbance of a solution of the duplex as a function of temperature. This produces 
a sigmoidal curve as shown in Figure 58. The point at which the duplex is 50 % 
dissociated, i.e. the temperature at which the UV absorbance is half the maximum, 
is known as the melting temperature (Tm). Changes in Tm are commonly used as a 
measure of the stabilising or destabilising effect on a duplex of a particular synthetic 
modification contained within one strand of the duplex or to establish whether a 




Figure 58: Example of a melting curve and Tm.
Melting experiments performed with single strands of (12) and (13) produced 
absorbance curves which were similar to those observed for a natural duplex. 
Although somewhat irregular, the sigmoidal trend of the graphs can be seen 
suggesting a melting temperature of approximately 51 °C for tetramer (12 see fig. 
59) and 57 °C for octamer (13 see fig. 60).
Figure 59: UV melting curve for peptide (12)
As already discussed, the hypochromic effect in an unmodified duplex is a 
result of base stacking, however, the model of peptide (12) obtained through the 
NMR experiments suggested that the inter-base distance was between 
approximately 5.57 -  5.87 A. This separation is much larger than that observed in 
either A- or B-form duplexes and is unlikely to support a TT-stacking interaction. This 
implies a more complex intermolecular relationship, such as interdigitation of the 
bases, as a more likely source of the melting behaviour. More extensive 
investigation is required to examine this hypothesis.
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Figure 60: UV melting curve for peptide (13)
Additionally, a melting experiment with (13) in the presence of a 
complementary strand of homooligomeric dA8 was also conducted in order to 
establish the hybridisation properties of the modified strand with natural DNA.
Figure 61: UV melting curve for modified T8 peptide strand (13) with dA8 DNA.
In an unmodified control experiment with T8/dA8 DNA strands, a melting 
curve was not recorded. The absorbance was found to rise linearly with temperature 
indicating the two strands failed to anneal. This finding was consistent with 
published data suggesting melting curves for duplexes of this type are usually only 
observed where high concentrations of salts are present.226 However, when (13)
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was subjected to the same experiment with a complementary dA8 DNA strand, a 
curve was observed (see fig. 61). Again, due to a slightly irregular shape, a melting 
temperature of between 59 -  64 °C was estimated. It is unclear whether this was 
due to the denaturation of the structure within the peptide strand, as the value was 
close to the 57 °C value estimated for the single strand experiment, or to melting of 
a duplex formed by two strands.
The presence of an 8-helix within the peptide chain was interesting for 
several reasons. Firstly, stable secondary structure in peptides as short as 4 
residues is rare. The presence of a helix in this case suggested strong steric 
influences on the conformation. Also the configuration of the sugars and bases 
compared to natural, double-stranded DNA presented the remarkable structural 
feature of having two planes of exposed heterocyclic bases either side of the helical 
core. This raised the possibility of conducting hybridisation studies, not only with a 
strand of complementary 2’-deoxyadenosine (dA) DNA homo-oligomer, but also 
with a strand of the corresponding dA derived peptide. It could be imagined that, if 
the dA analogue were to display the same conformational properties as the 
thymidine derived peptide, the potential existed to create a continuous array of 
parallel peptide strands held together by Watson-Crick hydrogen bonding. The 
natural progression of this project, therefore, was towards dA derived peptides 
produced from the appropriate dA p-amino acid (15) (see fig. 62).
Figure 62:2 ’-Deoxyadenosine derived peptide.
2.4 2’-Deoxyadenosine-derived p-Amino Acid Synthesis
The synthesis of the analogous 2’, 3’-dideoxyadenosine Fmoc amino acid 
was designed to follow a similar general strategy to that of the thymidine compound 
(see fig. 63). As with thymidine, the first step was protection of the 5’-OFI. Flowever, 
the exocyclic amine of adenine also required masking to prevent reaction at this site,
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not only through production of the monomer, but also through the course of solid- 





For this purpose, an orthogonal, acid-labile protecting group such as trityl or 
bis-N-Boc227 may have been appropriate for the exocyclic amine to enable the 
concurrent cleavage of the peptide from the resin and removal of protecting group 
from the heterocyclic base. This is a common tactic employed in the synthesis of 
PNA.209 Given then problems experienced with this type of procedure during 
attempts to make lysine appended thymidine oligomers, it was felt that a protecting 
group that could be removed whilst the peptide remained on the resin would carry a 
higher probability of successful characterisation of the peptide than an orthogonal 
method. Other combinations of protecting groups used for PNA synthesis include 
Boc with N-benzyl118 and Fmoc with N-benzyl.228 In each case Boc or Fmoc masks 
the peptidyl amine whilst benzyl protects the exocyclic amine of the purine or 
pyrimidine base.
The use of Fmoc in conjunction with acyl groups is also an established 
protecting strategy in PNA synthesis229 and appeared to be well suited to the 
synthesis of the target amino acid. It has been observed that N-acyl groups such as 
benzoyl offer stability under conditions commonly used for Fmoc SPPS.230 It is also 
known that a benzoyl protecting group can be selectively removed from the sugar 
hydroxyl groups on a nucleoside in the presence of an N-6-benzoyl group, without 
significant cleavage of the N-6-benzoyl itself.231 It was decided, therefore, that 
benzoylation of both the 5’-OH and exocyclic amine offered the simplest route to an 
appropriately protected monomer for both synthesis of the target Fmoc amino acid 
and SPPS. After protection of the reactive sites, two inversions of 3’- 
stereochemistry were required in a similar manner to that performed on thymidine to 
allow insertion of an azide with stereocontrol. As with the thymidine synthesis, after 




The key dibenzoylated intermediate (17, Scheme 5) was easily accessed 
from 2’-deoxyadenosine via either a two-step process, wherein 5’-C>-benzoyl-2’- 
deoxyadenosine (16) was isolated before further benzoylation of the amine,232 or by 
a more convenient one-pot method which directly afforded the di-protected 
compound233 (see scheme 5). In practical terms, the latter procedure was superior 
as the need to isolate and purify (16), which had a particularly difficult jelly-like 
physical form, was avoided. Thus 2’-deoxyadenosine in anhydrous pyridine was 
treated drop wise with a solution of 1.1 equivalents of BzCI also in anhydrous 
pyridine to introduce the 5’-0-benzoyl protecting group. As the exocyclic amine 
cannot be selectively benzoylated in the presence of the 3’-OH, the secondary 
hydroxyl group was then transiently protected with TMSCI before further treatment 
with BzCI afforded the fully protected nucleoside. The ability to selectively remove 
the silyl protecting group with base in the presence of the A/-benzoyl moiety was 
now demonstrated. The silyl group was removed with ammonia solution at 0 °C to 
give the desired di-benzoylated product (17) in yields of greater than 80 %. NMR 
experiments run in d6-DMSO showed an OH peak at 5.53 ppm which was confirmed 
by COSY to be the 3’-OH.
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The change from a pyrimidine to a purine nucleoside also altered the 
approach to the SN2 inversions for inserting the 3’-azide functionality. Neighbouring 
group participation from adenine could not be used in the same manner as thymine 










Techniques in the literature are mainly reliant on a 3’-0-sulfonyl strategy similar to 
the one earlier disregarded when considering inversion of the thymidine 3’-OH 
group. Both mesylate234 and trifluoromethanesulfonate235 are popular derivatives for 
this type of SN2 displacement reaction and both have remained so. Whilst mesylate 
is the poorer leaving group and requires longer reaction times, sources of triflate 
such as triflic anhydride are moisture sensitive and consequently more difficult to 
handle in practical terms. One notable exception to the use of sulfonate leaving 
groups is Gosselin and co-workers’ modified Mitsunobu-type procedure. This is 
performed using diethylazodicarboxylate and PPh3 with benzoic acid under 
conditions similar to those used to make 2,3’-anhydro thymidine derivatives.236 After 
hydrolysis of the resulting benzyl ester, this can be repeated to introduce azide with 
diphenyl phosphorazidate or hydrazoic acid.237
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Herdewijn’s route to 3’-azido-2’,3’-dideoxyadenosine using triflic anhydride238 
(see scheme 6) was chosen in preference to routes involving mesylate as it was 
believed that the benefit of the better leaving group outweighed the potential 
practical disadvantages. After first reacting the protected nucleoside with 1.5 
equivalents of triflic anhydride in anhydrous DCM/pyridine solution, water was 
added and the intermediate 3’-xylo compound (18) was obtained. In addition to the 
desired product, another compound of similar R, could be seen by TLC analysis. 
This compound was identified as 3’-benzoyl-3’-0-xy/o-2’-deoxyadenosine (22, see 
fig. 64) and was a result of undesired neighbouring group participation during the 
displacement reaction leading to some migration of the 5’-benzoyl group to the 
newly inverted 3’-OH.238 Although the two compounds were close on the TLC plate 
and had identical mass spectra and microanalysis compositions, distinguishing the 
two compounds by NMR was relatively easy.
22
Figure 64: Mechanism of 5’-0  -  3 ’-0  benzoyl migration.
The NMR spectra for the 3’-xy/o-OH compound had a very similar 
appearance to that of the starting dibenzoyl material, only slight shifts in the H3’ 
signal, from 4.64 ppm to 4.56 ppm, and a corresponding shift in the C3’ signal, from 
70.9 ppm to 69.7 ppm, were observed, however, the 3’-xy/o-OBz compound had a 
very different spectrum. As expected, large variations in the chemical shift of H3’, 
H5’, C3’ and C5’ were evident providing a strong indication that migration of the 
benzoyl group from the 5’- to the 3’-position had indeed occurred. Running the NMR 
experiments in cf6-DMSO revealed strong OH signals which were prominent enough
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to show COSY connectivity. The OH peak visible in both spectra could easily be 
assigned as either 5’- or 3’- due to COSY interactions, conclusively proving the 
identity of each of the compounds.
The 3’-0-benzoate is preferentially formed as the primary alcohol is a better 
leaving group than the secondary. Upon formation of the intermediate (21) it is more 
likely that the 5’-OH will depart resulting in isomerisation of the benzoyl group to the 
3’- position. Two solutions to the problem of benzoyl group migration were possible. 
The first was to add a single equivalent of benzoic acid to the reaction mixture in 
order to preferentially protonate the 3’-hydroxyl group and prevent (21) from forming.
An alternative method was to allow the formation of the 3’-0-benzoate then 
isomerise back to the 5’-benzoate using a weak base such as sodium hydrogen 
carbonate either in situ or after the completion of the reaction (see fig. 65). The 
latter method repeatedly produced a superior yield of the desired isomer, 
approximately 50 %, compared to half that for the benzoic acid procedure.
Figure 65: Mechanism of 3'-0 -  5 ’-0  benzoyl isomerisation.
The oily residue of the reaction of (17) with triflic anhydride was re-dissolved 
in methanol containing half an equivalent of NaHC03. The driving force behind the 
isomerisation reaction is the improved steric stability of the 5’-0-benzoate over the 
3’-0-benzoate. The use of NaHC03 catalyses the reformation of (21) and the 
sterically less hindered 5’- isomer now prevails. The slightly less acidic secondary 
3’-alcohol is more likely to be protonated in the presence of a weak base, preventing 




The displacement of the new 3’-xylo hydroxyl group was achieved with a 
repetition of the previous inversion reaction conditions; 1.5 equivalents of triflic 
anhydride in anhydrous DCM/pyridine, this time using LiN3 as the nucleophile 
instead of water. The fully protected azido nucleoside (19, scheme 6, p. 76) was 
obtained in an 86 % yield and, as with AZT, the compound was easily identified by 
the characteristic azide absorption in the IR spectrum at 2102 cm'1. 5’-OBz 
deprotection was performed using NaOH in a mixture of water, 1,4-dioxane and 
methanol at 0 °C.231 Strong base is selective for the removal of the O-benzoyl over 
the A/-benzoyl as the base deprotonates at A/-6-benzoyl leaving a delocalised 
negative charge at the amide. This negative charge then dramatically slows the rate 
of base-catalysed hydrolysis at this site allowing for the selective removal of the 
benzoyl group on oxygen, where this deprotonation process is not possible. 









At this stage it was proposed to follow the process that used to produce the 
thymidine Fmoc amino acid and reduce the azide by hydrogenation, followed by 
Fmoc protection and oxidation of 5’-C with TEMPO/BAIB to give the target amino 
acid (23, see scheme 7). The hydrogenation of the analogous AZT was carried out 
in methanol; however, (20) crystallised from methanol and could not be converted to
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the amine in this solvent, as the product was totally insoluble. A simple solution was 
to add water to the methanol. Whilst this did not solvate the starting material, the 
product solubility was much improved and the hydrogenation proceeded smoothly 
affording the amino nucleoside (24) in quantitative yield. Successful reduction was 
confirmed by the shift of H3’ 1 ppm upfield from 4.7 ppm in the azido nucleoside 
(20) to 3.7 ppm in amino alcohol (24).
Fmoc protection of (24) was successful as this reaction also required a 
water/organic solvent mix of 30 % aqueous 1,4-dioxane. Again, successful reaction 
was monitored by the shift of H3’ to 4.4 ppm as well as appearance of Fmoc peaks 
at 4.25 and 4.38 ppm and the characteristic Fmoc aromatic pattern between 7.3 -  
7.9 ppm. Unfortunately, the additional hydrophobicity introduced by the Fmoc group 
rendered the Fmoc alcohol (25) insoluble in aqueous acetonitrile, the solvent 
system required to oxidise the 5’-carbon with TEMPO/BAIB. Consequently, the 






Oxidation with TEMPO after reduction of the azido group was not possible 
as (24) was not sufficiently soluble in aqueous acetonitrile for the oxidation to occur. 
The poor solubility of the 3’-amino compound in aqueous solvents is likely to be due 
to the more aromatic character of adenine compared to thymine and this effect is 
exacerbated by the benzoyl protecting group of the exocyclic amine making the
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heterocyclic base even more hydrophobic. The final option was to oxidise (20) 
before reduction,239 producing the free amino acid (26, see scheme 8) which would 
subsequently be protected.
Oxidation proceeded smoothly using the standard conditions employed 
during thymidine oxidation195 to give (26) in 82 % yield. The azido acid was easily 
characterised by the absence of the H5’ protons in the 1H NMR and shift of C5’ to
171.4 ppm. The improved oxidation yield achieved with dA may lend support to the 
theory that the poorer crop of oxidised thymidine amino acid may be due to 
cleavage of the thymine double bond by BAIB205. With a much more aromatic 
character, adenine could be less prone to this type of oxidative cleavage of double 
bonds and hence the improved conversion rate. The improved yield alone is not 
sufficient to prove or disprove such a hypothesis.
Hydrogenation as a method of reduction for the azido nucleoside (26) 
proved unreliable, again due to solubility issues with both reactant and product. 
Combinations of water with methanol or ethanol were unsuitable. Addition of small 
quantities of dilute HCI,240 in an attempt to induce salt formation and increase the 
water solubility of the product, were unsuccessful. There are several reports in the 
literature of direct preparation of carbamates from azides using transition-metal 
catalysis241 or trimethylphosphine242 and corresponding carbamoyl chlorides. These 
rely on attack of the metal or phosphine on the chloroformate and producing a 
species similar to a Grignard reagent or phosphorus ylide. Attack of this 
intermediate on the azide then liberates N2 and subsequent hydrolysis gives the 
desired chloroformate. Attempts to utilise zinc powder241 with the azido acid (26) did 
not result in any recognisable product. Some of the more unusual methods of 
reduction of azides to amines include radical reactions with AIBN/Bu3Sn, lnCI3243 or 
Fe with AICI3 or BiCI3244 but by far the most popular alternative to hydrogenation for 
nucleosides is the Staudinger reaction.181 Triphenylphosphine attacks the azide 
forming an iminophosphorane then hydrolysis of this intermediate gives the desired 
amine and triphenylphosphine oxide.
The attractive aspect from our point of view was that there are many 
examples of Staudinger reductions with nucleosides in the literature performed in a 
variety of solvents.245 For application to a compound with difficult solubility, this was 
a promising possibility. Conversely, the biggest drawback to the Staudinger reaction 
is the production of triphenylphosphine oxide. This is not only the natural driving 
force for the reaction but is also notoriously difficult to remove from reaction
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mixtures. With already potentially difficult purification of the nucleoside in prospect, 
this was not desirable. However, resin bound triphenylphosphine246 or scavengers247 
offered prospective solutions for purification. With this in mind Staudinger conditions 
were tested for reduction of azido acid (26). Although formation of the 
iminophosphorane was extremely rapid as judged by TLC, the intermediate was 
stable to hydrolysis with water and with aqueous ammonia to the extent where 
partial debenzoylation of the exocyclic amine occurred. This extended stability of the 
intermediate iminophosphorane prevented the Staudinger method from being a 
suitable reduction procedure and further alternatives for the azide conversion were 
sought.
1,3-Propanedithiol248 and hydrogen sulfide155,182,249 are both known to reduce 
azides to amines in a relatively clean and efficient manner. Practically, their 
popularity is limited due to strong odours, especially in the case of 1,3- 
propanedithiol. For this particular reaction H2S appeared to be a good option for 
several reasons. Firstly, comparing the mechanism with that of 1,3-propanedithiol 
(see figs. 66 & 67), it can be seen how only elemental sulfur is produced as a by­
product. Combined with performing the reaction in Et3N/pyridine155, the primary 
product would be the triethylamine salt of the amino acid, which would be water 
soluble and easily separated from the sulfur by-product by water washes.
Figure 66: Mechanism of propanel,3-dithiol mediated reduction of an azide.
Lastly, directly obtaining a salt would prove useful in the final protection reaction 
with FmocCI as the salt would inevitably be required to solubilise the amino acid for 
this reaction to take place. The triethylamine salt (27) was indeed obtained after 
reaction with H2S in 15 % Et3N/pyridine. Along with large upfield chemical shift
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changes at H3’ and C3’, 5.06 ppm to 4.04 ppm and 63.5 ppm to 55.0 respectively, 
triethylammonium peaks were also present in both spectra.
Figure 67: Mechanism of H2S mediated reduction of an azide.
An interesting feature of the 1H NMR spectrum of compound (26) was a 
significant downfield shift of the adenine H8 proton (see fig. 68). This implies a 
change in the sugar pucker from C3’-exo to C3’-endo, or “south” to “north”. 
Electronegative substituents such as azide at C3’ favour a south configuration 
where the electronegative group adopts an axial position.250 Switching to a less 
electronegative group, as in this example converting an azide to an amine, releases 
this constraint and it can be seen that hydrogen bonding between H8 and the 5’- 
carbonyl would be possible, driving the sugar pucker to favour north (see fig. 69). 
This effect was not observed upon reduction of azido alcohol (20) to amino alcohol 
(24) and, therefore, must be linked to the presence of the 5’-carbonyl group. 
Favourable hydrogen bonding interactions are known to alter purine conformations. 
This behaviour is usually associated with guanine nucleotides,6 although the H-8 
proton of adenine has been observed to show similar hydrogen bonding interactions 
with the oxygen of the 5’-hydroxymethyl group.20 This theory was further supported 
by the return of H8 to the chemical shift observed in the azido compound upon 
introduction of the Fmoc protecting group on the 3’-amine.
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Figure 68: NMR spectra of H8 for azide (26) (left) and amine (27) (right)
Protection of the amine was achieved under the same conditions used for 
the thymidine analogue; a slight excess of FmocCI in aqueous 1,4-dioxane to afford 
(23) in 59 % yield. It was preferable to carry out the procedure at 0 °C to avoid di­
protection, something not seen when protecting the thymidine compound. As for the 
protected thymidine amino acid, the successful addition of the Fmoc group was 
shown by the additional resonances present in the proton NMR between 7 and 8 
ppm, assigned to the aromatic portion of the fluorenyl group, and at around 4.3 ppm, 
for the protons of the saturated 2-carbon chain.
Figure 69: Possible sugar pucker change upon reduction of 3 ’-azide group.
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With the protected amino acid in hand it was now possible to attempt to 
produce peptides similar to those made with the thymidine amino acid using the 
same SPPS techniques.
2.5 Solid-Phase Peptide Synthesis of 2’-Deoxyadenosine-derived p- 
Peptides
SPPS with the dA derived amino acid was initially performed using the 
optimised conditions developed for the analogous thymidine compound. Inter­
residue couplings were reasonably efficient, at around 95 %. However, coupling of 
the 5’-terminal residue to the resin was much less effective, at 31 %. This is possibly 
due to the increased steric bulk of the protected dA amino acid compared to the 
thymidine compound (see table 4). Optimisation showed that the preferred solvent 
for the dA monomer was DMF and HBTU remained the preferred coupling reagent. 
Although this initial coupling was still relatively poor for SPPS, as the following 
couplings were highly efficient this was acceptable as a significant amount of 
peptide would be produced. Using this combination, successful peptide synthesis 
was achieved. Due to the extra hydrophobicity imparted by the A/-6-benzoyl 
protecting groups, without removal of the 3’-terminal Fmoc moiety peptide (28, see 
fig. 70) proved too insoluble in aqueous solvents to be analysed by RP-HPLC. 
Characterisation of (28) by mass spectrometry was possible (see table 5).
Amino Acidb Solvent Coupling Agent Coupling Yield/%
mdA1 DMAc HBTU 31
mdA1 DMAc PyBOP 49
mdA1 DMF HBTU 74
mdA1 DMF PyBOP 24
mdA2 DMF HBTU 95
Table 4 bThe  en try  “m dA 1” re fers to  th e  firs t ad en o s in e  de rived  a m in o  ac id  cou p ling  to  th e  resin  and “m d A 2” 
re fe rs  to  the  second  ad enos ine  de rived  am in o  ac id  cou p ling  to  m d A 1 .
After removal of the terminal Fmoc group, peptide (29 see fig. 70) was 
successfully characterised by HPLC and ES-MS (see table 5). Attempts were then 
made to remove the A/-6-benzoyl protecting groups. Applying the common 
conditions for benzoyl group deprotection of aqueous ammonia at 55 °C251 resulted 
in complete degradation of the peptide.
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(28) n = 4, R = Fmoc




Figure 70: Nucleoside (3-peptides derived from 2 ’-deoxyadenosine produced by 
SPPS.
Oligomer n R Molecular Formula HR mass required
HR mass 
found









This is a problem which is known in PNA synthesis, especially with proline 
derivatives, and is usually a consequence of intramolecular attack of the A/-terminal 
amine on the carbonyl group of its nearest neighbour, forming a dihydropiperazine 
derivative (see fig. 71). This is then subject to further hydrolysis, eventually affording 
dipeptide units.252 Given the relative stereochemistry of the nucleoside (3-amino 
acids, this pathway is an improbable route for decomposition as the eight- 
membered piperazine intermediate would be extremely strained and unlikely to form. 
This was confirmed by the absence of any dipeptide fragments in the reaction 
liquors.
Figure 71:
An alternative, milder procedure to heating the peptide in ammonia solution 
is to dilute the ammonia solution with 50 % 1,4-dioxane as a co-solvent and perform 
the reaction at ambient temperature.253 Under these conditions some deprotection 
was observed by mass spectrometry. However, more than 10 other major peaks
86
were detected by HPLC leading to the conclusion ammonia was not a suitable 
reagent for the removal of the benzoyl groups. NaOH in aqueous methanol254 also 
produced a similar HPLC trace but no deprotection products were detected by mass 
spectrometry.
Using the optimum conditions developed for the synthesis of both the T and 
dA derived peptides a mixed sequence of the form TATA was successfully 
produced in Fmoc on (30) and off (31) forms (see fig. 71) and characterised by ES- 
MS (see table 6).
(30) n = 4, R = Fmoc
(31) n = 4, R = H
Figure 71: TATA mixed sequence peptides.
Oligomer Sequence R Molecular Formula HR mass required
HR mass 
found
30 TATA Fmoc C69H65N190 162+ 707.7423 707.7449
31 TATA H 054H55NigOi42+ 596.7083 596.7112
Table 6
Although different solvents were preferred by each nucleoside, T preferring DMAc 
whilst dA coupled best in DMF, switching between solvents during the synthesis 
was possible without greatly affecting coupling yields. This indicated that solvent 
interactions of the uncoupled monomer have a larger influence on coupling 
efficiency than solvation of the resin bound peptide. In the absence of viable 
deprotection conditions for the adenine A/-6 benzoyl group, structural 
characterisation of the dA tetramer was attempted with the protected oligomer.
2.6 Structural Characterisation of 2’-Deoxyadenosine-derived P-Peptides
As it was not possible to remove the benzoyl protecting groups without 
denaturing the peptide chain, structural characterisation of protected peptides (28) 
and (29) was attempted with the same set of NMR experiments used for the 
thymidine derived oligomers; DFQ-COSY, NOSEY, TOCSY and VT-NMR. 
Unfortunately, analysis of the NMR spectra obtained showed that, unlike the 
thymidine derived oligomers, the inter-residue amide protons were poorly resolved
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and also coincided in chemical shift with those of the benzoyl protecting groups. 
This made measurement of temperature coefficients extremely problematic and 
observation of nOe couplings was not possible. Therefore, the existence of structure 
within the protected dA derived peptides could not be determined by NMR.
2.7 Conclusion
Fmoc 3-amino acids derived from both thymidine and 2’-deoxyadenosine 
were successfully synthesised from the parent nucleosides. The T amino acid was 
produced in 6 steps with an overall yield of 18 % from thymidine and the dA amino 
acid obtained in 6 % yield over 7 steps from 2’-deoxythymidine. Both amino acids 
were polymerised using optimised Fmoc solid-phase peptide synthesis protocols 
affording homo-oligomers of varying lengths and a tetrameric mixed sequence of 
the form TATA. A tetrameric thymidine derived homo-oligomer was examined in de- 
DMSO solution by NMR (as the peptides were insufficiently soluble in CDCI3 or 
MeOD). This peptide was found to adopt an 8 helical conformation with the sugars 
occupying a zigzag arrangement at the centre of the structure and the bases 
presented in two planes on opposite sides of the helix. UV melting studies appeared 
to corroborate the findings of the NMR experiments and showed that single strands 
of 3-peptide produced an almost sigmoidal melting curve consistent with 
denaturation of ordered structure. It is still uncertain as to whether a thymidine- 
derived homo-oligomer successfully annealed with a complementary homo-dA DNA 
strand as this melting experiment was inconclusive.
Recently, Chandrasekar and co-workers have undertaken independent 
studies on the same thymidine derived oligomers produced using Boc-based 
solution-phase chemistry.160 Interestingly no significant issues of cleavage of the 
glycosylic bond under acidic deprotection conditions were reported. Structural 
analysis was performed in a mixture of MeOD/CDCI3 and resulted in assignment of 
the solution structure as a 12-helix, analogous to that of Gellman’s frans-(ACPC).160 
One major consistency with the current work was noted. As could be expected, both 
models of the tetramer placed the sterically demanding thymine towards the outside 
of the helix. The difference in NMR solvent is important as, even though DMSO is 
often the solvent chosen for NMR experiments with short peptides, changing 
solvents can produce quite different spectra for the same 3-peptide compound.89 
The possibility that a highly functionalised oligomer such as a nucleoside 3-peptide 
adopts solution conformations which are greatly solvent dependent cannot be ruled 
out without further investigation.
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It was not possible to assign any structure to the homo-oligomers derived 
from 2’-deoxyadenosine due to the presence of protecting groups. All attempts to 
remove the benzoyl moieties resulted in degradation of the peptide chain and, 
therefore, structural characterisation was attempted on the protected oligomers. 
Overlap of the benzoyl aromatic resonances with those from the inter-residue amide 
protons prevented the observation of through space connections and measurement 
of temperature coefficients which were key to assigning the structure of the 
thymidine derived oligomers. It is hoped that future work with an alternative N6- 
protecting group will facilitate structural analysis.
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Chapter 3
Results and Discussion 2: 
Fluorous-Phase Synthesis
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3 Results and Discussion 2
3.1 Introduction to Fluorous-Phase Synthesis
The technique of solid-phase synthesis for both peptides and 
oligonucleotides is limited by several factors; scalability, reduced reactivity at resin 
surfaces due to steric hindrance and lack of a reliable quantitative method of 
analysis of the coupling reactions. During SPPS for this project all of these 
drawbacks were evident. It was necessary to load the solid-phase resin at 25 % of 
its full capacity in order to prevent interchain aggregation as the polymers were 
extended. This had obvious implications for larger scale syntheses. As the 
nucleoside (3-amino acid was also sterically bulky, an extended reaction time of 5 
hours was required for coupling of the first residue to the resin and 30 minutes for 
each subsequent inter-residue coupling, significantly extending the synthetic cycle. 
The absence of compatible analytical methods for solid-phase was mainly an issue 
during optimisation of the Fmoc SPPS protocols. Colormetric tests such as the 
TNBS test were only suitable for giving a qualitative indication on the success or 
failure of any given coupling reaction. For any quantitative data it was necessary to 
either cleave the compound from the resin and analyse by UV or HPLC or to 
deprotect the Fmoc group and assay for dibenzofulvene. Both of these methods 
involved terminating the synthetic cycle and beginning the synthesis afresh. The 
combination of these factors made optimisation of the SPPS procedure extremely 
time consuming and labour intensive.
Whereas solid-phase procedures are subject to these types of constraint, 
solution-phase chemistry is commonly performed on industrial scale with full 
analysis possible at any point. It is clear that a reliable method of solution-phase 
synthesis for polypeptides would be attractive. Fluorous-phase synthesis (FPS) 
presents an interesting, solution-phase alternative to the traditional solid-phase 
approaches to oligomer production. It is known that short oligonucleotides, 
oligosaccharides and peptides can be synthesised in solution-phase via fluorous 
chemistry255 and that the fluorous components used are generally recyclable.256 
Additionally, the chemically inert, non-flammable, thermally stable257 and non­
toxic258 nature of the highly fluorinated solvents used makes this type of chemistry 
equally appealing with respect to environmental and safety considerations.
FPS utilises the unique solubility properties of highly fluorinated compounds 
as a handle for purification of organic compounds. The principle of FPS relies on the
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fact that organic compounds containing a high proportion of fluorine are 
preferentially soluble in perfluorinated solvents (perfluoroalkanes, perfluorodialkyl 
ethers and perfluorotrialkyl amines) and these perfluorinated solvents have a very 
low miscibility with organic solvents.259 Appending an organic compound with a 
removable perfluorinated tag provides a convenient method of purification of a 
product or removal of an unwanted by-product by simple partition between organic 
and fluorous phases.
This principle was first demonstrated in practice when Horvath and Rabai 
attempted to tackle the problems posed by separation of long chain aldehydes (C8 
or more) from the rhodium/triphenylphosphine catalyst used in the oxo process.260 
One solution was to use an aqueous biphasic system where organic products were 
easily partitioned from the preferentially water-soluble catalyst. This approach was 
limited by the poor solubility of the starting alkenes in water. As the alkenes were 
more soluble in fluorous solvents it was possible to perform the reaction in a 
biphasic mix of toluene and C7F14 in the presence of a specially designed, fluorous 
soluble Rh catalyst HRh(CO)(P[CH2CH2(CF2)5CF3]3)3.261 The product aldehydes 
were preferentially soluble in the organic phase and were easily separated from the 
catalyst, as this remained in the fluorous layer (see fig. 72). Since this initial 
demonstration of FPS, fluorous techniques focussed on liquid-liquid extraction have 









Figure 72: Fluorous-phase oxo reaction.
3.2 “Heavy” Fluorous Chemistry
Successful fluorous liquid-liquid extraction is dependent on the number and 
distribution of fluorines within a molecule. A fluorinated compound containing
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greater than 60 % fluorine gives the best performance in terms of partition.263 In 
addition, to protect the rest of the molecule from the powerful electron withdrawing 
effects of multiple fluorines, a hydrocarbon spacer must be present between the site 
of reaction and the perfluorinated chain. Usually (CH2)2 or longer, this organic 
soluble section must, as far as possible, be appropriately shielded from the fluorous 
solvent to maximise partition.264 FC-72 (perfluorinated hexane) is the solvent of 
choice for extractive work-up with organic solvents as it is the least miscible of all 
the commonly used fluorous solvents,265 ensuring the highest partition. Heavy 
fluorous methods (see fig. 73) have found extensive use in procedures such as the 
oxo process in which separation of one or more components of the reaction is 
problematic. A further example of this is the Mitsunobu reaction.
= Fluorous tag; <̂ H i  ̂ = Reactant 1; 0 5 D 1 = Reactant 2; 1 X 1 Y I = Organic 
reagents (e.g. base, catalyst)
Figure 73: Schematic of heavy fluorous-phase process.
Mitsunobu reactions are synthetically very useful but the presence of 
phosphine oxides and hydrazine derivatives as by-products often complicates 
purification. Mitsunobu reactions have been carried out with fluorous modifications
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to phosphine, azodicarboxylate and even the nucleophile, with excellent separation 
of the fluorous component.266 The gallic acid derivative 3,4,5-tris(4- 
(perfluorooctyl)butoxy)benzoic acid (see fig. 74) displays all the requirements for 
good liquid-liquid extraction; 60.9 % fluorine with good shielding of the hydrocarbon 




Figure 74: Johansson’s fluorous gallic acid derivative.
This fluorous gallic acid derivative was successfully reacted in a Mitsunobu 
procedure with a number of primary and secondary alcohols in the presence of 
DIAD and PPh3.267 Isolation of the pure products using conventional liquid-liquid 
extraction was found to be inefficient for some of the perfluorinated esters due to the 
altered ratio of fluorous to organic content. In these cases, purification was achieved 
using an alternative technique known as organic liquid/fluorous solid separation. 
Similar to a standard organic crystallisation, a fluorous compound soluble in one 
organic solvent, in this instance THF, is precipitated out of solution by the addition of 
another solvent, such as 50 % MeOH/CHCI3. Isolated yields for most of the alcohols 
tested exceeded 90 %.
3.3 “Light” Fluorous Chemistry
A distinct division emerged in the field of fluorous chemistry with the 
introduction of fluorous solid-phase extraction (F-SPE).268 Whereas much of the 
early work such as that on the fluorous oxo reaction was “heavy” , the new technique 
employed fluorinated silica to perform solid-phase extractions. Termed “light” 
fluorous chemistry, this method improved the scope of fluorous chemistry as the 
shorter fluorous tags used were much more soluble in common organic solvents. 
However, with less fluorination, these tags were now unsuitable for use in liquid- 
liquid extraction and separation via fluorous solid-phase was established as the 
purification method of choice.
F-SPE is, in essence, simplified column chromatography and as such has a 


















Figure 75: Normal-phase F-SPE (top) and reverse-phase F-SPE (bottom). (Figure 
adapted from reference 262).
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In the standard method, the crude mixture containing both fluorous and organic 
fractions is loaded onto a silica stationary phase functionalised with perfluoroalkyl 
chains, known commercially as FluoroFlash™. The column is then eluted first with a 
fluorophobic eluent, for example 80 % MeOH/H20, followed by a fluorophillic wash 
with an anhydrous organic solvent such as anhydrous methanol or acetonitrile. 
Water is considered the perfect fluorophobic solvent270 and as a result the aqueous 
solvent will not elute any fluorinated compound from the silica. All organic 
compounds will, however, be eluted in this fraction leaving the fluorous compounds 
to be removed by the later fluorophillic eluent. In reverse-phase F-SPE, non- 
fluorinated silica is used and eluted first with a blend of fluorous and organic 
solvents. Reverse phase is mainly used for removal of fluorous catalysts or 
reagents from organic targets as, after the removal of the first fluorous fraction, 
conventional column chromatography can then be performed on the retained 
organic compounds if required.
3.4 Fluorous-Phase Peptide Synthesis (FPPS)
For each stage in the synthetic sequence of peptides, fluorous chemistry has 
been applied in some way. Fluorous capping reagents have been used to both 
remove failure sequences and isolate finished peptides from crude mixtures cleaved 
from solid-supports. Filippov and co-workers functionalised a 35 residue a-peptide 
constructed by SPPS with a fluorous methanesulfonyl ethoxycarbonyl group and 
purified the tagged chain by fluorous FIPLC.271 Montanari and Kumar capped 
deletion sequences with a simple perfluoroalkyl chain and separated these from the 
unmodified peptide by F-SPE.272 A wealth of fluorous protecting groups and 
coupling reagents have recently become commercially available273 reflecting the 
increasing interest in this type of separation technology. By far the most radical 
approach to peptide synthesis utilising fluorous reagents is the replacement of solid- 
phase resins with “fluorous supports”.
Mizuno and co-workers synthesised the fluorous equivalent of Wang resin 
and also a trialkoxybenzhydryl and a f-butyl support from highly fluorinated 
compound hexakis-(fluorous chain) butanoic acid (Hfb-OH, see fig. 76) by reaction 
with 1,2-ethylenediamine and the appropriate linker.274 The tripeptide thyrotropin 
releasing hormone was produced by standard Fmoc peptide synthesis protocols 
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= fluorous support 
base; PG = protecting group
= Amino acid; = Coupling agent;
B
Figure 76: Mizuno’s Hfb-OH fluorous support and schematic of fluorous-phase 
peptide synthesis.
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The removal of the Fmoc group from the linker amine was achieved in a 
biphasic mix of FC-72 and 5 % piperidine in DMF. Dibenzofulvene was removed in 
the organic layer by simple separation of the two phases after the deprotection was 
complete. Coupling of amino acids was performed with PyBOP and DIPEA in a 
mixture of HFE-7200 (C4F9OEt) and CH2CI2 and the finished peptide was cleaved 
from the fluorinated support with 2.5 % aqueous TFA. All intermediates were 
purified using an extractive work-up with FC-72 and the final product separated from 
the fluorous compound by extraction with water. Pentapeptide salusin-a was also 
synthesised using a similar trialkoxybenzhydryl support.256 Even though both of 
these peptides still required purification by HPLC, the fact that production was 
possible and uncomplicated demonstrated the potential of fluorous chemistry to 
offer a real alternative to SPPS.
3.5 Towards Fluorous Synthesis of Nucleoside P-Peptides
Preliminary investigations into the application of heavy fluorous chemistry for 
synthesis for nucleoside p-peptides were conducted during a 12 week visit to the 
University of Tokyo. The fluorous support used in these experiments was the 
dendrimer FD-O(H) (32, see fig. 77) which is structurally reminiscent of Johansson’s 
highly fluorinated gallic acid derivative.
Figure 77: Fluorous dendrimer (FD-O(H)).
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The fluorine content, 61.69 %, is above the ideal 60 % required for liquid- 
liquid extraction and the phenyl rings and three methylene groups separating the 
hydroxy group from the perfluorinated alkyl chains provide excellent insulation of the 
reaction site from the electron withdrawing fluorines. Roughly following the method 
of Mizuno et a l274, it was proposed to couple the nucleoside p-amino acid with the 
fluorous dendrimer in a mixture of fluorous and organic solvents in the presence of 
an ester bond-forming reagent and base. After coupling, separation would be 
achieved by addition of FC-72 and extraction of excess reagents with water and 
other immiscible organic solvents. Deprotection could then be performed in a similar 
FC-72/DMF biphasic system in preparation for chain extension with the subsequent 




After screening many permutations of temperature, coupling reagents and 
solvents, no suitable reaction conditions for the coupling of the amino acid could be 
identified. Earlier SPPS work had demonstrated that the nucleoside amino acid was 
approximately 30 % less efficient in forming ester bonds than amide linkages with 
solid-phase resins (see section 2.2). The failure of this esterification was thought to 
be due to severe steric hindrance from both nucleoside and dendrimer similar to 
that found at the surface of a resin. Drawing the analogy with SPPS it was decided
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to attempt to attach a linker to the dendrimer in order to alleviate the problem of 
steric interference and facilitate coupling.
The ideal linker would not only be sterically small, in order to avoid the 
difficulties encountered by the large nucleoside, but would also offer a terminal 
amine group for condensation with the nucleoside amino acid instead of the alcohol 
moiety of the dendrimer. A smaller a-amino acid such as glycine would fit both 
criteria and with this in mind, attempts were made to couple Fmoc-Glycine-OH with 















Conducting the esterification reaction of Fmoc-Gly-OH with the dendrimer in 
solution allowed analysis of the mixture by TLC, something which is impossible with 
standard SPPS. Condensation was successfully accomplished using the ester bond 
forming reagent 1,3-dimethyl-2-(3-nitro-1,2,4-triazol-1-yl)-2-pyrrolidin-1-yl-1,3,2- 
diazaphospholidinium hexafluorophosphate (MNTP, see fig. 78)275. MNTP is a 
phosphonium coupling agent similar to PyBOP but incorporating a 3-nitro-1,2,4- 
triazole moiety instead of a hydroxybenztriazole and a bridged dimethyl-diaza 
functionality in place of two of the usual three pyrrolidine groups. The ester bond 
formed in under 1 hour in the presence of 5 equivalents of 2,4,6-collidine in THF at 
45 °C. Work-up of the reaction mixture was simply a matter of addition of a small 
volume of FC-72 and washing the resulting fluorous layer with water and CHCI3. As
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a precaution against loss in the washings, both water and organic layers were then 
backwashed with FC-72. It is uncertain if this was absolutely necessary as the 
contents of the respective layers were not analysed.
Figure 78: MNTP
Another major advantage of fluorous-phase synthesis in terms of analysis 
was then demonstrated. A sample of the residue after evaporation of the FC-72 was 
dissolved in a mixture of 3:1 CDCI3/C6F6 and analysed by NMR spectroscopy. After 
this data was obtained, the mixed NMR solvents could then be removed under 
reduced pressure, the sample returned to the bulk material and the synthetic 
procedure continued without loss of any material. The NMR spectrum showed a 
nearly identical resonance pattern in the aromatic region to that observed for the 
Fmoc group of Fmoc nucleoside p-amino acids (9) and (23) (see figs. 79 & 80). 
Peaks at 4.1 ppm and 5.3 ppm corresponding to Fmoc H-10 and H-9 were also 
observed.
Figure 79: Aromatic region of 1D NMR of FD-O(H).
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Figure 80: Aromatic region of 1D NMR of FD-O-Giy-NHFmoc (33)
The peak of the glycine CH2 was also plainly visible at 4.4 ppm. As for any solution- 
phase conversion it was also possible to establish an isolated yield (88 %) for the 
glycine derived dendrimer; a measurement which is unattainable in SPPS without 
termination of the synthesis. Identification of the glycine derived dendrimer (33) was 
later confirmed by MALDI-TOF mass spectrometry.
In order to test if the SPPS conditions used in previous syntheses of 
nucleoside p-peptides were directly transferrable to the fluorous-phase procedure, 
deprotection of the Fmoc group was attempted with a biphasic mixture of FC-72 and 
2 % DBU/DMF. The Fmoc group was successfully removed within a few minutes of 
exposure to the base, however, significant cleavage of the glycine from the 
dendrimer was also observed. This is most likely due to formation of an oxazolone 
derivative by attack of the imidate oxygen generated by deprotonation of the Fmoc 
amide. This mechanism is similar to racemisation of activated N-acyl protected 
amino acids (see fig. 81). This problem is commonly encountered in PNA 
synthesis122 and in this case resulted in the cleaved dendrimer being the major 
product isolated in the fluorous layer after work-up. To suppress this side reaction 
the reactive imidate could be trapped out by the addition of a silylating agent to form 
a silyl enol ether and this could subsequently be hydrolysed by an acidic wash 
which would also serve to neutralise the DBU.
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Figure 81: N-acyl transfer resulting in cleavage of glycine from the fluorous 
dendrimer.
A more straightforward approach was to replace DBU with the less basic 
piperidine which has been observed not to give acyl migration products during Fmoc 
synthesis of PNA.228 Successful deprotection was achieved by treatment with a 
10 % solution of piperidine in DMF in biphasic conditions for 30 minutes. The NMR 
spectrum showed disappearance of the Fmoc resonances and shift of the glycine 
and dendrimer methylene protons to 3.56 and 5.18 ppm respectively.
Thymidine nucleoside amino acid (9) was condensed with the glycine 
derived dendrimer using HBTU in a THF suspension in the presence of 2,4,6- 
collidine. After 24 hours at ambient temperature the reaction was not complete; the 
product to starting material ratio was approximately 3:1 by NMR. Peaks 
corresponding to H1 ’, H3’ and H4’ of the sugar ring were all clearly visible alongside 
the same aromatic pattern for the Fmoc protons as seen with glycine. The reaction 
proceeded no further after extended periods of time. Heating the reaction to 45 °C 
also failed to drive the reaction beyond approximately 50 % completion. It is thought 
that the major barrier to a smooth reaction is the vastly different solubility of the 
dendron compared to the amino acid. Whilst THF is a suitable solvent for the 
dendron, the nucleoside was only sparingly soluble and caused aggregation of the 
fluorous component when coupled. Although encouraging coupling results were 
achieved in this solvent, the system requires further optimisation.
Cleavage of the dipeptide unit was achieved by treatment of a THF solution 
of the dendrimer with concentrated ammonia at ambient temperature for 2 hours. 
After partition with FC-72 the fluorous dendron was recovered in 93 % yield
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demonstrating that recycling of the fluorous support would be possible after the 
completion of a synthetic cycle.
3.6 Limitations and Extensions of FPS for Peptide Synthesis
One of the more challenging aspects of the use of heavy fluorous chemistry 
for oligomerisation protocols is the need to maintain the ratio of 60 % fluorine for 
efficient partition in extractive work-up. In the case of the thymidine (3 amino acid (9) 
coupling only two residues, glycine and a single thymidine amino acid, to the 
fluorous dendrimer reduces the fluorine ratio to under 56 %. As the peptide chain is 
lengthened, the fluorine content will progressively diminish until it reaches a level at 
which partition with fluorous solvents is no longer effective.
This problem could potentially be solved by the inclusion of a fluorous moiety 
in the amino acids themselves. The best prospect for introduction of such a group 
would be as part of the protecting strategy. Fluorous fmoc (see fig. 82) is 
commercially available but presents only a limited opportunity to improve the 
fluorine ratio of any peptide if it is only incorporated as the W-terminal protecting 
group. The other site that requires protection in this type of amino acid is the 
nucleobase. Whilst a protecting group for thymine was not explicitly necessary 
during the synthesis or oligomerisation of the T amino acid, the exocyclic amine of 
adenine required masking to prevent unwanted side reactions from occurring. 
Protection of the nucleobase with a fluorous group could provide the additional 
fluorines required for successful peptide synthesis by heavy fluorous methods.
It is also interesting to consider the use of fluorous protecting groups for 
conventional SPPS. Benzoyl protection of the exocyclic amine of the dA derived 
amino acid was found to be problematic in terms of deprotection and an alternative 
is required for production of fully deprotected peptides. Orthogonal, acid-labile 
protecting groups are an attractive option; however, when removed at the same 
time as the peptide is cleaved from the resin, these groups present an obvious 
impurity in the final product. These impurities would require removal by HPLC and 
this would impose limitations on the scale of production. If it were possible to 
introduce a fluorous, acid-sensitive functionality as the nucleobase protecting group, 
for example a fluorous trityl derivative, then it is, in principle, possible to consider 





Figure 82: Fluorous fmoc (top) and dimethoxytrityl (bottom).
The fluorous trityl derivatives which are already commercially available (see 
fig. 80)273 would not be appropriate for heavy fluorous chemistry, as the fluorine ratio 
is too low, but would be ideally suited to a standard F-SPE process. Conversely, the 
use of fluorous Fmoc on the peptide N-terminus and an organic nucleobase 
protecting group would also have the same potential for separation by standard F- 
SPE and this type of procedure has already been successfully demonstrated with 
small dipeptides276.
3.7 Conclusion
A model peptide synthesis using fluorous-phase chemistry with nucleoside 
p-amino acids has been performed. The intermediate compounds from each of the 
individual deprotection, coupling and cleavage steps were all purified without the 
need for chromatography and analysed whilst still bound to the fluorous support. 
Equivalent purification and analysis is not possible with traditional SPPS 
approaches.
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FPS is, however, not without issues which will require addressing for the 
future of this technology. The maintenance of the 60 % fluorine ratio has already 
been discussed in the previous section and this is something which can be 
considered in conjunction with a reaction that is yet to be attempted by fluorous 
means; capping of failure sequences. Capping could possibly be attempted in either 
single phase system in a manner similar to the coupling step or a biphasic approach 
akin to the deprotection step. It is not easy to speculate on which will offer the most 
efficient pathway, as much will depend on the solvent compatibility of the capping 
reagent with the fluorous or organic solvent systems. Optimum conditions should be 
relatively straightforward to determine experimentally. Failure sequences are also 
as much of a problem in this type of FPPS as in SPPS. A possible solution is to, 
once more, utilise the 60 % ratio as a handle for separating complete from deletion 
sequences by differentially capping the completed peptide. This, however, would be 
far from ideal as the capping reagent would require a large molecular weight in 
order to significantly alter the fluorine ratio. Even if such a cap could successfully be 
attached to the peptide, efficient partition would not be guaranteed.
There are many more possible and alternative opportunities to utilise FPS 
chemistry in peptide synthesis. This procedure most of all represents one of the 
major attractive aspects; the ease of purification of fluorous compounds. Isolation of 
oligonucleotides and peptides made by more conventional means often relies on 








Analytical thin layer chromatography (tic)
Performed on 2 cm x 5 cm Merck silica gel 60 F254 aluminium plates. Plates were 
visualised with a 254 nm UV lamp before staining with p-anisaldehyde “dip” (see 
general reagents). Nucleoside compounds were stained blue on exposure to a heat 
gun.
Flash column chromatography
The required quantity of silica gel (40 -  63 pm particle size from BDH) was made 
into a slurry with column eluent and applied to the column over a sand base layer. 
Crude material was introduced in either a minimal volume of column eluent or 
adsorbed onto silica.
High Performance Liquid Chromatography (HPLCt
HPLC was performed on an automated Gilson HPLC system equipped with an 
autoinjector, a photodiode array detector and a dual hydraulic pump. 
Chromatographic data was handled using UniPoint Version 3.0 and absorptions 
measured at 254 nm.
Separations were performed on a Phenomenex® reverse-phase 250 mm x 4.6 mm, 
Gemini 5u C18 110 A  column using a gradient of 0 -  30 % MeCN in aqueous 
triethylammonium bicarbonate (TEAB, 0.1 M) for thymidine oligomers and 0 - 4 0  % 
MeCN in aqueous triethylammonium bicarbonate (TEAB, 0.1 M) for 
deoxyadenosine oligomer over 30 minutes. The gradient was followed by a 10 
minute column flush with the 30 or 40 % MeCN eluent.
NMR Spectroscopy
Spectra were recorded on a Bruker AMX-400 MHz machine. Coupling constants are 
reported in Hz and chemical shift values are given in ppm from an internal standard 
of tetramethylsilane (TMS). Chemical shift values for some aromatic protons, 




Spectra for thymidine compounds were recorded in nujol mulls on a Perkin Elmer 
FT-IR Paragon 1000 spectrometer. 2’-Deoxyadenosine samples were recorded neat 
on a Jasco FT-IR 4100 spectrometer equipped with an ATR sample holder.
UV Spectroscopy
Spectra were recorded at the stated wavelengths on a Hewlett Packard 8452A 
spectrodiode array in 1 cm quartz cuvettes.
Mass Spectrometry
Electrospray spectra were recorded by Mr Allan Mills of the University of Liverpool 
mass spectrometry service on a Micromass LCT using electrospray ionisation (El) in 
the specified ionisation mode with a direct infusion syringe pump.
CHN Microanalvsis
Obtained by Mr Steve Apter of the University of Liverpool microanalysis service on a 
Thermo FlashEA 1112 series CHNSO analyser.
Melting Point
Where physical form allowed, melting point was determined on a Gallenkamp 
melting point apparatus.
Solvents
Unless stated solvents were purchased from Fisher Scientific or BDH. Anhydrous 
solvents were obtained as follows:
Dichloromethane: Distilled from calcium hydride.
/V,A/-Dimethylacetamide, W./V-dimethylformamide & 1,4-dioxane: Sure-seal™ 
anhydrous reagents purchased from Sigma-Aldrich.
Methanol: Distilled from magnesium and iodine.
Pyridine: Distilled from calcium hydride
General Reagents
Unless stated, reagents were purchased from Sigma-Aldrich, Fluka or BDH and 
used as supplied. Thymidine was purchased from Alfa Aesar, 2’-deoxyadenosine
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was purchased from ChemGenes (USA) in monohydrate form and dried by co­
evaporation with anhydrous pyridine before use. 2-(1 H-Benzotriazole-1-yl)-1,1,3,3- 
tetramethylaminium hexafluorophosphate (HBTU) and benzotriazole-1-yl-oxy-tris- 
pyrrolidino-phosphonium hexafluorophosphate (PyBOP®) were purchased from 
Lancaster Synthesis and stored at 4 °C over silica desiccant before use..
p-Anisaldehyde “dip” was prepared as follows: p-Anisaldehyde (6 ml) was mixed 
with sulfuric acid (8.0 ml), acetic acid (2.4 ml) and ethanol (218 ml) and stored at 
room temperature in darkness.
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4.1 Synthesis of 3’-N-(9-fluoromethoxycarbonyl)-amino-3’-deoxythymidine- 
5’-carboxylic acid
Preparation of 2-3’-anhydro-5’-0-(4-O-methoxybenzoyl) thymidine (5)
0
Thymidine (10.0 g, 41 mmol) and PPh3 (16.2 g, 62 mmol) were dissolved in 
anhydrous DMF (120 ml). To this stirred mixture was added p-methoxybenzoic acid 
(9.4 g, 62 mmol) followed by DIAD (12.2 ml, 62 mmol) drop-wise over 30 minutes. 
The reaction vessel was kept at < 2 °C in an ice/water bath during this addition. The 
solution was left to stir at ambient temperature for 15 minutes then a further aliquot 
of PPh3 (19.6 g, 75 mmol) and DIAD (14.7 ml, 75 mmol) was added in the same 
manner. After half the DIAD addition, an off-white precipitate had appeared. The 
reaction mixture was left to stir at ambient temperature for a further 2 hours then 
poured into Et20  (1250 ml) and cooled to 4 °C overnight. The white powdery 
precipitate was filtered off and thoroughly washed with Et20.
Yield: 14.9 g, 41 mmol, > 99 %, m.pt. > 250 °C
51H (400 MHz, DMSO-cfe) 1.74 (3H, s, CH3, Thy), 2.52 (1H, m, H2’), 2.61 (1H, m, 
H2’), (3H, s, CH30), 4.31 (1H, dd, 2J5. = 11.76 Hz, 3J4' = 6.44 Hz, H5’), 4.48 (1H, dd, 
2JS = 11.84 Hz, 3J4' = 5.20 Hz, H5’), 4.57 (1H, dt, 3J5• = 5.74 Hz, 3J3. = 2.36 Hz, H4’), 
5.41 (1H, bs, H3’), 5.89 (1H, pseudo-d, J =  3.80 Hz, H1’), 7.00 (2H, d, J =  7.28 Hz, 
o-Ar-H), 7.56 (1H, d, 4JCh3 = 0.96 Hz, H-6), 7.86 (2H, d, J=  8.92 Hz, m-Ar-H),
513C (100 MHz, DMSO-cfe) 13.3 (CH3, Thy), 33.1 (C2’), 55.9 (CH30), 62.6 (C5’), 
77.6 (C3’), 82.4 (C4’), 87.3 (C1’), 114.4 (m-Ar-C), 116.5 (C5), 121.7 (ipso-Ar-C),
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131.7 (o-Ar-C), 137.0 (C6), 153.7 (C2), 163.7 (p-Ar-C), 165.4 (COO, anisyl), 171.2 
(C4).
Analysis found C 59.97 H 5.00 N 7.82; C18H18N206 requires C 60.30 H 5.02 N 7.82
Found m/z (ES+) 381.1073 ([M + Na]+ 100 %); [C18H18N206 + Na]+ requires 
381.1063
Preparation of 3’-azido-3’-deoxy-5’-0-(4-methoxybenzoyl)-thymidine (6)
2’-3’-Anhydro-5’-0-(4-0-methoxybenzoyl) thymidine (5, 11.7 g, 32.5 mmol) and LiN3 
(4.8 g, 98 mmol) were dissolved in anhydrous DMF (90 ml) and heated to 125 °C for 
4 hours using an oil bath. After this period no starting material remained and the 
orange coloured reaction mixture was poured into 5% aqueous HCI (295 ml) then 
extracted with EtOAc (3 x 600 ml). The combined organic extracts were washed 
with water (500 ml) and brine (500 ml) then dried over MgS04. The solvents were 
reduced to a minimum volume under vacuum and the crude product was purified by 
flash column (EtOAc : hexane, 2 : 1 ) .  The pure product was obtained as a white 
foam after evaporation of the chromatography solvents.
Yield: 8.6 g, 24.7 mmol, 65 %
61H (400 MHz, CDCI3) 1.72 (3H, s, CH3, Thy), 2.36 (1H, m, H2’) 2.54 (1H, m, H2’), 
(3H, s, CH30), 4.21 (1H, pseudo-q, H4’), 4.36 (1H, dt, 3J = 7.4 Hz, 3J  = 4.89 Hz, H3’), 
4.53, (1H, dd, %  = 12.32 Hz, 3J4. = 4.00 Hz, H5’), 4.64 (1H, dd, 3JS = 12.44 Hz, 3J4. 
= 3.72 Hz, H5’), 6.17 (1H, t, 3J? = 6.24 Hz, H I’), 6.93 (2H, m, o-Ar-H) 7.22 (1H, d, 




513C (100 MHz, CDCI3) 12.6 (CH3, Thy), 38.2 (C2’), 55.9 (CH30), 61.1 (C3’), 63.8 
(C5’), 82.6 (C4’), 85.8 (C1’), 111.7 (C5), 114.4 (2 x m-Ar-C), 121.9 (ipso-Ar-C),
132.3 (2 x o-Ar-C), 135.4 (C6), 150.6 (C2), 164.3 (C4), 164.4(p-Ar-C), 166.1 (anisyl 
COO).
Found m/z (ES+) 424.1231 ([M + Na]+ 100 %); [C18H18N206 + Na]+ requires 
424.1233
IR Nujol mull: v = 2099.9 cm'1 (azide asymmetric stretch)
Preparation of 3’-azido-3’-deoxythymidine (2)
3’-Azido-3’-deoxy-5’-0-(4-methoxybenzoyl) thymidine (6, 6 g, 15 mmol) was 
dissolved in MeOH (60 ml) and NaOMe (3.24 g, 60 mmol) in H20  solution (66 ml) 
was added and the reaction stirred for 3.5 hours. Upon further addition of H20  (60 
ml) white crystals, later analysed to be p-methoxybenzoic acid, were formed and 
isolated by filtration. After a further crystallisation with H20  (60 ml) the aqueous 
solution was washed with Et20  (2 x 60 ml) and Amberlite® H+ ion exchange resin 
(12 g) added. The mixture was stirred for 15 minutes then the Amberlite removed by 
filtration and the solvents removed under reduced pressure to give a yellow glassy 
solid. The crude product was purified by flash column (EtOAc : MeOH, 4:1) to give 
AZT as a fine off-white powder after removal of the chromatography solvents.
Yield: 3.14 g, 11.8 mmol, 78 %, m.pt. 110-112 °C
51H (400 MHz, MeOH-dy (1.88, 3H, s, CH3, Thy), 2.40 (2H, m, H2’), 3.74 (1H, dd, 
2J5. = 12.14 Hz, 3J4. = 3.22 Hz, H5’) 3.83 (1H, dd, 2JS- = 12.14 Hz, 3J4. = 3.42 Hz, H5’),
O
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513C (100 MHz, MeOH-d4) 12.8 (CH3, Thy), 38.7 (C2’), 62.0 (C5’), 62.9 (C3’), 86.5 
(x2, C1\ C4’), 112.0 (C5), 138.4 (C6), 152.7 (C2), 166.8 (C4).
Analysis found C 44.98 H 4.88 N 26.02; C10H13N5O4 requires C 44.98 H 4.91 N 
26.22
Found m/z (ES+) 290.0876 ([M + Na]+ 100 %); [C10H13N5O4 + Na]+ requires 
290.0865
IR Nujol mull: v = 2081.7 cm'1 (azide asymmetric stretch)
Preparation of 3’-amino-3’-deoxythymidine (7)
3.91 (1H, dt, %■ = 4.81 Hz, 3J5' = 3.24 Hz, H4’), 4.35 (1H, m, H3’), 6.17 (1H, t , 3J? =
6.44 Hz, H1 ’), 7.78 (1H, s, H-6).
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3’-Azido-3’-deoxythymidine (2, 2.7 g, 10.0 mmol) was dissolved in anhydrous MeOH 
(27 ml) and palladium on activated carbon (1 microspatula) added to the vigorously 
stirred solution. The reaction vessel was then evacuated and flushed with H2 (g) 
three times then stirred for 4 hours. The Pd catalyst was removed by filtration 
through Celite® and the filter medium washed thoroughly with MeOH. The solvent 
was removed under reduced pressure to give the product as an amorphous white 
foam.
Yield: 2.4 g, 9.9 mmol, 99 %
51H (400 MHz, MeOH-d4) 188 (3H, s, CH3 Thy), 2.21 (1H, m, H2’), 2.28 (1H, m, 
H2’), 3.56 (1H, pseudo-q, H3’), 3.73 (1H, m, H4’), 3.80 (1H, m, H5’) 3.86 (1H, dd,
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513C (100 MHz, MeOH-d4) 12.9 (CH3, Thy), 42.1 (C2’), 50.1 (C3’), 62.6 (C5’), 86.4 
(C1’), 89.2 (C4’), 111.7 (C5), 138.7 (C6), 152.9 (C2), 167.0 (C4).
Found m/z (ES+) 264.0960 ([M + Na]+ 100 %); [C10H15N3O4 + Na]+ requires 
264.0996, 527.1842 ([2M -  H + 2Na]+ 30.60 %); [C2oH29N60 8 + 2Na]+ requires 
527.1846
2J5. = 12.16 Hz, 3J4 = 3.04 Hz, H5’), 6.18 (1H, dd, 3J =  6.94 Hz, 3J =  4.82 Hz, H1’),
7.85 (1H, d ,4JCH3 = 1.12 Hz, H-6).
Preparation of 3’-/V-(9-fluoromethoxycarbonyl)-3’-deoxythymidine (8)
O
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3’-Amino-3’-deoxythymidine (7, 190 mg, 3.7 mmol) was dissolved in 1,4-dioxane : 
water (2 : 1, 4 ml) and K2C 03 (218 mg, 1.6 mmol) added. The reaction mixture was 
allowed to stir for 30 minutes at ambient temperature before being reduced to 0 °C 
in an ice bath. FmocCI (265 mg, 1.0 mmol) was added and product as a white 
powdery solid was observed to precipitate out of solution almost immediately. After 
30 minutes stirring at ambient temperature the solution had turned thick and opaque, 
therefore water (30 ml) was added, causing more white solid product to precipitate 
out which was collected by filtration and washed thoroughly with water.
Yield: 276 mg, 0.6 mmol, 76 %, m.pt.178-181 °C
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51H (400 MHz, MeOH-c/4) 1.87 (3H, s, CH3 Thy), 2.29 (2H, m, H2’), 3.68 (1H, m, 
H4’), 3.82 (2H, m, H5’), 4.19 (1H, t, 3J10 = 6.28 Hz, Fmoc H-9), 4.26 (1H, pseudo-q, 
H3’) 4.40 (2H, m, Fmoc H-10) 6.18 (1H, t, 3JZ = 5.98 Hz, H1’), 7.29, (2H, m, Fmoc 
H-2, 7), 7.33, (2H, m, Fmoc H-3, 6) 7.63 (2H, d, 3J2,7 = 7.00 Hz, Fmoc H -1,8), 7.78 
(2H, d, 3J3,e = 7.40 Hz, Fmoc H-4, 5), 7.86 (1H, s, H-6).
513C (100 MHz, MeOH-d4) 12.5 (CH3, Thy), 39.0 (C2’), 49.0 (Fmoc C-9) 51.6 (C3’),
62.3 (C5’), 67.7 (Fmoc C-10) 85.8 (C1 ’), 86.5 (C4’), 111.5 (C5), 121.0 (Fmoc C-4, 5),
126.1 (Fmoc C-1, 8), 128.2 (Fmoc C-2, 7), 128.8 (Fmoc C-3, 6), 138.2 (C6), 142.7 
(Fmoc-C**), 145.2 (Fmoc-C*), 152.3 (C2), 158.4 (Fmoc C=0) 166.5 (C4).
Analysis found C 64.60 H 5.59 N 8.89; C25H25N30 6 requires C 64.79 H 5.44 N 9.07
Found m/z (ES+) 486.1637 ([M + Na]+ 100%); [C25H25N30 6 + Na]+ requires 
486.1641
Preparation of 3’-W-(9-fluoromethoxycarbonyl)-3’-deoxythymidyine-5’- 
carboxylic acid (1)
3’-N-(9-fluoromethoxycarbonyl)-3’-deoxythymidine (8, 5.4 g, 11.6 mmol) was 
suspended in MeCN/H20  (108 ml). To this suspension TEMPO (1.8 g, 11.6 mmol)
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and BAIB (8.2 g, 25.6 mmol) were added and the bright orange mixture stirred at 
ambient for 3 hours. After this time product in the form of a pale brown precipitate 
had formed and was isolated by filtration and washed with Et20. After a further 12 
hours stirring at ambient, a further crop of pale brown precipitate had formed and 
the solution had separated into two distinct layers. The precipitate was isolated by 
filtration and washed with Et20. The remaining reaction mixture was left for a further 
24 hours at ambient and a further crop of precipitate isolated and washed.
Yield: 1.98 g, 4.1 mmol, 46 %
51H (400 MHz, MeOH-c/4) 1.80 (3H, s, CH3 Thy), 2.25 (2H, bs, H2’), 4.25 (1H, t, 
\710= 6.64 Hz, Fmoc H-9), 4.30 (1H, d, 3J3. = 3.76 Hz, H4’), 4.35 (3H, m, H-10, H3’), 
6.34 (1H, m, HT), 7.35 (2H, m, Fmoc H-2, 7), 7.42 (2H, m, Fmoc H-3, 6), 7.70 (2H, 
d, 3J2,7 = 7.04 Hz, Fmoc H-1, 8), 7.89 (2H, d, 3J3,6 = 7.40 Hz, Fmoc H-4, 5), 7.98 (1H, 
s, H-6), 8.04, (1H, bs, 3’-NH), 11.31 (bs, NH).
513C (100 MHz, MeOH-d4) 12.7 (CH3, Thy), 36.5 (C2’), 47.1 (Fmoc C-9), 54.8 (C3’) 
66.0 (Fmoc CH2) 81.8 (C4’), 85.5 (C1’), 109.7 (C5), 120.1(Fmoc C-4, 5), 125.5 
(Fmoc C -1,8), 127.4 (Fmoc C-2, 7), 128.0 (Fmoc C-3, 6), 136.7 (C6), 141.1 (Fmoc- 
C**), 144.1 (Fmoc-C*), 150.8 (C2), 155.9 (Fmoc C=0) 164.0 (C4), 172.5 (C5’).
Analysis found C 62.60 H 4.78 N 8.68; C25H23N30 7 requires C 62.89 H 4.85 N 8.80 
Found m/z (ES ) 476.1466 ([M - H] 100%); [C25H23N30 7 - H]' requires 476.1548
Preparation of 3’-amino-3’-deoxythymidine-5’-carboxylic acid (9)
O
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To a stirred solution of 3’-amino-3’-deoxythymidine (2, 2.4 g, 9.9 mmol) in MeCN/ 
H20  (1 : 1,72 ml) was added TEMPO (310 mg, 2 mmol) and BAIB (7 g, 21.0 mmol) 
and the reaction stirred at ambient temperature for 4 hours. At this point a white 
precipitate of product had formed in the upper layer of the now biphasic orange 
mixture which was isolated by filtration. The remaining solution was stirred for a 
further 24 hours then further TEMPO (1.2 g, 8.0 mmol) and BAIB (3.2 g, 10.5 mmol) 
added. After 30 minutes further stirring more white precipitate was formed and 
isolated by filtration, which, after drying, was a very fine powder-like solid.
Yield: 592 mg, 2.3 mmol, 23 %
51H (400 MHz, DMSO-de) 2.15 (1H, m, H2’), 2.29 (1H, m, H2” ), 3.86 (1H, m, H3’), 
4.19 (1H, d, 3Jz = 2.84 Hz, H4’), 6.32 (1H, t, 3JZ = 6.64 Hz, H1’), 8.75 (1H, s, H-6).
513C (100 MHz, DMSO-d6) 12.7 (CH3, Thy), 36.6 (C2’), 54.7 (C3’), 83.8 (C4’), 85.3 
(CV), 109.1 (C5), 138.1 (C6), 150.9 (C2), 164.3 (C4) 172.6 (C5’).
Found m/z (ES ) 254.0773 ([M - H]' 100%); [C10H12N3O5 - H]‘ requires 254.0777
4.2 Synthesis of N6-benzoyl-3’-N-(9-fluorenylmethoxycarbonyl)-amino-2’- 
3’-dideoxyadenosine-5’-carboxylic acid
Preparation of W6-benzoyl-2’-deoxyadenosine (16)
2’-Deoxyadenosine monohydrate (9.1 g, 34 mmol) was dried by co-evaporation with 




was added dry Et3N (14.2 ml, 102 mmol) followed 30 minutes later by TMSCI (21.6 
ml, 170 mmol). A further aliquot of dry pyridine (40 ml) was added to facilitate 
stirring of the now thick pink slurry. After a further 30 minutes stirring BzCI (5.9 ml, 
51 mmol) was added and the slurry left to stir for 2 hours. Ice bath cooling was 
applied to the reaction vessel before H20  (45 ml) and cNH3 (45 ml) were added and 
the now yellow solution stirred at ambient temperature for 30 minutes. The resulting 
orange solution was evaporated under reduced pressure, dissolved in H20  (100 ml) 
and washed with EtOAc (100 ml). Crystallisation of the product began in the 
separating funnel and a thick slurry was obtained by the time separation was 
complete. The white solid was filtered off and the remaining solution refrigerated 
overnight to yield a second crop of product as a powdery white solid.
Yield: 9.0 g, 25.3 mmol, 75 %
51H (400 MHz, DMSO-cfe) 2.38 (1H, ddd, 2JZ = 13.28 Hz,3Jr = 6.24Hz, 3J3. = 3.44 
Hz, H2’), 2.81 (1H, m, H2’), 3.55 (1H, dd, 2JS = 11.66 Hz, 3J4. = 4.46, H5” ), 3.64 (1H, 
dd, 2J5. = 11.76 Hz, 3J4- = 4.56 Hz, H5’), 3.91 (1H, pseudo-q, H4’), 4.47 (1H, m, H3’), 
6.49 (1H, t, 3J2. = 6.74 Hz, H1’), 7.55 (2H, t, 3JP = 7.5 Hz, m-Ar-H), 7.65 (1H, t, 3Jm = 
7.40 Hz, p-Ar-H), 8.05 (2H, d, 3Jm = 7.20 Hz, o-Ar-H), 8.67 (1H, s, H8), 8.75 (1H, s, 
H2), 11.16 (bs, NH).
513C (100 MHz, DMSO-cfe) 39.7 (C2’), 62.0 (C5’), 71.1 (C3’), 84.1 (C1’), 88.4 (C4’),
126.3 (C5), 128.8 (o-, m-Ar-C), 132.8 (p-Ar-C), 133.8 {ipso-Ar-C), 143.4 (C8), 150.7 
(C6), 151.9 (C2), 152.3 (C4), 166.0 (C=0).
Found m/z (ES+) 378.1161 ([M + Na]+ 100%); [C17H17N50 4 +Na]+ requires 378.1178
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Preparation of N-6, 5’-0-dibenzoyl-2’-deoxyadenosine (17)
O
2’-Deoxyadenosine (2 g, 8.0 mmol) was dried by co-evaporation with dry pyridine (2 
x 10 ml) then dissolved in dry pyridine (30 ml). BzCI (1 ml, 8.8 mmol) in dry pyridine 
solution (20 ml) was added dropwise over approximately 30 minutes and after 15 
minutes another portion BzCI (0.2 ml 1.8 mmol) was added and the reaction stirred 
for a further 30 minutes. To the now bright green solution TMSCI (5.1 ml, 40 mmol) 
and BzCI (2.8 ml, 24 mmol) were added in succession, dropwise, and the cloudy 
green mixture stirred for 1.5 hours. With the reaction vessel in ice bath cooling a 
MeOH (10 ml) quench was applied before cNH3 (10 ml) was dropped in and the 
green slurry stirred at 0 °C for 30 minutes. The suspension was evaporated under 
reduced pressure before being partitioned between CHCI3 and H20  (50 ml each). 
The organic layer was separated, dried over MgS04 and evaporated to give a dark 
green oil which was purified by flash column (5 % MeOH/ CHCI3) to give the desired 
product as a white foam after solvent removal.
Yield: 2.9 g, 6.4 mmol, 80 %
51H (400 MHz, DMSO-d6) 2.43 (1H, m, H2” ), 2.96 (1H, m, H2’), 4.15 (1H, dt, 3J5. = 
5.72 Hz, 3J3. = 4.28, H4’), 4.41 (1H, dd, 2JS = 11.76 Hz, 3J* = 5.88, H5’), 4.52 (1H, 
dd, 2J5' =11-86 Hz, 2J4. = 4.26 Hz, H5’), 4.64 (1H, bs, H3’), 5.53 (1H, bs, 3’-OH), 
6.47 (1H, t, 3JZ = 6.64 Hz, H1’), 7.45 -  7.51 (4H, m, m-, m -Ar-H), 7.57 (2H, m, p-, 
p-Ar-H), 7.86, 7.99 (4H, m, o-, o ’- Ar-H), 8.58 (1H, s, H8), 8.65 (1H, s, H2), 11.09 
(bs, NH).
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513C (100 MHz, DMSO-d6) 38.8 (C2’), 64.7 (C5’), 70.9 (C3’), 84.1 (C1’), 84.6 (C4’),
126.3 (C5), 127.8 -  129.5, 131.5 -  133.8 (10 x Ar-C), 129.8 (ipso-Ar-C), 134.7 
(ipso-Ar-C), 143.7 (C8), 150.8 (C6), 151.9 (C2), 152.2 (C4), 165.9 (5’-OBz C=0),
168.3 (NHBz C=0).
Found m/z (ES+) 460.1630 ([M + H]+ 100%); ^HsaNsOs]* requires 460.1621
Analysis found C 62.72 H 4.61 N 15.19; C24H21N5O5 requires C 62.74 H 4.61 N 
15.24
Preparation of N-6, 5’-0-dibenzoyl-3’-xy/o-2’-deoxyadenosine (18) (and N-6, 3’- 
0-dibenzoyl-3’-xy/o-2’-deoxyadenosine (22))
Method A:
A/-6-5’-Dibenzoyl-2’-deoxyadenosine (17, 5.4 g, 11.8 mmol) was dissolved in DCM 
(160 ml) containing pyridine (2.8 ml, 35.4 mmol) and the solution cooled to -30 °C in 
a dry ice/EtOAc bath. To the cold solution was added (TfO)20  (2.8 ml, 35.4 mmol, 
10 % v/v solution in DCM) dropwise. Following the addition the temperature of the 
reaction was raised to 0 °C over 30 minutes and PhC02H (4.3 g, 35.4 mmol) and 
H20  (11.7 ml) added. The solution was stirred overnight at approximately 0 °C then 
the organic layer separated, dried over MgS04 and evaporated. The crude mixture 
of isomers was purified by flash column ( 0 - 3  % MeOH/CHCI3) to give both 
products as pale yellow foams after solvent removal.
Yield: 1.23 g, 2.7 mmol, 23 %
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Method B:
/\/-6-5’-Dibenzoyl-2’-deoxyadenosine (17, 5.4 g, 11.8 mmol) was dissolved in DCM 
(250 ml) containing pyridine (10 ml) and the solution cooled to -30 °C in a dry 
ice/EtOAc bath. (TfO)20  (2.8 ml, 35.4 mmol, 10 % v/v solution in DCM) was 
introduced dropwise then the cooling bath removed and the reaction stirred for a 
further 45 minutes before water (5 ml) was poured in. The resulting emulsion was 
stirred at ambient for 2 hours then a further aliquot of water (25 ml) added and the 
organic layer separated, dried over MgS04 and evaporated to give an amorphous 
yellow foam. This foam was redissolved in MeOH and the solution adjusted to 
approximately pH 8 (estimated with pH paper) with NaHC03 and stirred at ambient 
for a further two hours. At this point the solution was evaporated and crude product 
purified by flash column (3 % MeOH/CHCI3) to yield the title compound as a yellow 
foam after the removal of column solvents.
Yield: 2.2 g, 4.8 mmol, 40 %
51H (400 MHz, DMSO-cfe) 2.45 (1H, m, H2’), 2.89 (1H, m, H2’), 4.38 (1H, dt, 3J3. = 
7.50 Hz, 3J5' = 3.70 Hz, H4’), 4.51 -  4.57 (2H, m, H5’, H3’), 4.67 (1H, dd, 2J5. = 11.76 
Hz, 3J4. = 3.78 Hz, H5’), 5.85 (1H, d, 3J3. = 4.36 Hz, 3’-OH), 6.47 (1H, dd, 3J- = 8.34, 
1.90 Hz, HT), 7.50 -  7.57 (4H, m, m-, m -ArH), 7.64 (2H, m, />, p ’-ArH), 7.97, 8.05 
(4H, m, o-, o ’- Ar-H), 8.72 (1H, s, H8), 8.76 (1H, s, H2), 11.16 (bs, NH).
513C (100 MHz, DMSO-d6) 41.0 (C2’), 64.4 (C5’)> 69.7 (C3’), 82.5 (C4’), 83.4 (C1’), 
125.9 (C5), 128.8 -  129.6, 132.8 -  133.1 (10 x Ar-C), 130.0 (ipso-Ar-C), 133.7 
(ipso-Ar-C), 143.5 (C8), 150.7 (C6), 151.9 (C2), 152.2 (C4), 166.0 (NHBz C=0, 5’- 
OBz C=Q).
Analysis found C 62.66 H 4.61 N 15.30; C24H2i N505 requires C 62.74 H 4.61 N 
15.24
Found m/z (ES+) 460.1638 ([M + H]+ 100%); [C24H22N50 5]+ requires 460.1621
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o
Isolated yield from method A: 850 mg, 1.8 mmol, 15 %
51H (400 MHz, DMSO-d6) 2.98 (1H, m, H2” ), 3.09 (1H, m, H2’), 3.79 (2H, m, H5’), 
4.37 (1H, m, H4’), 4.94 (1H, t, 3J5' = 5.50 Hz, 5’-OH), 5.74 (1H, t, J =  4.08 Hz, H3’), 
6.54 (1H, dd, 3J=  7.50, 2.74 Hz, H1’), 7 .50-7 .57  (4H, m, m-, m-Ar-H), 7.65 (2H, m, 
p-, p ’-Ar-H), 7.81, 8.04 (4H, m, o-, o ’- Ar-H), 8.60 (1H, s, H2), 8.65 (1H, s, H8), 
11.13 (bs, NH).
513C (100 MHz, DMSO-cfe) 38.1 (C2’), 59.6 (C5’), 73.4 (C3’), 83.8 (C1’, C4’), 126.1 
(C5), 128.8-129.6, 132.7 -  133.8 (10 x Ar-C), 130.0 (ipso-Ar-C), 133.1 (ipso-Ar-C), 
142.6 (C8), 150.6 (C6), 151.9 (C2), 152.2 (C4), 165.3 (N-benzoyl CO, 5’-0-benzoyl 
CO).
Found m/z (ES+) 460.1638 ([M + H]+ 100%); [C24H22N5O5 +Na]+ requires 460.1621
Isomerisation of Af-6, 3’-0-dibenzoyl-3’-xy/o-2’-deoxyadenosine (22) to N-6, 5’- 
0-dibenzoyl-3’-xy/o-2’-deoxyadenosine (18)
/V-6-3’-Dibenzoyl-3’-xy/o-2’-deoxyadenosine (22, 700 mg, 1.5 mmol) and NaHC03 
were dissolved In dry methanol (50 ml) and stirred at ambient temperature for 6 
hours. The solvent was removed under reduced pressure and the crude product 
purified by flash column ( 0 - 3  % MeOH/CHCI3) to give the title compound as a 
clear oil.
Yield: 330 mg, 0.7 mmol, 48 %
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A/-6-5’-Dibenzoyl-3’-xy/o-2’-deoxyadenosine (18, 3.2 g, 7.0 mmol) was dissolved in 
a mixture of anhydrous DCM (64 ml) and anhydrous pyridine (6.5 ml) and the 
solution cooled to -30 °C in a dry ice/EtOAc bath before (TfO)20  (2.9 g, 10.4 mmol) 
was introduced dropwise. After the addition the solution was allowed to warm to 
room temperature over approximately 30 minutes at which point LiN3 (3.4 g, 70 
mmol) in DMF solution (40 ml) was added as a single aliquot, turning the solution a 
deep red colour. The reaction was allowed to stir at ambient for 90 minutes then 
partitioned between water (100 ml) and CHCI3 (300 ml) and the organic layer 
separated, washed with water (2 x 200 ml) and dried over MgS04. Following 
evaporation of the CHCI3 the oily yellow residue was co-evaporated with toluene 
and with MeCN to remove traces of pyridine and DMF respectively. The crude 
product was purified by flash column (1 % MeOH/CHCI3) and the solvents removed 
to give the title compound as a yellow foam.
Yield: 2.9 g, 6.0 mmol, 86 %.
51H (400 MHz, DMSO-cfe) 2.72 (1H, m, H2’), 3.21 (1H, m, H2’), 4.30 (1H, pseudo-q, 
J =  5.05 Hz, H4’), 4.53 (1H, dd, %  = 12.06 Hz, 3J* = 5.22 Hz, H5’), 4.59 (1H, dd, 
2J5. = 12.02 Hz, 3J4. = 4.26 Hz, H5’), 4.94 (1H, pseudo-q, J=  6.32 Hz, H3’), 6.51 (1H,
dd, 3J =  7.12 Hz, 5.40 Hz, H1’), 7.54 (4H, m, m-, m -ArH), 7.66 (2H, m, p-, p-Ar-H), 
7.91, 8.04 (4H, 2 x m, 0-, o ’-Ar-H), 8.71 (1H, s, H8), 8.65 (1H, s, H2), 11.22 (bs, 
NH).
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513C (100 MHz, DMSO-cfe) 36.0 (C2’), 61.7 (C3’), 64.1 (C5’), 81.7 (C4’), 83.6 (C1’),
126.3 (C5), 128.8, 128.9, 129.1, 129.6 (o, o ’, m, m -Ar-C), 129.56 {ipso’-Ar-C), 132.8,
133.7 (p, f t-Ar-C), 133.9 (/pso-Ar-C), 143.7 (C8), 150.8 (C6), 152.0 (C2), 152.1 (C4),
165.8 (5’-OBz C=0) 166.0 (NHBz C=0).
Analysis found C 53.65 H 4.21 N 29.53; C24H21N80 4 requires C 53.68 H 4.24 N 
29.46
Found m/z (ES+) 485.1686 ([M + H]+ 100%); [C24H21N804 + H]+ requires 485.1686 
IR v = 2102.0 cm'1 (azide asymmetric stretch)
Preparation of W-6-benzoyl-3’-azido-2’-3’-dideoxyadenosine (20)
O
A/-6-5’-Dibenzoyl-3’-azido-2’-3’-dideoxyadenosine (19, 5.7 g, 11.8 mmol) was 
dissolved in a mixture of 1,4-dioxane/MeOH/water (210 ml, 5:4:1) and the solution 
cooled to 0 °C. 1 M NaOH (25 ml) was added and the reaction stirred for a further 
30 minutes before being neutralised with Amberlite® H+ ion exchange resin. The 
resin was removed by filtration and the reaction solvents evaporated under reduced 
pressure to give crude product as a yellow oil. This yellow oil was purified by flash 
column ( 0 - 4  % MeOH/CHCI3) to give the desired product as a fine white powder 
after removal of the solvents. Recrystallisation from MeOH changed the physical 
form to a crumbly white powder.
Yield: 2.2 g, 5.8 mmol, 49 %, m.pt. 181-183 °C
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51H (400 MHz, DMSO-d6) 2.20 (1H, m, H2’), 3.05 (1H, m, H2’), 3.61 (2H, m, H5’), 
3.97 (1H, pseudo-q, J =  6.92 Hz, H4’), 4.68 (1H, dt, 3J4. = 6.64 Hz, 3J2. = 5.26 Hz, 
H3’), 5.21 (1H, t, 3J5' = 5.6 Hz 5’-OH), 6.47 (1H, t, 3JZ = 6.26 Hz, H1’), 7.56 (2H, m, 
m-Ar-H), 7.64 (1H, m, p-Ar-H), 8.05 (2H, m, o-Ar-H), 8.71 (1H, s, H8), 8.65 (1H, s, 
H2), 11.24 (bs, NH).
513C (100 MHz, DMSO-cfe) 36.5 (C2’), 61.0 (C3’), 61.4 (C5’), 83.6 (C4’), 85.1 (C1’),
126.2 (C5), 128.9 (o, m-Ar-C), 132.8 (p-Ar-C), 133.7 (ipso-Ar-C), 143.4 (C8), 150.7 
(C6), 152.0 (C2), 152.2 (C4), 166.0 (C=0).
Analysis found C 53.65 H 4.21 N 29.53; C17H16N803 requires C 53.68 H 4.24 N 
29.46
Found m/z (ES+) 381.1430 ([M + H]+ 100%); [C17H17N80 3 + H]+ requires 381.1424 
IR v = 2096.2 cm'1 (azide asymmetric stretch)
Preparation of /V-6-benzoyl-3’-amino-2’-3’-dideoxyadenosine (24)
O
A/-6-Benzoyl-3’-amino-2’-3’-dideoxyadenosine (20, 400 mg, 1.0 mmol) and Pd/C 
was suspended in MeOH/H20  (2:1, 8 ml) and stirred vigorously under an H2 
atmosphere for 2 hours at ambient temperature. Pd/C was removed by filtration 
through Celite and the filter medium washed with 30 % aqueous MeOH and the 
solvents removed under reduced pressure to give the desired compound as an 
amorphous white foam.
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Yield: 372 mg, 1.0 mmol, > 99 %
51H (400 MHz, DMSO-cfe) 2.28 (1H, m, H2’), 2.66 (1H, m, H2’), 3.56 (1H, m, H4’), 
3.67 (3H, m, H3’, H5’), 4.98 (1H, bs, 5’-OH), 6.45 (1H, dd, 3J2- = 6.98 Hz, 3J? = 4.42 
Hz, H I’), 7.54 (2H, t, 3J =  7.48 Hz, m-Ar-H), 7.63 (1H, t, 3Jm = 7.36 Hz, p-Ar-H), 8.05 
(2H, m, oAr-H), 8.67 (1H, s, H8), 8.72 (1H, s, H2), 11.24 (bs, NH).
513C (100 MHz, DMSO-d6) 41.0 (C2’), 51.8 (C3’), 61.7 (C5’), 83.7 (C1’), 88.6 (C4’),
126.2 (C5), 128.7, 128.8 (o, 2-Ar-C), 132.6 (p-Ar-C), 134.2 {ipso-Ar-C), 143.0 (C8),
151.2 (C6), 151.8 (C2), 152.0 (C4), 166.2 (C=0).
Analysis found C 57.30 H 5.07 N 23.55; C17H18N60 3 requires C 57.62 H 5.12 N 
23.72





/V-6-Benzoyl-3’-amino-2’-3’-dideoxyadenosine (24, 200 mg, 0.56 mmol) was 
dissolved in 1,4-dioxane : water (1 : 1,4 ml) and K2C 03 (156 mg, 1.12 mmol) added. 
After stirring for 30 minutes at ambient temperature the solution was cooled to 0 °C 
in an ice bath. FmocCI (161 mg, 0.62 mmol) was added and the reaction stirred at 
0 °C for 6 hours. TLC analysis showed an incomplete reaction after this time, 
therefore, further FmocCI (30 mg, 0.11 mmol) was added to the now cloudy white 
suspension and stirred for 30 minutes at 0 °C. Water (10 ml) was added, causing 
more white solid product to precipitate out which was collected by filtration, washed 
thoroughly with water and purified by flash column ( 2 - 4  % MeOH/CHCI3) to give 
product as a white foam after removal of chromatography solvents.
Yield: 256 mg, 0.44 mmol, 79 %
51H (400 MHz, DMSO-d6) 2.47 (1H, m, H2’), 2.84 (1H, m, H2’), 3.55, 3.67 (2H, m, 
H5’), 3.95 (1H, pseudo-t, H4’), 4.26 (1H, t, 3J10 = 6.68 Hz Fmoc H-9), 4.38 (3H, m, 
H3\ Fmoc H-10), 5.05 (1H, t, %  = 5.46 Hz, 5’-OH), 6.51 (1H, t, 3J2. = 6.26 Hz, H1’), 
7.36 (2H, t, 3J = 7.44 Hz, Fmoc H-2, 7), 7.43 (2H, t, 3J=  7.50 Hz, Fmoc H-3, 6), 7.56 
(2H, t, 3J = 7.54 Hz, m-Ar-H), 7.63 (1H, m, p-Ar-H), 7.72 (1H, d, 3J2,7= 7.48 Hz, 
Fmoc H-1,8), 7.83 (1H, d, 3J3 = 7.60 Hz, 3’-NH), 7.90 (2H, d, 3J3,6= 7.32 Hz, Fmoc 
H-4, 5), 8.05 (2H, d, 3Jm = 7.40 Hz, o-Ar-H), 8.72 (1H, s, H8), 8.77 (1H, s, H2).
513C (100 MHz, DMSO-cfe) 37.6 (C2’), 47.1 (Fmoc C-9), 51.4 (Fmoc C-10), 61.9 
(C5’), 65.8 (C3’), 83.7 (C1’), 85.9 (C4’), 120.5 (Fmoc C-4, 5), 125.5 (Fmoc C-1, 8),
126.2 (C5), 127.4 (Fmoc C-2, 7), 128.0 (Fmoc C-3, 6), 128.8 (o, m-Ar-C), 132.8 (p- 
Ar-C), 133.6 (ipso-Ar-C), 141.1 (Fmoc-C**), 143.2 (C8), 144.2 (Fmoc-C*), 150.7 
(C6), 151.9 (C2), 152.2 (C4), 156.2 (Fmoc C=0), 166.0 (NHBz C=0).
Found m/z (ES+) 599.2035 ([M + Na]+ 100%); [C32H28N60 5 + Na]+ requires 599.2019
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Preparation of AM3-benzoyl-3’-azido-2’-3’-dideoxyadenosine-5’-carboxylic acid
/\/-6-Benzoyl-3’-azido-2’-3’-dideoxyadenosine (20, 800 mg, 2.1 mmol) was
suspended in MeCN/H20  (1 : 1, 13 ml) and TEMPO (329 mg, 2.1 mmol) and BAIB 
(1.5 g, 4.6 mmol) were added. After 2 hours a white precipitate had appeared and 
no starting material remained by TLC, therefore, Et20  (25 ml) was added to the 
suspension and the powdery precipitate isolated by filtration.
Yield: 682 mg, 1.7 mmol, 82 %
51H (400 MHz, DMSO-d6) 2.65 (1H, m, H2’), 3.03 (1H, m, H2’), 4.60 (1H, d, 3J3. =
4.08 Hz, H4’), 5.06 (1H, dt, 3J4' = 4.65 Hz, 3J2. = 6.50 Hz, H3’), 6.58 (1H, m, H1’), 
7.56 (2H, m, m-Ar-H), 7.65 (1H, m, p-Ar-H), 8.05 (2H, m, o-Ar-H), 8.70 (1H, s, H8), 
8.76 (1H,s, H2), 11.23 (bs, NH).
513C (100 MHz, DMSO-cfe) 36.4 (C2’), 63.5 (C3’), 82.1 (C4’), 84.2 (C1’), 126.0 (C5),
128.8 (o, m-Ar-C),132.8 (p-Ar-C), 133.7 {ipso-Ar-C), 143.3 (C8), 150.7 (C6), 152.1 
(C2), 152.4 (C4), 166.0 (NHBzC=0), 171,4(C5’).





acid triethylamine salt (27)
0
A/-6-Benzoyl-3’-azido-2’-3’-dideoxyadenosine-5’-carboxylic acid (26, 605 mg, 1.5 
mmol) was dissolved in anhydrous 15 % Et3N/pyridine (6 ml), cooled to 0 °C and 
H2S bubbled through the solution for 5 minutes. The now brown solution was stirred 
for a further 30 minutes before H20  (5 ml) was poured in causing a precipitate to 
appear. This precipitate was removed by centrifugation and the remaining 
supernatant evaporated under reduced pressure to give the desired product as a 
pale yellow amorphous solid.
Yield: 405 mg, 0.86 mmol, 56 %
51H (400 MHz, DMSO-cfe) 1-09 (3H, t, 3J = 7.24 Hz, Et3N CH3), 2.55 (1H, m, H2’), 
2.70 (1H, m, H2’), 2.87 (2H, q, 3J = 7.25 Hz, Et3N CH2), 4.04 (1H, m, H3’), 4.31 (1H, 
d, 3J3. = 3.32 Hz, H4’), 6.69 (1H, t, 3J? = 6.54 Hz, H1’), 7.55 (2H, t, 3J =  7.84 Hz, m- 
Ar-H), 7.63 (1H, m, p-Ar-H), 8.04 (2H, m, o-Ar-H), 8.73 (1H, s, H2), 9.23 (1H, s, H8).
513C (100 MHz, DMSO-db) 9.6 (Et3N CH3) 37.5 (C2’), 45.6 (Et3N CH2) 54.9 (C3’), 
84.0 (CV), 84.4 (C4’), 126.0 (C5), 128.1 (o, m-Ar-C),132.8 (p-Ar-C), 133.8 (ipso-Ar- 
C), 144.2 (C8), 150.4 (C6), 151.8 (C2), 152.3 (C4), 166.0 (NHBz C=0), 172.5 (C5’).





/V-6-Benzoyl-3’-amino-2’-3’-dideoxyadenosine-5’-carboxylic acid triethylamine salt 
(27, 395 mg, 0.84 mmol) was dissolved in 1,4-dioxane/H20  (2:1, 8 ml) containing 
K2C 03 (116 mg, 0.84 mmol). The solution was cooled to 0 °C before FmocCI (260 
mg, 1.0 mmol was added in a single portion and the solution stirred at 0 °C for 1 
hour. The solution was then acidified to pH 2 with KHSO4 causing the product to 
precipitate out of solution as a white powdery solid which was isolated by filtration.
Yield: 292 mg, 0.5 mmol, 59 %
51H (400 MHz, DMSO-cfe) 2.56 (1H, m, H2’), 2.92 (1H, m, H2’), 4.27 (1H, m, Fmoc 
H-9), 4.38 (2H, m, Fmoc H-10), 4.43 (1H, m, H4’), 4.64 (1H, m, H3’), 6.67 (1H, m, 
HT), 7.35 (2H, m, Fmoc H-2, 7), 7.42 (2H, m, Fmoc H-3, 6), 7.54 (2H, m, m-Ar-H), 
7.64 (1H, m, p-Ar-H), 7.74 (1H, m, Fmoc H-1, 8), 7.84 (1H, d, 3J3- = 7.40 Hz, NH), 
7.90 (2H, m, Fmoc H-4, 5), 8.05 (2H, m, o-Ar-H), 8.75 (1H, s, H8), 8.77 (1H, s, H2).
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513C (100 MHz, DMSO-cfe) 36.1 (C2’), 46.6 (Fmoc C-9), 54.6 (C3’), 65.5 (Fmoc C10), 
82.1 (C1’), 84.0 (C4’), 120.0 (Fmoc C-4, 5), 125.0 (Fmoc C-1, 8), 127.0 (C5), 127.5 
(Fmoc C-2, 7), 128.3 (o, m-Ar-C), 128.8 (Fmoc C-3,6), 132.3 (p-Ar-C), 133.4 (ipso- 
Ar-C), 140.6 (Fmoc-C**), 143.8 (C8), 144.3 (Fmoc-C*), 149.9 (C6), 151.2 (C2),
151.8 (C4), 155.5 (Fmoc C=0), 172.2 (C5’).
Found m/z (ES+) 589.1833 ([M - H]’ 100%); [C32H25N60 6 - H]‘ requires 589.1836
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4.3 Manual Solid Phase Peptide Synthesis.
Peptides were synthesised manually in a batch procedure. /V-Fmoc-9-amino- 
xanthe-3-yloxymethy-Sieber amide resin (0.71 mmol/g NHFmoc) was purchased 
from Novabiochem.
NMR Spectroscopy
1H NMR spectra were recorded on either a Varian Unity Inova 500 MHz or a Bruker 
DRX 500 MHz machine by Julie Fisher and co-workers, University of Leeds.
TNBS Test.
The TNBS test was performed using the following reagents:
Reagent A: 10 % v/v DIPEA in DMF 
Reagent B: 1 % v/v TNBS in DMF
Approximately 10 resin beads were extracted from the drained resin bed and placed 
in a microcentrifuge tube. One drop of each reagent solution was added to the 
beads and the tube left to stand at ambient temperature for five minutes, then the 
colour of the beads noted; red - positive (free amino groups present; successful 
deprotection or failed coupling steps), yellow -  negative (no free amino groups 
present; unsuccessful deprotection or successful coupling steps).
General procedure for solid phase synthesis of 5’-amide peptide oligomers:
Couplings were performed on Sieber amide resin (200 mg, 142 pmol NHFmoc) 
loaded at 25 % capacity using the following quantities:
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Coupling Component Quantity
1 Fmoc amino acid 35.5 pmol
0.2 M HBTU 178 pi
DIPEA 6.8 pi, 39 pmol
2 onwards Fmoc amino acid 50 pmol
0.2 M HBTU 250 pi
DIPEA 9.5 pi, 55 pmol
Swelling and deprotection of Sieber amide resin.
The bed of Sieber amide resin was swelled overnight with three times resin bed 
volume of DCM. The swelling solvent was removed and the resin washed with 
DMAc/DMF (x 5) and drained. Deprotection solution (2 % v/v DBU in DMAc/DMF) 
was applied to the resin to remove the Fmoc protecting group. The resin bed was 
covered with the deprotection solution and the reaction vessel agitated on an orbital 
shaker for 5 minutes. The deprotection solution was removed and fresh solution re­
applied a further two times. A TNBS test was performed to confirm the removal of 
the protecting group. The resin bed was then washed thoroughly with DMAc/DMF (x 
5).
Coupling of the first nucleoside monomer residue.
The nucleoside P-amino acid (35.5 pmol) was dissolved in DMAc/DMF (178 pi) and 
pre-activated for 60 s with FIBTU in DMAc/DMF (0.2 M, 178 pi) and DIPEA (6.8 pi, 
39.0 pmol). The deprotected resin bed was then treated with this solution and 
agitated at ambient temperature for five hours. Following removal of the coupling 
solution the resin bed was washed with DMAc/DMF (x 5) and capped as below.
Capping unreacted sites.
Capping solution (Ac20, DMAc/DMF, collidine, 1:8:1) was added to cover the resin 
bed and the reaction vessel agitated for 5 minutes on an orbital shaker. The resin 
bed was then washed thoroughly with DMAc/DMF (x 5).
Further residue coupling.
The cycle of deprotection, coupling and capping was continued according to the 
above procedure for further nucleoside residues. For residues after the first,
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coupling times were reduced to 30 min and a TNBS test performed to confirm 
successful couplings. Quantities for subsequent couplings are shown in the tables 
above. When all the required amino acid couplings had been performed, to obtain 
Fmoc off compounds the resin was subjected to a further deprotection step. To 
obtain Fmoc on compounds this extra deprotection was omitted from the procedure. 
The resin bed was dried by washing with DMAc/DMF (x 5), DCM (x 5), MeOH (x 5) 
and vacuum applied to the reaction vessel for 30 minutes. Finally the vessel was 
stored in a vacuum dessicator for 24 hours.














The dry resin was swelled in DCM for 30 minutes then washed three times with 
fresh DCM. The resin was covered with cleavage solution (1 % v/v TFA in DCM) 
and agitated for 2 minutes on an orbital shaker. The cleavage mixture was removed 
and the procedure repeated nine further times. Residual peptide was washed from 
the resin bed with DCM (x 3) and MeOH (x 3) then the combined cleavage solutions 
evaporated to dryness under reduced pressure. The peptide was then triturated with 




Oligomer n R Retention Time/mins
10 2 H 17.88
11 4 H 21.59
12 4 Fmoc 37.49
13 8 H 25.18
14 8 Fmoc 34.88
2’-Deoxyadenosine peptides
Oligomer n R Retention Time/mins
28 4 Fmoc N/A
29 4 H 27.66
Mixed sequence peptides
Oligomer Sequence R Retention Time/mins
30 TATA Fmoc N/A
31 TATA H 21.40
Selected NMR data 
Peptide 12
NH NH2 HT H2' H3' H4' H-6 OMe
1 8.85 7.60 6.48 2.41/2.33 4.60 4.35 8.06 1.90
2 8.92 N/A 6.33 2.46/2.39 4.64 4.38 8.06 1.90
3 8.94 N/A 6.33 2.46/2.34 4.66 4.39 8.21 1.90
4 8.13 N/A 6.32 2.43/2.30 4.44 4.40 8.06 1.90
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4.4 Thermal Melting Studies
UV melting curves were recorded on a Hewlett-Packard 8452A diode array 
spectrophotometer equipped with a peltier device. dA8 and T8 DNA strands were 
synthesised by James Gaynor. Solutions of the following were made up in 10 mM 
NaH2P04 buffer containing 100 mM NaCI adjusted to pH 7.0 with HCI:
Solution Components
A dT8 (6 pM), dA8 (6 pM)
B Peptide (13) (3 pM), dA8 (3 pM)
C Peptide (12) (6 pM)
D Peptide (13) (3 pM)
Solutions were heated to 90 °C for 3 minutes then cooled gradually.
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4.5 Fluorous-Phase Synthesis 
Reagents
FC-72 was purchased from 3M (Japan) and Acota (UK) Ltd.
THF: Distilled from sodium/benzophenone.
MNTP was prepared by the group of Associate Prof. Takeshi Wada, Graduate 
School of Frontier Sciences, University of Tokyo.275
FD-O(H) refers to the fluorous dendrimer shown below and was also prepared by 
the group of Associate Prof. Takeshi Wada:
Mass Spectrometry
MALDI-TOF Mass Spectra were obtained by the EPSRC National Mass Spec 
Centre, Swansea on a Voyager DE-STR MALDI-TOF spectrometer using a 
pentafluorobenzoic acid matrix with NaOAc additive.
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Fmoc-glycine (30 mg, 0.1 mmol) was dissolved in anhydrous THF (1 ml) and FD- 
O(H) (470 mg, 0.1 mmol) was suspended in this solution. To this mixture was added 
2,4,6-collidine (65 pi, 0.5 mmol) and MNTP (108 mg, 0.24 mmol) and the reaction 
heated to 45 °C and stirred at this temperature for 1 hour. After cooling to ambient, 
the now biphasic solution was washed with water (5 ml) and CHCI3 (5 ml) and both 
the aqueous and organic phases backwashed with FC-72 (10 x 5ml). The combined 
fluorous phases were then evaporated to give the desired product as an amorphous 
white solid.
Yield: 440 mg, 0.88 mmol, 88 %
51H (400 MHz, CDCI3/C6F6, (3:1)) 2.04 -  2.11 (18H, m, CF2CH2CH?). 2.31 -  2.38 
(18H, m, CF2CH2), 3.82 (4H, t, 3J = 5.60 Hz, OCH2 (Ar3, Ar5, Chain 4), 3.92 -  4.04 
(14H, m, OCH2, Ar3 (Chains 3, 5), Ar4, (Chains 3, 4, 5) Ar5, (Chains 3, 5), 4.13 (2H, 
d, 3J h-9 = 5.68 Hz, Fmoc H-10), 4.43 (2H, d, 3J =  7.2 Hz, Gly-CH2) 4.96 (2H, s, Ar-O- 
CHg-Ar4), 5.06 (4H, s, Ar-Q-CH?-Ar3. Ar-Q-CH?-Ar51. 5.24 (2H, s, Ar-CH^-O-Gly), 
5.27 (1H, t, 34 h- 10= 5.78 Hz, Fmoc H-9), 6.68 (2H, s, o-Ar4), 6.71 (4H, s, o-Ar3, o- 
Ar5), 6.80 (2H, s, o-Ar), 7.30 (2H, dt, J=  7.68 Hz, J=  0.84 Hz, Fmoc H-2, 7), 7.39 
(2H, m, Fmoc H-3, 6), 7.60 (1H, m, Fmoc H-1, 8), 7.58 (2H, m, Fmoc H-4, 5).
513C (100 MHz, CDCI3/C6F6, (3:1)) 19.9 (CF2CH2CH,1. 27.0 (CF?CH?1. 67.0 (Gly-O- 
CH2-Ar), Ar3-Q-CH,-CHo. Ar5-Q-CH,-CH, (chain 4)), 67.6 -  72.1 (Ar3, Ar5-Q-CH?- 
CH2 (chains 3 and 5), Ar4-Q-CH?-CH? (chains3, 4, 5), 68.1 (Gly- CH2), 105.7 -
140
106.1 (o-ArC, o-Ar3-C, o-Ar4-C, o-Ar5-C), 120.0 (Fmoc C-4, 5), 125.2 (Fmoc C -1,8),
127.3 (Fmoc C-2, 7), 128.0 (Fmoc C-3, 6), 138.0 (p-ArC, p-Ar3-C, p-Ar4-C, p-Ar5-C),
140.9 (Fmoc-C**), 143.5 (Fmoc-C*), 152.0 (m-ArC, m-Ar3-C, m-Ar4-C, m-Ar5-C)
Found (MALDI-TOF) 5013.3 ([M + Na]+ 100%); 5029.3 ([M + K]+ 34%);
Preparation of FD-O-Glycine (34)
h 2n
FD-O-N-Fmoc-glycine (33, 110 mg, 22 pmol) was dissolved in FC-72 (1.0 ml) and 
10 % piperidine in DMF solution (1.0 ml) added. The biphasic mixture was stirred at 
ambient temperature for 30 minutes before MeCN (5 ml) was added and the layers 
separated. The organic layer was extracted with further FC-72 ( 5 x 5  ml) and all the 
fluorous phases combined and evaporated to give product as an off-white 
amorphous foam.
Yield 70 mg, 14.5 pmol, 66 %
51H (400 MHz, CDCI3/C6F6, (3:1)) 2.04 -  2.12 (18H, m, CF2CH2CHg), 2.31 -  2.37 
(18H, m, CF?CH?). 3.56 (2H, s, Gly-CH2), 3.81 (4H, t, 3J =  5.56 Hz, OCH2 (Ar3, Ar5, 
Chain 4), 3.94 -  4.04 (14H, m, OCH2, Ar3 (Chains 3, 5), Ar4, (Chains 3, 4, 5) Ar5, 
(Chains 3, 5), 4.98 (2H, s, Ar-Q-CH?-Ar41. 5.07 (4H, s, Ar-Q-CH2-Ar3. Ar-O-CHo- 
Ar5), 5.18 (2H, s, Ar-CHj-O-Gly), 6.68 (2H, s, o-Ar4), 6.72 (4H, s, o-Ar3, o-Ar5), 
6.80 (2H, s, o-Ar).
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FOLDAMERS DERIVED FROM NUCLEOSIDE /3-AMINO ACIDS: 
PNA OR DNA? CAN WE HAVE BOTH IN ONE PLACE?
Richard Threlfall and Andrew Davies □ Department of Chemistry, University 
of Liverpool, Liverpool, United Kingdom
Nicola Howarth □ School of Engineering and Physical Sciences, Heriot-Watt 
University, Riccarton, Edinburgh, United Kingdom
Richard Cosstick □ Department of Chemistry, University of Liverpool, Liverpool, 
United Kingdom
a The synthesis o f a modified thymidine (nucleoside /3-amino acid) monomer and preliminary 
investigations into the solid phase peptide synthesis o f PNA/DNA chimeras containing a neutral, 
intemucleoside amide linkage are described.
Keywords Peptide nucleic acid; chimera; foldamers; nucleoside beta-amino acid
INTRODUCTION
The majority of natural biological processes rely on macromolecules 
with defined tertiary structures, the most obvious examples being RNA and 
protein catalysis. The specificity of these macromolecules is derived from 
their ability to adopt compact folded architectures, which, in turn, are as­
semblies of secondary structure motifs, such as helices and sheets. U nnatu­
ral oligomers that display similar propensity to adopt conformers are term ed 
“foldamers”.[1] Even with the emergence of peptide nucleic acid (PNA),[2] 
there has only been limited exploration into combining the structural po­
tential of nucleosides (predictable nucleobase association) and the peptide 
bond. The synthesis of a novel nucleoside /1-amino acid has been completed. 
Derived from thymidine, the com pound contains a 5'-carboxylic acid moi­
ety and a 3'-amino function to enable the construction of peptide bonds 
by standard solid-phase peptide synthesis procedures. Investigation into the 
synthesis of an amide-backboned oligonucleotide/polypeptide hybrid is cur­
rently underway.
Address correspondence to Richard Threlfall, Department of Chemistry, University of Liverpool, 
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2
a) PPh3, DIAD, Anisic acid, DMF; b) PPh3, DIAD, DMF; c) LiN3, DMF 
125 °C; d) NaOMe, MeOH; e) Pd/C, H2 MeOH; f) FmocCI, K2C03l 
1,4-dioxane/H20; g) TEM PO, BAIB, MeCN/H20
SCHEME 1
RESULTS AND DISCUSSION
The synthesis of the target Fmoc-protected nucleoside /3-amino 
acid (mT, see Scheme 1) was achieved beginning with the 3'-azido-3'- 
deoxythymidine (AZT) synthesis of Czernecki et a lP K  Starting from thymi­
dine, two Mitsunobu style reactions perform ed in tandem allowed sequen­
tial, one-pot protection of 5'-OH with a PMB group whilst stereoselectively 
displacing 3'-OH by forming the anhydro com pound (1) using neighboring 
group participation from the heterocyclic base. Yields of the anhydro species 
were improved by more than 10% over that obtained at room temperature 
by cooling the reaction mixture to a constant 15°C in a water bath during 
exotherm ic DIAD additions. The anhydro species was then opened from 
the ct-face by Ng in DMF at 125°C. Little difference in yield was observed 
using either NaN3 or LiN3, both giving around 50% yield after purification. 
Attempts to improve the yield by the addition of a proton source (benzoic 
acid) to assist in the reprotonation of thymine N3 also made very little dif­
ference to the overall yield.
By far the simplest m ethod for reduction of the 3'-azide was catalytic hy­
drogenation over Pd /C  giving the 3'-amino com pound a 97% yield. Fmoc 
protection of the 3'-amine was afforded by treatm ent of (2) with FmocCI 
and K2C 0 3 in aqueous 1,4-dioxane. From many available, the m ethod cho­
sen for oxidation of the 5'-OH was using free radical TEMPO and hyperva- 
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a) 2 % DBU/DMAc; b) Fmoc-Lys-(Mtt)-OH, HBTU, DIPEA, DMAc; 
c) 2 % DBU/DMAc, Compound (3), HBTU, DIPEA, DMAc
SCHEME 2
solvent for this reaction (aqueous acetonitrile) the Fmoc-protected nucleo­
side is only sparingly soluble, leading to reaction times of greater than 24 
hours and low yields of around 45%.
It was believed that these neutral-backboned oligomers would not be 
readily soluble in aqueous media and that natural a-amino acids should be 
included in an attem pt to improve aqueous solubility. Therefore, it was de­
cided that lysine residues should be included at both C- and iV-terminals 
(see Scheme 2). Initial studies on oligomerisation of the Fmoc-protected nu­
cleoside /1-amino acid were based on the method of Gude et a/.[5] Loading 
o f Fmoc-Lys-(monomethyltrityl)-OH onto the solid support (Sieber amide 
resin) was determ ined by UV assay of dibenzofulvene at X =  294 and 304 
nm liberated during the deblocking step.
The technique was also extended to the first two couplings of mT to 
inspect the coupling efficiencies with the natural amino acid and with 
itself. This qualitative m ethod was sufficient to show that little differ­
ence was observed for the coupling of lysine to mT when using either 
Benzotriazole-l-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate 
(PyBOP) or 2-(lH-Benzotriazole-l-yl)-l,l,3,3-tetramethylaminium hexaflu­
orophosphate (HBTU) as the coupling reagent. However, NMP and DMF 
were particulary poor solvents. The mT to mT couplings were also solvent 
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com bination of HBTU with DMF but increased greatly with the addition of 
20% DMSO. The superior solvent/coupling reagent combination was found 
to be A^AUdimethylacetamide with HBTU.
CONCLUSIONS
The modified thymidine monomer, mT, has been synthesized success­
fully in reasonable yield from thymidine and the production of oligomers
via solid-phase peptide synthesis protocols is currently under investigation.
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Peptides of varying length (dimers to octamers) were prepared 
from nucleoside P-amino acids and conformational studies, 
based on NOE observations, show that the p-peptides form an 
unusual 8-helix.
U nnatural oligomers th a t have a  propensity to  adop t well-defined 
com pact conform ations have been term ed foldam ers1 and  possess 
the potential to  m im ic structural motifs found in complex 
biopolymers such as proteins and R N A . A num ber o f  exciting 
applications can be envisaged for foldam ers including peptidom i- 
metics,2 antimicrobial agents3 and com ponents in nanostructured 
materials.4 O f all the  unnatu ral oligomers under investigation, the 
folding preferences o f  P-peptides have been the m ost intensively 
studied. In particular, studies on  p-am ino acids derived from  
conformationally restrained systems such as cycloalkanes5'6 and 
sugars,7 show that they form  peptides tha t adopt strongly helical 
structures. Gellm an and  co-w orkers have shown th a t P-peptides 
derived from tra/w-2-am inocyclopentanecarboxylic acid5 (trans- 
AC PC. Fig. 1) a d o p t a  12-helix, whereas peptides prepared  from  
ira/w-2-aminocyclohexanecarboxylic acid6 (truns-ACHC), form  
a 14-helix.
Whilst inspiration for the construction o f  foldam ers has largely 
been drawn from  p ro te in  chemistry, nucleosides also possess a  
num ber o f  features th a t m ake them  attractive m onom ers for this 
purpose. The m ost no tab le  o f  w hich are well established m ethods 
fo r oligomer synthesis and  predictive associative properties o f  the 
nucleobases. The association o f  peptide helices th rough  base­
pairing provides a  potentially  pow erful m ethod for controlling the
assembly o f  com plex tertiary structures. A s p ro o f o f  principle, 
Bruckner et al. have dem onstrated  tha t helices containing P-hom o- 
alanine functionalised with nucleobases can associate th rough  base 
pairing.8 W e were struck by the fact th a t nucleosides can be readily 
converted to  P-am ino acids which are closely related to  G ellm an’s 
helix-forming trans-A C PC  m onom er and  now  report the synthesis 
o f  peptides derived from  the thym idine P-am ino acid 1 (Fig. 1) and 
their structural properties.
T he target m onom er9 3 (Scheme 1), was synthesised from  the 
previously rep o rted 10 fluorenylm ethoxycarbonyl (Fm oc)-protected 
am ino alcohol 2 by oxidation w ith [bis(acetoxy)iodo]benzene 
(BAIB) and 2,2,6,6-tetram ethypiperidinyloxy (T E M P O )11 in 
aqueous acetonitrile. A lthough the oxidation proceeds in relatively 
low yield (46%) the m ethod has the advantage tha t the Fm oc- 
protected am ino acid precipitates out o f  the reaction m ixture and 
is obtained pure after filtration and w ashing w ith diethyl ether.
The choice o f  resin fo r Fm oc solid-phase peptide synthesis 
(SPPS) was influenced by the sensitivity o f  the glycosidic bon d  to  
acid. W ith this in m ind, the hyperacid-labile Sieber am ide resin12 
was chosen, which, on  cleavage, produces peptides w ith a  prim ary 
am ide a t the carboxylate term inus. The peptide assembly used 
2-( 1 //-benzo triazo le-1 -yl)-1,1,3,3-tetram ethyluronium  hexafluoro- 
phosphate (H B T U ) in A'.A'-dimethylacetamide as the coupling 
agent an d  followed standard  Fm oc protocols.13 U sing this 
procedure, dim ers, tetram ers and octam ers, bo th  w ith and  w ithout 
the Fm oc group, were prepared (Scheme 1). Following cleavage 
from  the  support an d  w ashing w ith water, the oligomers gave 
clean N M R  spectra and  were also shown, by m ass spectrom etry, 






Fig. I tram-ACPC and thymidine (5-amino acid (1).
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Table I Temperature-dependent chemical shifts of NH protons of 6 
in (4-DMSO solution
Residue
number 25 X 30 X 35 X o o n 45 X
Average shift 
difference/ppb K 1
I 8.845 8.818 8.790 8.764 8.729 5.80
2 8.910 8.882 8.857 8.830 8.783 6.35
3 8.980 8.951 8.926 8.902 8.851 6.45
4 8.117 8.098 8.084 8.069 8.054 3.15
C onform ational features o f  the Fm oc-protected tetram er 6  and  
the  fully deprotected octam er 7, in ¿4-D M  SO an d  c/5-pyridine solu­
tion  respectively, have been determ ined using N M R  spectroscopy.
A complete 'H  resonance assignm ent has been achieved for 6 
th rough  the com bined use o f  D Q F-C O SY , T O C SY  and  N O ESY  
spectra (see ESI for num bering  and  N M R  assignm ent detailst). 
T he amide N H s are well resolved and  th rough  their chemical shifts 
in the 2D  spectra the rem aining assignm ents could be m ade. The 
N H  chemical shifts a re  w orthy  o f  note. T he N H  o f  residue 4 
(the Fm oc-protected am ino  term inus) is alm ost identical to  th a t 
observed for the Fm oc-protected  m onom er. This observation, 
together with the lowfield shift o f  the  rem aining secondary am ide 
p ro tons, is supportive o f  a  hydrogen bonding netw ork involving 
th e  three interresidue N H s .14 V ariable tem perature experim ents 
perform ed over the tem perature range 25 to  45 °C resulted in 
tem perature dependent chemical shift changes to  highfield o f  
approxim ately 6 ppb  K _1 for the N H s o f  residues 1 to  3, but only 
3 ppb  K _l for residue 4  (T able 1).
It is the convention to  assum e th a t small shift changes w ould 
arise for amide p ro to n s involved in intram olecular hydrogen 
bonds and large changes fo r solvent exposed N H s. However, 
fo r essentially linear systems, as here, if  hydrogen bonding is 
intram olecular then a  large tem perature coefficient w ould be 
observed.15 Thus these results are also consistent w ith hydrogen 
bonding  within the tetram er. T he possibility o f  a  hydrogen 
bonding  array is also suggested by the m odel, form ed th rough  
consideration o f a  series o f  N O E  connectivities identified in 
the  N O ESY  spectrum, an d  built using M acro-M odel.16 M ore 
specifically, through-space connections are observed between 
N H ( I) H3'(2), 3 H 6 -2 H 3 ', N H (3)-H 4 '(4). These, together w ith a 
num ber o f other interresidue N O E s and  intraresidue connections 
(see Fig. 2 and  E S It), have been utilised to  build a  m odel for the 
te tram er (Fig. 3). All o f  th e  N O E s observed are  consistent w ith this 
m odel. N M R  studies o f  4  had  revealed the  sugar puckers o f  the 
first an d  second rings to  be 60% and  50% south, respectively. 
Consequently, in the m odeling procedure sugar puckers were
Fig. 3 Model of the structure formed by tetramer 6 produced using 
Macro-Model and NMR constraints.1819 The dashed lines are provided to 
indicate hydrogen bonded NHs and carbonyls. The Fmoc group has been 
deleted for ease of viewing.
constrained to  50% south, w ith dihedral angles perm itted to  vary 
by ±  10°.
In Fig. 3 a  zig-zag arrangem ent o f  the deoxyribose rings is 
apparen t, leading to  the thym ine bases occupying opposite faces o f  
the extended chain. In  this conform ation  the N H  o f  residue 1 
com es close in  space to  the carbonyl attached  3 ' to  residue 2. 
Similarly the N H  o f  residue 2 com es close in space to  the carbonyl 
3 ' to  residue 3 and  finally the N H  o f  residue 3 is close in space to  
the carbonyl o f  the  Fm oc group. A n a to m  count between these 
groups reveals an  8-helix. W hilst 12- and  14-helices a re  m uch m ore 
com m on, a  num ber o f  examples o f  8-helix have appeared  in the 
literature.14 D oerksen et al. found  the 8-helix to  be energetically 
m ost favourable fo r their conform ationally-constrained oxanor- 
bom ene P-peptides. W hilst the current systems have m ore 
flexibility in the pentose ring com pared to  the oxanorbom ene 
systems, the helical arrangem ent observed here m ay be due to  
steric factors im posed by the thym ine nucleobase. In  this respect, it 
has been suggested th a t trans-\CPC m onom ers w ith relatively 
small substituents on  the  4  position (which is com parable to  the 
anom eric position o f  1) pertu rb  the 12-helix conform ation .17
Residue 1 2  3 4
Fig. 2 Diagram of peptide 6 presenting some of the NOE connections used in determining the model for 6 shown in Fig. 3.
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Similar studies have been perform ed for the deprotected 
octam er 7, in ¿/-pyrid ine solution, although  resonance assignm ent 
is n o t yet com plete.18 Residues 1 and  8 have been unam biguously 
identified and despite the change in solvent, these look rem arkably  
similar to  the first an d  last residues o f  the tetram er 6. A  series o f  
interresidue N H -H 3 7 H 4 ' N O E  connections have been observed, 
together with a  n u m b er o f  N H -N H , and  N H -H 6  (interresidue); 
the latter NOEs being m ore apparen t a t low tem perature (10 °C). 
These N O E connectivities bear similarities to  those observed for 
tetram er 6 and im ply a  similar helical arrangem ent fo r the octam er 
7, bu t more extensive resonance assignm ent is required for this to  
be confirmed. V ariable tem perature experiments over the range 20 
to  45 C have revealed chemical shift changes fo r the secondary 
am ide protons o f  betw een 8.3 and  9.4 ppb  K  1 to  highfield. In 
contrast, the average chemical shift change for the thym ine H 6 
pro tons was 3 ppb K '. These d a ta  a re  consistent w ith a  hydrogen 
bonded system in w hich there is little o r  no  base stacking (as 
suggested by Fig. 3). W ith  the aid  o f  the m odel derived fo r the 
tetram er 6 it is an tic ipated  th a t full assignm ent and  structure 
determ ination for the  octam er 7  will be forthcom ing. Sim ilar 
features are observed fo r 7 in D M SO  solution, however there is 
better resolution in the  H 6 chemical shifts for 7 in (¿¡-pyridine.
In conclusion, peptides derived from  a  thym idine [Tamino acid 
have been prepared an d  their conform ation  studied by N M R  
spectroscopy. Interestingly, the tetram er 6  form s an  8-helical 
conform ation, which differs considerably from  the 12-helix derived 
from  the related trans-A C PC . A n im portan t long term  aim  is to  
investigate association between helices derived from  adenine and  
thym ine and thus capable  o f  nucleobase-pairing. These systems 
w ould offer a  new structural m o tif which w ould have applications 
in the  assembly o f  innovative m acrom olecular architectures.
W e wish to th an k  the  E PSR C  and BBSRC for providing 
support for R T  an d  A D , respectively. W e also th an k  A. Mills 
(Liverpool) for m ass spectrom etry and C . K ilner (Leeds) for 
preparation o f Fig. 3.
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ABSTRACT
We have recently shown that peptides derived from 
nucleoside p-amino acids adopt an unusual 8-helical 
conformation in solution1. These P-peptide homo­
oligomers were constructed using Fmoc solid-phase 
peptide synthesis protocols (SPPS); however, we found 
these procedures to be somewhat limiting in terms of 
scale and lacking a quantitative method of monitoring 
reactions. Preliminary investigations into the use of 
fluorous dendrons as an alternative to SPPS have been 
conducted and show that coupling reactions with 
modified nucleoside (1) and fluorous dendrimer (2) are 
possible in the presence of a glycine linker. Significantly, 
success of the coupling reactions could be monitored by 
NMR without loss of materials or termination of the 
synthetic sequence and this promises much for the 
future of both oligonucleotide and polypeptide synthesis.
INTRODUCTION
In  m an y  re sp ec ts  th e  d ev e lo p m en t o f  o lig o n u c le o tid e  and 
p o ly p ep tid e  c h e m is try  h a s  fo llo w ed  a s im ila r  p a th , n o  m o re  
so  th an  w ith  th e  in tro d u c tio n  o f  so lid -p h a se  sy n th es is2'3. 
S o lid -p h ase  te c h n iq u e s  a ttem p t to  ta ck le  th e  p rob lem  faced  
b y  all ch em ists  w hen  p e rfo rm in g  re a c tio n s  in  so lu tio n : 
sep ara tio n  o f  p ro d u c ts  a n d  reag en ts . In  so lid -p h ase  
sy n th es is  a  su b stra te  is  a tta ch ed  to  a  su rface , fo r ex am p le  a 
c o n tro lle d  pore  g la s s  b ead  o r a c ro ss  lin k ed  p o ly s ty ren e  
re s in , an d  re a g e n ts  flooded  o v e r  th is  su rface  in  o rd e r to  
p e rfo rm  reac tio n s . S ep ara tio n  is th en  s im p ly  a  m a tte r  o f  
w ash in g  th e  sp en t rea g e n ts  fro m  th e  su rface  an d  o lig o m eric  
co m p o u n d s can be p ro d u ced  by  ite ra tio n  o f  th is  p rocess.
D u rin g  o p tim isa tio n  o f  so lid -p h a se  p ro ced u re s  en route 
to  o lig o m ers d e riv ed  from  m o d ified  th y m id in e  (1 , F ig . 1) 
th e  lim ita tio n s  o f  so lid -p h a se  sy n th e s is  in  te rm s o f  sca le  
a n d  ju d g in g  th e  su ccess  o f  co u p lin g  re a c tio n s  becam e very  
ap p aren t. In o rd e r to  p rev en t ag g re g a tio n  o f  th e  g ro w in g  
c h a in s  du rin g  S P P S  it w as n e c e ssa ry  to  lo ad  th e  re s in  a t a 
s ig n ifican tly  lo w er c o n cen tra tio n  th a n  lu ll c ap a c ity  a n d  th is  
h a s  obvious im p lic a tio n s  fo r la rg e -sca le  p ro d u c tio n . 
S eco n d ly , a lth o u g h  reac tio n  su ccess  o r fa ilu re  can  be 
assessed  q u a lita tiv e ly  b y  c o lo u rm e tric  m e th o d s4, th e se  a re  
n o t a lw ay s re lia b le  an d  th e re  a re  few  a lte rn a tiv e , 
q u an tita tiv e  a n a ly tic a l te ch n iq u es  av a ilab le  th a t can  be 
p e rfo rm e d  w ith o u t te rm in a tio n  o f  th e  sy n th es is . It is  c lea r 
th a t a  so lu tio n -p h ase  te c h n iq u e  w h ich  can  be ca rried  o u t on 
a m u ch  la rg er sca le  th an  so lid -p h a se  m e th o d s  bu t w ith
e q u iv a le n t p u rif ic a tio n  p e rfo rm a n c e  is d esirab le . T h e  
p o ss ib ility  o f  in c lu d in g  reac tio n  m o n ito r in g  in  an y  such  
p ro c e ss  w o u ld  a lso  be e x tre m e ly  a ttrac tiv e .
1
Fig. 1 Nucleoside P-amino acid derived from thymidine (Fmoc = 
9-fluorenylmethoxycarbonyl)
F lu o ro u s-p h a se  c h em is try  h a s  re c e n tly  a ttrac ted  m u ch  
a tten tio n  fo r its in te re s tin g  a p p lic a tio n s  in the  p u rific a tio n  
o f  o rg a n ic  co m p o u n d s5. F lu o ro u s  tec h n o lo g y  a llo w s 
c o m p o u n d s  a n d  in te rm ed ia te s  a p p e n d e d  w ith  p e rf lu o rin a te d  
ta g s  o r “ flu o ro u s  su p p o rts”  to  b e  p u rified  b y  s im p le  
ex trac tio n  w ith  f lu o ro u s so lv e n ts  w ith o u t th e  n e e d  for 
ch ro m a to g rap h y . It o ccu rred  to  u s  th a t o lig o m ers  co u ld  be 
sy n th es ised  b y  a  cy c le  o f  re a c tio n  fo llow ed  by ex tra c tio n  
a n d  a m a jo r ad v an ta g e  o f  th is  sys tem  w o u ld  be th e  ab ility  
to  ac c u ra te ly  m o n ito r  th e  su ccess  o f  in d iv id u a l c o u p lin g s  
b y  N M R  w ith o u t c lea v in g  the  o lig o m e r from  th e  support.
W e n o w  p re se n t th e  re s u lts  o f  in itia l te s tin g  o f  su ch  
flu o ro u s  te c h n iq u e s  fo r sy n th es is  o f  h o m o -o lig o m ers  
d e riv ed  fro m  n u c le o s id e  p -a m in o  ac id  (1 ) u s in g  a  f lu o ro u s 
su p p o rt (2 , d e s ig n a te d  F D -O  (FT)) in p lace  o f  a so lid -p h ase  
res in .
ORf
F _ F _ F _ F
ORf =
F F F F  
Fig. 2 Fluorous dendrimer (FD-O (H))
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RESULTS AND DISCUSSION
N u c leo sid e  [1-am ino a c id  (1 )  w as  sy n th es ised  ac c o rd in g  
to  th e  p u b lish ed  ro u te 1 a n d  th e  firs t step  in m im ic k in g  th e  
c y c le  o f  SPPS p re v io u s ly  a p p lie d  in  th e  p ro d u c tio n  o f  
n u c le o s id e  p -p ep tid e s  in v o lv ed  este rif ic a tio n  o f  th is  am in o  
a c id  w ith  flu o ro u s d e n d rim e r (2 )  in a  m ix tu re  o f  m isc ib le  
o rg a n ic  an d  flu o ro u s  so lv e n ts , su c h  a s  D M F /H F E -7 1 0 0 , 
u ti lis in g  a co u p lin g  re a g e n t su ch  a s  H B T U  o r N M T P 6.
U n fo rtu n a te ly , a f te r  sc reen in g  m a n y  p e rm u ta tio n s  o f  
tem p era tu re , c o u p lin g  re a g e n ts  a n d  so lv en ts  n o  su itab le  
reac tio n  co n d itio n s  c o u ld  be found . T h e  fa ilu re  o f  th e  
c o u p lin g  is th o u g h t to  h av e  been  d u e  to  ex ten s iv e  s tc ric  
in te rfe ren ce  from  b o th  n u c le o s id e  a n d  d e n d rim e r a lik e . In 
an  e ffo rt to  c irc u m v e n t th is  p ro b lem , an a lo g y  w as d raw n  
w ith  S P P S  p ro c e d u re s  in  w h ich  th e  am in o  a c id  is  n o t 
c o u p led  d ire c tly  w ith  th e  re s in , b u t to  a  linker.
It w as h y p o th e s ise d  th a t a  su ita b le  lin k e r w o u ld  be 
s te r ic a lly  u n d em a n d in g  in  o rd e r to  fac ilita te  in itia l reac tio n  
w ith  th e  d en d rim er. F ro m  p rev io u s  S P P S  s tu d ie s  (1 ) w as 
k n o w n  to  su c c e s s fu lly  fo rm  a m id e  b o n d s  w ith  th e  
x a n th en y l am in e  lin k e r  o f  S ieb e r a m id e  re s in . T h u s  
in c lu s io n  o f  a  m u ch  sm a lle r  am in o  a c id  such  a s  g ly c in e  to  
a c t a s  a lin k er w o u ld  d e c re a se  th e  s te ric  b a rr ie r en c o u n te re d  
b y  th e  n u c leo s id e  a m in o  ac id  w h ils t s im u lta n e o u s ly  
c h a n g in g  the  c o n n ec tio n  to  th e  d en d rim er from  es te r  to  
a m id e  and  im p ro v e  th e  p ro b a b ility  o f  su ccessfu l c o u p lin g .
FD-O(H)
FD-O' NHFmoc
Scheme 1 i) Fmoc-Gly-OH, 2,4,6-Collidine, NMTP, THF ii) 
FC-72, 2 % DBU/DMF iii) (1), 2,4,6-Collidine, HBTU, THF
C o u p lin g  o f  th e  d e n d rim e r w ith  F m o c-g ly c in e -O H  
p ro c e e d e d  sm o o th ly  in  u n d e r o n e  h o u r u s in g  5 eq u iv a le n ts  
o f  2 ,4 ,6 -c o llid in e  a n d  2 .4  e q u iv a le n ts  o f  N M T P  in  T H F  a t 
4 5 ° C  (scheme 1). T h e  re a c tio n  w o rk -u p  s im p ly  c o n s is te d  
o f  ad d itio n  o f  F C -7 2  (p e rflu o rin a te d  h e x a n e ), sep a ra tin g  
a n d  w ash in g  th e  f lu o ro u s  lay er w ith  ch lo ro fo rm  th en  w a te r  
a n d  ev ap o ra tin g  th e  F C -7 2  to  a ffo rd  c o u p led  p ro d u c t (3 ) in 
e x c e lle n t y ie ld  w ith  n o  c h ro m a to g ra p h y  req u ired .
A s  w ell as th e  sy n th es is  b e in g  p e rfo rm e d  in  so lu tio n  
w ith o u t th e  n eed  fo r lab o rio u s  p u rif ic a tio n  a n o th e r  a n d  
p o ss ib ly  m o re  s ig n if ic a n t a d v a n ta g e  o f  th is  f lu o ro u s 
p ro c e ss  w as th e n  v iv id ly  illu s tra ted . A  sam p le  o f  th e
re a c tio n  re s id u e  w as d isso lv ed  in  a  m ix tu re  o f  C D C l3/C 6F 6, 
an a ly se d  b y  N M R , th en  th e  so lv en ts  re m o v e d  o n ce  m o re  
a n d  th e  m a te ria l reco v e red . T h e  re s id u e  w as  su c c e ss fiilly  
c h a ra c te r ise d  a s  (3 ) b y  N M R  a n d  n o  lo ss o f  p ro d u c t o r 
te rm in a tio n  o f  th e  sy n th es is  w as n ecessa ry . L a te r  M A L D I- 
T O F  m ass  sp e c tro m e try  (M S ) c o n firm e d  th e  id e n tity  o f  (3 ).
R em o v a l o f  th e  F m o c  g ro u p  w as  p e rfo rm e d  in  a b ip h a s ic  
m ix  o f  F C -7 2  a n d  2 %  D B U /D M F  w ith  a s im ila r  e x tra c tiv e  
w o rk -u p . D ep ro te c tio n  w as  o b se rv ed  to  o ccu r in  a  few  
m in u te s ; u n fo rtu n a te ly  c o n s id e ra b le  c le a v a g e  o f  th e  g ly c in e  
fro m  th e  d e n d rim e r w as a lso  o b se rv ed . T h is  is  m o s t lik e ly  
d u e  to  fo rm a tio n  o f  an  o x a z o lo n e  d e riv a tiv e  b y  th e  im id a te  
o x y g en  g e n e ra te d  b y  d e p ro to n a tio n  o f  th e  F m o c  a m id e . T o  
su p p re ss  th is  s id e  re a c tio n  d ep ro tec tio n  sh o u ld  be 
p e rfo rm e d  w ith  a  w e a k e r b a se  such  as  p ip e r id in e , to  
p re v e n t a m id e  d e p ro to n a tio n . C o u p lin g  o f  th e  n u c le o s id e  p- 
a m in o  a c id  (1 ) to  th e  free  a m in e  o f  g ly c in e  w a s  a tte m p te d  
w ith  H B T U  in th e  p re se n c e  o f  ex cess  c o llid in e  in  T H F  a t 
a m b ie n t te m p e ra tu re . A fte r 24  h o u rs  an  e s tim a te d  3:1 ra tio  
o f  p ro d u c t to  s ta r tin g  m ate ria l w as e v id e n t b y  N M R  a n d  
w h ils t th is  re a c tio n  w as in co m p le te , it w as a v a s tly  
im p ro v e d  re s u lt  c o m p ared  to  c o u p lin g s  w ith o u t th e  g ly c in e  
lin k er.
CONCLUSION
A lth o u g h  th e  flu o ro u s  d e n d rim e r w as  re lu c ta n t to  re a c t 
w ith  b u lk y  n u c le o s id e  d e riv a tiv e  (1 ) th e  re a c tio n  w ith  a -  
g ly c in c  w as  sm o o th  a n d  h ig h  y ie ld in g , re q u ir in g  n o  
p u rif ic a tio n  o th e r an  e x trac tiv e  w o rk -u p . D cp ro tc c tio n  a n d  
fu r th e r reac tio n  o f  th e  g ly c in e  fu n c tio n a lise d  d e n d rim e r 
w ith  th e  n u c le o s id e  a m in o  a c id  w as a lso  ach ie v e d  to  a 
le sse r d e g re e  o f  su ccess ; h o w ev e r, in teg ra tio n  o f  N M R  
m o n ito r in g  in to  th e  p ro cess  c le a rly  d e m o n s tra te s  th a t 
f lu o ro u s-p h a se  c h e m is try  is  a  p o te n tia lly  p o w e rfu l 
a lte rn a tiv e  to  so lid -p h a se  o lig o m e r syn th esis .
W e w o u ld  lik e  to  th a n k  th e  D a iw a  A n g lo -Ja p a n e se  
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ABSTRACT
Peptides derived from a thymidine beta-amino acid 
have been prepared by solid-phase synthesis and their 
conformation investigated by NMR. Interestingly, NMR 
and modelling studies indicate that the tetramer and 
octamer form an unusual 8-helical conformation. 
Studies are currently underway to investigate the 
synthesis of peptides derived from the other 
deoxyribonucleosides with the intention of examining 
the association between helices capable of nucleobase- 
pairing.
RESULTS AND DISCUSSION
T he ta rg e t m o n o m er (2, Scheme 1), w as sy n th es ised  
fro m  th e  p rev io u sly  rep o rted 4 flu o ren y lm e th o x y ca rb o n y l 
(F m o c )-p ro te c te d  am in o  a lco h o l (1 ) by  o x id a tio n  w ith  bis- 
a c e to x y io d o b e n z e n e  (B A 1B ) and 2 ,2 ,6 ,6 -
te tra m e th y p ip e rid in y lo x y  (T E M P O ) in  aq u eo u s  ace to n itr ile . 
A lth o u g h  th e  o x id a tio n  p ro ceed s  in  re la tiv e ly  low  y ie ld  
(4 6 % ) the  m eth o d  is ad v an ta g eo u s  in th a t th e  F m oc- 
p ro tec ted  am in o  ac id  p re c ip ita te s  o u t o f  reac tio n  m ix tu re  
and  is o b ta in ed  pu re  a fte r filtra tio n  and w ash in g  w ith  
d ie th y le th e r.
INTRODUCTION
There has b e e n  c o n s id e ra b le  in te re s t in  n u c le ic  acid  
an a lo g u es in w h ic h  th e  p h o sp h o d ie s te r  b ack b o n e  is 
rep laced  by an a lte rn a tiv e  iso ste ric  back b o n e . T hese  
o lig o m ers a re  o ften  d es ig n e d  to  b ind  s tro n g ly  to 
com plem en tary  R N A  se q u e n c e s  and  th u s h av e  ap p lica tio n  
as an tisense or R N A i ag en ts . In  g en era l, th e  in h eren t 
confo rm ational p ro p e r tie s  o f  s in g le  s tran d ed  n u cle ic  acid  
an a lo g u es has n o t b e e n  an  a re a  o f  in terest. H o w ev er, the 
w o rk  o f  G ellm an , h a s  d raw n  a tten tio n  to  the  p o ten tia l u ses 
o f  unnatural o lig o m e rs  (te rm e d  fo ld am ers) th a t h a v e  a 
p ropensity  to a d o p t w e ll-d e fin e d  co m p ac t co n fo rm a tio n s , 
p a rticu la rly  h e lice s  a n d  can  th u s  m im ic  s tru c tu ra l m otifs 
fo u n d  in com plex  b io p o ly m e rs  su ch  as p ro te in s an d  R N A .1 
W h ils t in sp ira tion  fo r th e  co n stru c tio n  o f  fo ld am ers has 
largely  been d raw n  fro m  p ro te in  ch em istry , n u c leo s id es  
a lso  possess a n u m b e r fe a tu re s  w h ich  m ak e  them  a ttrac tiv e  
m o n o m ers for th is  p u rp o se . T h e  m o s t n o tab le  o f  w h ich  are 
w ell estab lished  m e th o d s  fo r o lig o m er sy n th es is  and 
p red ic tiv e  asso c ia tiv e  p ro p e rtie s  o f  the n u c leo b ases .
W e w ere  s tru c k  b y  th e  fa c t th a t n u c leo s id es  can  be 
read ily  converted  to  P -am in o  ac id s w h ich  are  c lose ly  
re la ted  to  G e llm a n ’s h e lix -fo rm in g  trans-2- 
a m in o cy c lo p en tan eca rb o x y lic  ac id  m o n o m er2 and  n ow  
rep o rt the  syn thesis o f  p ep tid e s  d e riv ed  from  th e  th y m id in e  
b e ta -am in o  acid  (Scheme 1) an d  th e ir stru c tu ra l p ro p e rtie s .3 
T h e  ana lo g o u s am in o  ac id  d e riv ed  fro m  2 ’- 








R = Fmoc or H
Schem e 1. Synthesis of oligomers derived from the thymidine 
beta-amino acid. T = thymin-l-yl; SPPS = solid-phase peptide 
synthesis.
C h o ice  o f  re s in  fo r F m oc so lid -p h ase  p ep tid e  sy n th es is  
(S P P S ) w as  in flu en ced  by  th e  sen s itiv ity  o f  th e  g ly co s id ic  
b o n d  to  acid . W ith  th is  in m in d , th e  h y p e r ac id -lab ile  S ieb er 
am id e  res in  w as  ch o sen  w h ich  on c lea v ag e , p ro d u ces  
p ep tid e s  w ith  a  p rim ary  a m id e  a t the  ca rb o x y la te  te rm in u s. 
T h e  p ep tid e  a ssem b ly  u sed  H B T U  in N,N- 
d im e th y la c e ta m id e  as th e  c o u p lin g  ag e n t and fo llo w ed  
s tan d ard  F m o c  p ro to co ls . U sin g  th is  p ro ced u re  d im ers, 
te tram ers  and  o c tam ers , b o th  w ith  and w ith o u t th e  F m oc
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g ro u p , w ere p re p a re d  (Scheme 1). In all c a se s  th e  
o lig o m e rs  w ere  su ff ic ie n tly  p u re  fo r a n a ly s is  fo llo w in g  
c le a v a g e  from  the  s u p p o r t an d  w ash in g  w ith  w a te r.
S truc tu ra l N M R  s tu d ie s  w e re  p erfo rm ed  o n  b o th  the  
F m o c-p ro tec ted  te tra m e r  an d  th e  d e p ro tec ted  o c ta m e r. 
D e ta iled  N M R  s tu d ie s  o n  th e  te tra m e r e s tab lish ed  a  se r ie s  
o f  n O e  c o n ec tiv itie s  w h ic h  w ere  u tilized  to  b u ild  a  m o d e l 
u s in g  M acro -M o d e l. T h e  m o d e l p ro d u ced  w as c o n s is te n t 
w ith  an 8 -m em b ered  r in g  b e tw e e n  th e  b a c k b o n e  am id e  
g ro u p s  co rre sp o n d in g  th e re fo re  to  an  “ 8 -h e lix ” . T h is  h e lic a l 
a rran g em en t p lace s  th e  th y m in e  b ase s  on  th e  o u ts id e  o f  th e  
h e lix  w here  th e y  c o u ld  p o ten tia lly  H -b o n d  to  a  
co m p lem en ta ry  a d e n in e  b ase . W ith  th is  in m in d , w e  h av e  
th e re fo re  em b ark ed  on  th e  sy n th e s is  o f  the  c o rre sp o n d in g  
ad en in e -d e riv ed  o lig o m e rs  in o rd e r to  e x p lo re  th e  
p o ss ib ility  o f  he lix  a s s o c ia tio n  d riv en  by b ase  p a ir in g .
T h e  syn thesis o f  th e  2 ’-d eo x y a d e n o s in e  m o n o m e r (6 ) 
s ta r ts  from  the  p re v io u s ly  rep o rted  a z id o n u c le o s id e 3 (3 , 
Scheme 2) and u tiliz e s  b e n z o y l p ro tec tio n  o f  th e  ad e n in e  
b ase . In th is case , th e  m o s t e ff ic ie n t red u c tio n  o f  the  az id e  
w as  ob ta ined  u s in g  h y d ro g e n  su lfid e . C u rren t s tu d ie s  a re  
u n d e rw ay  on th e  so lid -p h a se  sy n th e s is  o f  p e p tid e s  d e riv ed  
fro m  aden ine  m o n o m e r (6 ).
a sso c ia tio n  b e tw een  h e lic e s  cap ab le  o f  n u c le o b a se -p a ir in g , 
su ch  sy s tem s  w o u ld  o ffe r  a  n ew  m o tif  in th e  search  fo r 
in n o v a tiv e  m a c ro m o le c u la r  a rc h ite c tu re s
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Schem e 2, Synthesis o f  2 ’-deoxyadenosine-derived beta-amino 
acid.
CONCLUSION
In  conclusion , p e p tid e s  d e riv e d  fro m  a th y m id in e  b e ta - 
a m in o  acid  h av e  b e e n  p re p a re d  and th e ir co n fo rm a tio n  
s tu d ie d  b y  N M R . In te re s tin g ly , th e  te tram er fo rm s an  8- 
h e lix , w hich  d iffe rs  c o n s id e ra b ly  from  the  12-helix  d e riv ed  
fro m  th e  rela ted  rra /w -2 -a m in o c y c lo p e n ta n e c a rb o x y lic  acid . 
S tu d ie s  are  c u rren tly  u n d e rw a y  on th e  sy n th es is  o f  the  
co m p lem en ta ry  a d e n in e  p e p tid e s  in o rd e r to  in v es tig a te
